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Abstract 
 
Development requires the strict coordination of signalling pathways driving proliferation, 
differentiation and migration. Adaptor proteins play an important role in the regulation of 
specific signalling pathways by linking activated cell-surface receptors to their 
downstream intracellular targets and mediating crosstalk mechanisms between pathways. 
ShcD/RaLP, the latest identified member of the Shc family of adaptor proteins showed a 
unique expression pattern from the other members of the family. It is expressed early 
during embryogenesis in the pluripotent epiblast and is re-expressed in the developing 
central and peripheral nervous system and its expression is confined to the brain in the 
adult. In the pathological context, RaLP is expressed in melanomas and its expression level 
correlates with disease progression. The physiological role of this protein is still largely 
uncharacterised. The aim of this PhD project was to characterise the function of RaLP and 
to understand how this family of adaptor proteins have evolved to modulate distinct signal 
transduction within different cell types. This could also provide insight on how its 
deregulation could contribute to pathogenesis. 
RaLP knockout (KO) and heterozygote (HT) embryonic stem cells (ESCs) were used as 
the in vitro model system to dissect the role and signalling pathway of RaLP in 
development. We found that RaLP expression was recapitulated in vitro as in vivo as it was 
tightly regulated during the formation of the epiblast in several differentiation programs 
and then re-expressed when neuronal commitment initiated. Using the recent protocol that 
allows the transition of pluripotent ESCs to another pluripotent stem cell type, epiblast 
stem cells (EpiSCs), we specifically investigated the role of RaLP in the establishment of 
this cell identity. We found that the genetic deletion of RaLP resulted in an impairment of 
the establishment and maintenance of EpiSCs due to defective proliferation capacity upon 
differentiation. Furthermore, we have also described for the first time, the emergence of 
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Cdx2 expressing cells during ESC commitment to EpiSC fate and we observed that the 
absence of RaLP results in an enrichment of this population and enhanced levels of 
MAPK/Erk1/2 activation. Our data suggests that RaLP plays an important role in the 
switch of key pathway/s involved in determining EpiSC identity and that the absence of 
RaLP perturbs the commitment process. 
RaLP is also implicated in the differentiation of neural stem cells to neuronal fate. As 
RaLP is highly expressed in the brain, we sought to understand whether it plays a role in 
this commitment process. We found that the RaLP KO NSCs showed severe defects in 
neuronal formation and we are currently analysing our RaLP KO mouse model to obtain a 
further understanding of the physiological role of RaLP. 
In summary, our studies showed that RaLP is involved in EpiSC formation and 
maintenance as well as neurogenesis, and this dual role is unique for this member of the 
Shc family, providing an interesting insight into the mechanisms that the cell has evolved 
to regulate signalling pathways through adaptor proteins in a cell specific manner.
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 1 
Introduction 
 
1. Signalling through adaptor proteins 
 
Cells are continuously subjected to multiple stimuli from both external and internal 
environments. They must integrate a wide range of input and generate an appropriate 
response that can vary from proliferation to cell-cycle arrest and differentiation. During 
evolution, several mechanisms that confer specificity, timing and the directionality of 
signal transduction as well as the cross-talk between them have developed, and the class of 
adaptor or scaffolding proteins represents one of them. Adaptor proteins operate 
downstream to many receptors of the cell surface and in response to their activation, 
couple the receptors to their intracellular targets, amplify and propagate the signal [1]. This 
mechanism allows the organisation of the plethora of protein kinases and protein 
phosphatases that have relatively broad substrate specificity into specific signalling 
pathways in a controlled and efficient manner. Therefore adaptor proteins through their 
selective protein-protein interactions play a crucial role in organising the processes within 
the cell in a spatial and temporal manner. 
The identification and emergence of the class of adaptor proteins closely followed the first 
studies on protein structures by Michael G. Rossman that identified the presence of 
structural domains and associated these domains to the protein function [2]. This study 
gave way to the idea that protein domains could be defined based on the comparison with 
homologous sequences in other proteins, their structure, their spatial separation within the 
protein, their function and their active center. This idea then was succeeded by Pawson and 
colleagues who performed bioinformatic screening for domains present within a protein 
through amino acid sequence comparison. In this way, one of the now most characterised 
protein-protein interaction domain, the src-homology 2 (SH2) domain, was identified 
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within the amino terminus of the Src non-receptor tyrosine kinase [3,4]. The presence of 
this domain was then characterised in many other proteins and not long afterward, a large 
number of other types of conserved non-catalytic modules was identified, such as the src-
homology 3 (SH3) domain [1], pleckstrin homology (PH) domain [5] and phosphotyrosine 
binding domain (PTB) [6], developing the idea of common protein binding modules used 
in different combinations within signalling transducers. It was found that the combination, 
arrangement and number of these domains contained within the protein determine its 
specific biological function. Biochemical analysis of different types of adaptor proteins 
containing these protein binding modules demonstrated that these domains are important 
for their function and evidenced the crucial role of this class of proteins in signal 
transduction. 
The modular interaction domains that constitute adaptor proteins define their function by 
selectively recognising and binding to specific regions of their target proteins, thereby 
mediating the formation of signalling complexes. The formation of these multiprotein 
complexes plays an important role in regulating the transduction of specific pathways in 
two manners: (i) increasing the efficiency by bringing in proximity the components of a 
signalling pathway or (ii) disrupting or inhibiting a pathway by sequestering activation 
elements so that they cannot propagate the signal. Furthermore, adaptor proteins are not 
simply coupling devices that bring together the components of signalling pathways. This 
system is highly dynamic, as many of the regions that are recognised by the modules 
contain amino acids that are subjected to a diverse set of post-translational modifications 
(PTMs). Currently the list of protein modifications has risen to well over 200, such as 
phosphorylation, ubiquitination, acetylation and methylation. These PTMs reflect the 
cellular state, as the cell responds to its environment by activating and silencing specific 
pathways by placing reversible covalent modification on specific residues or by modifying 
chemical groups on existing molecules. Therefore, as the adaptor proteins can recognise 
Introduction 
 3 
and mediate signalling pathways according to the PTM of effector proteins, the current 
view is that the cell uses modular protein-interaction domains as a device to decode the 
state of its protein and lipid modifications, thereby coupling PTMs to cellular organization 
[7]. 
 
2. The Shc family of adaptor proteins 
 
2.1. Gene ontology 
The Shc (Src homologue and collagen homologue) family of adaptor proteins is a crucial 
linker of receptors such as the tyrosine kinase receptors, cytokine receptors, G-protein 
coupled receptors and integrins, to their downstream effectors. The Shc family members 
are involved in several important cellular processes, such as the regulation of proliferation, 
survival and differentiation. ShcA (formally Shc) was the first member of the family to be 
identified, and was discovered in 1992 by a low-stringency hybridisation to human cDNA 
libraries using an SH2-coding sequence as a probe [8]. The transcript that was isolated 
possessed two in-frame ATGs and encoded two polypeptides: the p52Shc and p46Shc [8]. 
Then a few years later, a third isoform was characterised, the p66Shc [9]. Subsequently, 
two other members of the family, ShcB (Sli/SCK) and ShcC (Rai/N-Shc) were identified 
[10] and in silico reconstruction of the genomic organization of the Shc locus across 
species showed that despite considerable differences in length, they possessed an almost 
identical exonic organization for the human, the mouse, the Fugu rupripes and the single 
Shc in Drosophila melanogaster and Caenorhabiditis elegans [11]. This suggested the 
existence of a common ancestor and that the Shc gene expanded during evolution between 
insects and mammals. Furthermore, it suggests for a conserved role for the Shc proteins 
across species. Recently, a fourth member of the family the ShcD/RaLP (for Rai Like 
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Protein) was identified by our laboratory using the TBLASSTn analysis of the human and 
mouse genome with ShcA, ShcB and ShcC [12]. 
A feature of this family of adaptors, is the encoding of several isoforms for each member 
due to alternative intiation codon usage and splicing patterns. As mentioned earlier, the 
Shc gene encodes three isoforms, two proteins of 46 and 52 kDa that are translated from 
two different intiation sites [8], while the third isoform of 66 kDa is a spliced variant [13] 
resulting in an extended region at the amino-terminal portion of the protein. There are two 
ShcB isoforms, 52 kDa and 47 kDa, as well as two ShcC isoforms of 52 kDa and 64 kDa. 
These isoforms are encoded by the same transcript for each gene with alternative usage of 
in-frame ATGs [14]. 
 
2.2. Biochemical characteristics 
The Shc proteins identified in mammals all share a conserved, modular organisation 
(Figure 1) [10]. They possess two independent protein binding domains: the PTB at the 
amino-terminal and the carboxy-terminal SH2 domain. The PTB domain was first 
described in Shc and it binds to specific pTyr-containing motifs on activated receptor 
tyrosine kinases [6]. The PTB based binding to its target is influenced by residues N-
terminal to the pTyr and the consensus sequence on its target proteins recognised by this 
domain is Asn-Pro-X-Tyr motif (X is any amino acid) [15]. However, recent studies have 
shown that the majority of PTB domains can also recognise non-phosphorylated peptide 
ligands or phosphoinositides [16], suggesting also the possibility that the proteins can 
anchor to the membrane through this domain. The SH2 domain represents one of the 
largest classes of pTyr-recognition domains and in contrast to the PTB, its binding 
requirements are less stringent. It recognises short phospho-peptide motifs composed of 
pTyr followed by three to five carboxy-terminal residues [17]. These two domains are 
linked by a central stretch of amino acids that is glycine and proline rich, the Collagen 
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homology 1 (CH1) region that contains important tyrosine consensus sequences that are 
phosphorylated upon its engagement by an activated receptor. Sequence alignment 
revealed the conservation of the tyrosine residues 239 and 240 also in the Drosophila, 
suggesting a crucial and conserved role for the CH1 domain in signalling [18]. These 
phosphorylated tyrosine residues on Shc then in turn become target for downstream 
signalling molecules that bind and propagates the signal, such the Growth factor receptor 
bound protein 2 (Grb2) adaptor through the binding to these residues by its SH2 region. 
The CH1 region also contains an adaptin-binding motif, which has been shown to interact 
with adaptins, proteins involved in the formation of clathrin-coated pits [19]. An additional 
stretch of amino acids similar to the CH1, the Collagen homology 2 (CH2), is positioned in 
the amino-terminal portion of the protein. The long isoforms of the ShcA, ShcB, ShcC and 
RaLP contain the CH2 and this region can mediate interaction with proteins containing 
SH3 domains as well as serving as a substrate for serine kinases, as it contains important 
regulatory serine residues. The CH2-PTB-CH1-SH2 modularity together with the sequence 
of these domains, is a unique feature of this protein family [11]. 
 
 
Figure 1. The Shc family members and their modular organisation. Shc proteins contain an SH2 protein 
binding domain at their C-terminus, a central proline and glycine rich region CH1 and the PTB domain at the 
N-terminus. The CH1 region contains three conserved tyrosine residues that are phosphorylated upon their 
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recruitment to signalling pathways (indicated as yellow dots). The longer isoforms contain an extra CH2 
region at their N-terminus. 
 
2.3. Expression pattern of the Shc members 
The Shc family members have distinct expression patterns, reflecting their specific 
functions. The p52ShcA and p46ShcA isoforms are expressed at the same levels, 
ubiquitously during development and also in the adult, where it is expressed in the majority 
of the tissues except for the brain where its mRNA remains present only in the proliferative 
areas of the ventricular zone, the region of adult neurogenesis [8,20]. The expression of the 
third isoform on the other hand, p66ShcA, is restricted to certain tissues and cell lines, 
being mainly found in epithelial cells, in most haematopoietic cell lines and in peripheral 
blood lymphocytes [8]. 
ShcB is expressed throughout the developing embryo at the level of the developing central 
nervous system (CNS) and the peripheral ganglia such as the dorsal root ganglia and 
superior cervical ganglion [21]. ShcC on the other hand, is expressed at very low levels 
during development and is then strongly upregulated within the CNS around the time of 
birth [21]. And in the adult mouse, unlike ShcA, both ShcB and ShcC expression become 
confined to the nervous system in post-mitotic and mature neurons [20,21]. Analysis of 
ShcA and ShcC in the brain revealed that there is a transition of the levels of these two 
members during the proliferation and differentiation of neural stem cells 
(NSCs)/neuroblasts to neurons. As the NSCs cease to proliferate and terminally 
differentiate to post-mitotic neurons, ShcA is downregulated and is replaced by ShcC. This 
suggests that one possible mechanism that the cells have adopted to regulate pathways, is 
the differential expression of proteins so that their variation in the availability influences 
the response of the cell to the same external stimuli [20]. 
Detailed characterisation of RaLP expression was part of this study and will be discussed 
in the results (see results section 1). It is expressed in the epiblast of the preimplantation 
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and peri-implantation embryo, in the developing CNS and peripheral nervous sytem, the 
adult brain and in the skeletal muscle [22]. 
 
2.4. Signalling via the Shc proteins 
Despite their high homology in structure, the different family members are implicated in 
distinct signalling pathways that lead to a variety of cellular events. The most characterised 
role of p52 and p46 isoforms of ShcA is its implication in mitogenic and motogenic 
signalling through the Ras activation downstream to several tyrosine as well as non 
tyrosine kinase receptors. ShcA phosphorylation can be induced by a plethora of stimuli, 
such as epidermal growth factor (EGF) [8] platelet-derived growth factor (PDGF) [23], 
hepatocyte growth factor (HGF) [24], insulin growth factor (IGF) [25], fibroblast growth 
factor (FGF) [26], nerve growth factor (NGF) [27], transforming growth factor β (TGF-β) 
[28], as well as interleukins [29] and integrins [30]. ShcA is phosphorylated on its tyrosine 
residues of the CH1 region by the activated tyrosine kinase receptor and this leads to the 
formation of a complex with Grb2, which in turn through its SH3 domain binds to the Ras 
guanine nucleotide exchange factor, Sos1. ShcA is still associated to the receptor and so 
the Shc-Grb2-Sos complex is localised to the membrane in this way, ultimately leading to 
mitogen activated protein kinase (MAPK) and phosphatidyl inositol 3’ kinase (PI3K) 
activation (Figure 2). A similar mechanism of MAPK activation was seen upon the 
activation of several other types of receptors such as integrins and G-protein coupled 
receptor. Interestingly, the p66ShcA isoform is implicated in a completely different 
pathway. It mediates stress induced response of the cell through the regulation of reactive 
oxygen species metabolism and apoptosis as well as exerting a negative effect on MAPK 
activation [13]. This particular role of the p66 isoform is mediated through its amino-
terminal CH2 region in which the serine residue is phosphorylated upon environmental 
stresses such as ultraviolet light or reactive oxygen species (ROS) [9]. In this way, 
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p66ShcA mediates p53 dependent apoptotic responses through its production of ROS, the 
regulation of mitochondrial permeability and hence Cytochrome C release [31,32]. 
ShcC isoforms are specific substrates of the c-RET receptor, a tyrosine kinase receptor for 
the glial cell line derived neurotrophic factor family, as well as the EGF receptor and Trk 
receptors, in a similar fashion to ShcA [14].  They are implicated in the signalling via the 
PI3K activation that plays an important role in sustaining neuronal cell survival [33]. 
Notably, ShcC can be activated and propagate the signal to PI3K directly after hypoxia or 
oxidation insults, even in the absence of growth factors [34], suggesting an interesting 
mechanism of the recruitment of these adaptors not only upon growth factor stimulation. 
The signalling pathway in which ShcB is implicated in is still unknown, although to some 
extent, genetic studies that will be discussed further on, seem to suggest they have 
overlapping functions. 
The signalling pathway/s in which RaLP is implicated are still largely unknown. So far, it 
was seen to associate to the muscle-specific kinase (MuSK) receptor at the neuromuscular 
junction, primarily through its PTB domain [22].  This interaction could contribute to the 
early Src-dependent phase of agrin-induced MuSK signalling which is important for the 
regulation of the stability of Acetylecholine receptor (AChR) clusters. The biological 
relevance of this finding remains to be understood. In the human system, RaLP was 
reported to be expressed in melanocytes and it mediates MAPK through association with 
Grb2 [12]. 
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Figure 2. Signalling pathways mediated by growth factor receptor tyrosine kinase and Shc adaptor 
proteins. Upon growth factor binding to the receptor, the receptor dimerizes and undergoes 
autophosphorylation on its intracellular portion. The Shc family of adaptor proteins are recruited to the now 
phosphorylated tyrosine residues on the receptor, which are recognised by its protein binding domain. This 
results in the activation of various downstream effectors such as MAPK/Erk1/2 and PI3K/Akt signalling 
which then leads to the regulation of the expression of its target genes, leading to different outcomes such as 
the promotion of survival and cytoskeleton regulation. Adapted from [35]. 
 
One of the most interesting aspects of the Shc adaptor family is its versatility in signalling. 
Despite their similarity in structure, they are involved in a broad range of signalling 
pathways and furthermore, they are tyrosine phosphorylated and recruited upon the 
activation of many types of receptors and other stimuli. In fact, one of the central issues 
that surround Shc function that remains unsolved is why Shc is recruited upon in so many 
signalling receptor systems and how the members have evolved to mediate distinct 
functions. 
 
2.5. The Shc knockout mouse models 
The important role of Shc in vivo has been demonstrated a few years ago by Lai and 
Pawson by the generation of a knockout mouse model for the ShcA gene [36]. All three 
isoforms, p66, p52 and p46 were ablated by gene targeting of exons two and three, which 
encode for the entire PTB domain. The homozygous mutants died at embryonic day 11.5 
(E11.5) due to severe defects in heart development and the formation of mature blood 
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vessels. The depletion of ShcA resulted impaired sensitivity to growth factors and a loss of 
MAPK activation. Furthermore, ShcA mutant embryos exhibited adhesion defects in the 
heart, yolk sac and major blood vessels due to aberrant focal contact organisation and actin 
stress fibres, due to the additional role of Shc in cytoskeleton organisation, as they are 
substrates of the focal adhesion kinase. In contrast, the single knockout for the p66ShcA 
isoform generated mice with higher tolerance to oxidative stress that has a longer lifespan 
[13]. This was found to be due to the decreased accumulation of oxidative damage to 
mitochondrial DNA, which is one of the critical events during the ageing process, in 
tissues of p66ShcA null mice. 
 The genetic deletion of ShcB, ShcC or both genes results in mice that are viable and 
fertile. ShcC null mice appear to show no gross anatomical abnormalities, while the ShcB 
knockout (KO) mice as well as the double mutant ShcB/ShcC null mice showed a partial 
loss of peptidergic and non-peptidergic nociceptive sensory neurons that did not influence 
their physiological functions [21]. Furthermore, the double mutants demonstrated a 
reduction in neuronal number within the sympathetic nervous system, while the single 
mutants did not. However, the single mutants as well as the double mutants did not show 
gross alterations in auditory, olfactory or visual functions, despite their high expression in 
the brain and sensory ganglia [21]. Taken together, these studies suggested that ShcB plays 
a role in the survival of sensory neurons and acts together with ShcC in supporting 
sympathetic development and survival mainly through the TrkA receptor signalling and 
also through some other receptors, which have not yet been identifed.  
The RaLP KO mouse has been generated by our laboratory in collaboration with 
Genoway. The characterisation of the mutant mouse is currently ongoing and will be partly 
discussed in the results in this thesis (see results section 5). 
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2.6.  The fourth Shc member, RaLP, what is known so far 
The characterisation of the fourth member of the Shc family of adaptor proteins, 
ShcD/RaLP is still in its infancy. It has been identified only a few years ago and there is 
very little information on its biological function as well as the signalling pathway it is 
regulating. The mouse RaLP gene is located on the chromosome 2F1 and the longest open 
reading frame of the homology-based reconstructed cDNA predicts a protein of 69 kDa. 
Several shorter isoforms have been predicted for RaLP, due to multiple potential initiator 
methionine residues present in the region encoding for the CH2 as well as due to 
alternative splicing. These isoforms are predicted to have molecular weights of 38 kDa and 
24 kDa. 
The comparison of the amino acid sequences of mammalian Shc members evidenced the 
highest similarity between RaLP and ShcA [22]. The highest homology between RaLP and 
the other members was seen in regions of the PTB and SH2, but with more divergence in 
the CH1 and CH2 regions. The RaLP protein possesses several biochemical characteristics 
that render it unique from the other family members. The CH2 region is extended in RaLP 
and it contains several unique proline-rich motifs that could be recognised by proteins 
containing SH3 domains. It also possesses a non-conventional Shc PTB domain that 
contains an unusual histidine residue at the 5’ position relative to the Tyr, not present in the 
other family members. The carboxy-terminal sequence also differs from the corresponding 
sequences of the other members and the peptide of this region was used to raise antibodies 
against RaLP in collaboration with Giuseppe Ossolengo of the Biochemistry Unit at the 
IFOM-IEO campus (for detailed description, see materials and methods section 2.1). RaLP 
also has specific characteristics in the CH1 region: (i) the absence of the adaptin-binding 
motif which is present in all the other members and, (ii) an additional tyrosine residue that 
can also mediate binding to Grb2, resulting in three Grb2 binding sites compared to two 
found in the other members. Although the part of the expression pattern of RaLP overlaps 
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with that of ShcB and ShcC, its unique structural characteristics together with its specific 
expression in the early embryo, suggests a non-redundant and specific role of this protein 
and merits further investigation. 
Deregulated levels of RaLP have been shown to be implicated in tumourigenesis. In 
particular, it is highly expressed in aggressive and metastatic human melanomas. [12]. 
RaLP is a substrate of IGF-1 and EGF receptors and its overexpression in melanoma cell 
lines resulted in the increase of Ras-MAPK signalling which led to the induction of cell 
migration. On the other hand, RaLP silencing did not affect MAPK signalling, suggesting 
that RaLP may be involved in both Ras-dependent and independent pathways. 
The characterisation of this family member would provide further insight into how this 
family of adaptor proteins have evolved to modulate distinct signal transduction within 
different cell types and would provide important information on how adaptor proteins play 
an important role in the fine-tuning and regulation of different signalling pathways. 
Furthermore, understanding the physiological function of this protein might shed some 
light in understanding how deregulated levels of the protein can be involved in disease. 
 
3. Early embryonic development and pluripotent lineages 
 
As will be discussed in more detail in the results, the characterisation of RaLP expression 
in the mouse, evidenced its bi-phasic expression during development: its expression in the 
epiblast of the early embryo, the developing central and peripheral nervous sytem, and the 
adult brain (see results section 1). This led to the development of the project to understand 
what role RaLP plays during embryogenesis and which signalling pathways are regulated 
by it during these two time-windows. Both these aspects could be addressed by using 
mouse embryonic stem cells as they represent the ideal model to study pluripotency and 
differentiation in vitro, in parallel with the characterisation of our RaLP KO mouse model. 
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3.1. ESCs as a tool to study development in vitro 
Ever since the isolation and the characterisation of mouse embryonic stem cells (ESCs) in 
1981 by Evans, Kaufman and Martin [37,38], these cells have represented both an essential 
tool to address developmental questions but also an entity that has intrigued researchers 
since decades because of their remarkable properties. The discovery of ESCs was preceded 
in the 70’s by the isolation of a similar pluripotent cell type that was first isolated from 
teratocarcinomas from the mouse testis, the embryonic carcinoma cells (ECs). Teratomas 
are tumours that contain in a disorganised manner, a mixture of differentiated cell 
populations that derive from the three germ layers. They were seen to arise spontaneously 
in mice of the 129 strain and the ECs isolated from these tumours showed clonal ability, 
pluripotency and when reintroduced into a blastocyst they could sometimes contribute to 
the developing fetus [39], suggesting an identity similar to that of early embryonic 
lineages. ECs were derived and maintained efficiently in vitro by the co-culture with 
fibroblasts [40] and because they recapitulated many features of normal development, they 
provided the first system to study embryogenesis in vitro. The unique characteristics of 
these cells then led to the idea of the possibility to isolate cells directly from the 
preimplantation embryo and this proved possible, generating cells that are now known as 
ESCs. 
What makes ESCs so remarkable and now a powerful instrument that is routinely used to 
generate genetically modified mouse models, are two main characteristics: their 
pluripotency, in other words, their ability to differentiate into all cell types deriving from 
the germ layers and their self-renewal capacities. Their pluripotency confers them the 
ability to contribute to all the tissues of the adult mouse including the germline, when 
introduced into host blastocysts and they can pass their genetic inheritance to the following 
generation [41,42]. This opened the possibility to study gene function in vivo by generating 
ESCs with the desired genetic mutation and then reintroducing these cells into the 
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blastocyst to generate chimeras to obtain genetically manipulated mouse models. The 
second defining feature of ESCs is their ability to undergo symmetrical cell division called 
self-renewal, to generate identical pluripotent progeny without differentiating. Therefore, 
these cells can be maintained and expanded indefinitely in vitro. 
In addition to their developmental potential in vivo, ESCs are also used as a model to study 
embryogenesis in vitro, as they are able to undergo differentiation to different cell types in 
culture. Studies over the past 20 years have led to the development of specific culture 
conditions and protocols for the generation of a variety of cell lineages from ESCs. Also 
for this reason, the discovery of ESCs has caused excitement for its huge potential in cell 
replacement therapy, especially when human ESCs were first isolated in 1998 [43]. 
Furthermore, several protocols have now been characterised at the molecular level and 
have shown that the events that occur during the differentiation in vitro mimic those in 
vivo. For example, one of the first differentiation protocols that were implemented for 
studying developmental processes is the embryoid body formation. This was first 
introduced by Evans and co-workers using ECs and it was adapted for ESCs by 
Doetschman [44]. When ESCs are grown in the absence of feeder cells in culture dishes 
that do not allow their adherence and in the absence of the self-renewal factor leukemia 
inhibitory factor (LIF), they spontaneously differentiate by aggregating into spheres called 
embryoid bodies (EBs). The cells then start to undergo a differentiation program that 
mimics the preimplantation embryo stage up to the postimplantation gastrulation stages, 
generating intermediate cell types such as the primitive ectoderm, endoderm and 
mesoderm, and subsequently more differentiated cells, such as cardiomyocytes, neurons 
and endothelial cells. This process of ESC differentiation in EBs recapitulates quite 
accurately early embryonic development. Gene expression profiling and 
immunohistochemical studies have shown that the EBs progress through the specific stages 
of embryogenesis, starting from a morula-like stage and then progressing to form the 
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epiblast surrounded by primitive endoderm. The epiblast then starts to cavitate as well as 
differentiate, forming germ layer progenitors of the mesoderm, then progressing to form 
neuroectoderm. A recent study even showed the formation of a gradient driven by Wnt 
signalling, just like in vivo, is responsible for the determination of the apical-polar axis of 
the embryo [45], demonstrating a high degree of organisation in EBs than previously 
thought. These progenitor tissues then give rise to populations of differentiated cell types. 
Specific stages of development can be observed during EB differentiation, now 
characterised at the cellular and molecular level, rendering this protocol a valuable tool to 
study the role of developmental genes, in vitro (Figure 3). 
 
 
Figure 3. Embryoid body differentiation of ESCs mimic embryonic development. (A) Schematic 
representation of the different phases of EB formation and the cell types that are generated during the first 
few days of differentiation. From [46]. (B) Characterisation of the different phases of differentiation by 
global gene expression patterns. The temporal expression of marker genes is similar to the pattern in vivo, 
suggesting that the progeny of ESC differentiation in vitro can reflect the comparable states of cells in vivo. 
From [47]. 
 
In addition to the EB differentiation that generates simultaneously many cell types, there 
are currently several protocols that have been developed over the years that allow more 
specific differentiation towards certain cell lineages. One of the most widely used systems 
for studying the neural commitment of ESCs is the differentiation under defined 
monolayer culture conditions in the absence of serum and the addition of two growth 
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factors important for the self-renewal of neural progenitors, fibroblast growth factor 2 
(FGF2) and the epidermal growth factor (EGF) [48]. This protocol induces the ESCs to 
undergo autoinductive signals to commit to a neural fate and then the neural 
progenitors/neural stem cell population is selected and enriched by culturing these 
committed cells in the presence of the growth factors. Studies have shown convincingly 
that these ESC-derived neural stem cells are bona fide radial glial cells, which are the 
neural stem cells found in vivo, as they are able to differentiate into the three lineages of 
the CNS, astrocytes, oligodendrocytes and neurons [49]. These cells also undergo 
symmetrical division in vitro, like other stem cell types and are capable of undergoing self-
renewal indefinitely. Furthermore, these ESC-derived NS cells have been transplanted into 
brains of adult mice and were able to integrate into the host, proving their true stem cell 
capacity. 
Like the EB differentiation, this protocol has been recently shown to closely mimic 
neurogenesis in vivo. Detailed characterisation by gene expression profiling (Figure 4) and 
immunochemistry techniques have demonstrated that the cells transit through all the 
intermediates states generated during development, providing not only an efficient protocol 
to obtain neural stem cells but also an invaluable in vitro model system to dissect 
mechanisms underlying neuronal commitment of ESCs [50,51]. 
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Figure 4. Clustering analysis of differentially expressed genes during ESC differentiation to neural 
fate. (A) Frequency distribution of the expression levels of the genes belonging to the five defined groups. 
(B) Dendogram of the relationship of expression of genes belonging to each group (with biological replicates 
being represented by the letters A, B, C and D) and examples of genes that are present in the five defined 
groups. (C) Schematic representation of the successive cellular states that occur along the path to neural 
differentiation. Abbreviations: embryonic stem cells (ES cells), Pr. Ectoderm (primitive ectoderm), transient 
neuroepithelial progenitors (tNPs), neurogenic neuroepithelial progenitors (nNPs). From [50]. 
 
These characteristics rendered the ESCs a valuable tool to dissect the mechanisms of self-
renewal and differentiation, as well as dissecting the function of many proteins involved in 
the signalling pathways of these processes. 
 
3.2. The formation of early embryonic lineages and derivation of stem cells 
The first differentiation event that occurs during embryonic development is the segregation 
of the trophectoderm from the inner cell mass during the passage from the late morula 
stage to the blastocyst at E3.5 [52] (Figure 5). The trophectoderm gives rise to the chorion 
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and trophoblast, which will then form the placenta, a vital organ that will sustain the 
growth and survival of the fetus. The inner cell mass will give rise primarily to the 
embryonic lineages [53]. At the peri-implantation stage of the blastocyst, at E4.5, the inner 
cell mass has further segregated into the epiblast called also the primitive ectoderm and 
surrounded by a monolayer of primitive endoderm, also called the hypoblast, on its 
blastocoelic surface. The primitive endoderm constitutes another extraembryonic lineage 
to support fetal development, the yolk sac cavity and the exocoelom, as well as playing an 
important role in the establishment of the anterior/posterior axis. At this point, these three 
lineages are restricted in fate, demonstrated by extensive lineage tracing and chimera 
studies in the mouse. This is also reflected by their distinct transcriptional profile and 
epigenetic status. Upon implantation, the embryo undergoes rapid proliferation and at 
E5.5, it consists of an expanded epiblast surrounded by the extraembryonic endoderm 
which will then further segregate into the visceral and parietal endoderm, while the 
trophoblast has expanded and differentiated to contain self-renewing trophoblast stem 
cells, intermediate cells and giant cells. The major event that occurs is gastrulation during 
which the epiblast cells generate the three germ layers of the embryo, the ectoderm, 
mesoderm and definitive endoderm. The hallmark of this process is the formation of the 
primitive streak, which begins at E6.5. The endo-mesoderm precursors ingress through the 
primitive streak while the cells that will take on the ectodermal identity do not. These 
primary germ layers are the progenitors of all the tissues of the organism. These 
progenitors are further specified by the activation of tissue specific genes while genes 
involved in the pluripotency are gradually restricted. This process is tightly controlled by 
cellular interactions and cell signalling [54]. 
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Figure 5. Cell lineage formation from egg to egg cylinder. (A to H) Schematics of the morphological 
changes and cell lineage specification that occur in a mouse embryo, from its fertilization at embryonic day 
(E) 0.5 to the early egg cylinder stage (E5.5). The coloured bars show the progressive allocation of totipotent 
blastomeres to outer and inner cells and to the trophectoderm and inner cell mass lineages. The cell types in 
the embryos are colour coded. Abbreviations: abembryonic-embryonic (Abemb Emb) axis of the blastocyst, 
distal visceral endoderm (DVE). From [55].  
 
During the early stages of embryogenesis, several types of stem cells can be derived. ESCs 
[37,38], trophoblast stem cells (TSCs) [56] and extraembryonic endoderm cells (XEN) 
[57]. Each stem cell type, according to their gene expression and epigenetic profile, 
morphology and most importantly, their ability to recapitulate the behavior of their 
precursors when injected into blastocysts, reflects the lineage restriction of the tissue from 
which they were isolated. 
ESCs can be derived from the embryos as early as the morula at E2.5 [58] to the late 
blastocyst E4.5 [37,38]. They are dependent on the expression of key transcription factors, 
Oct4, Sox2 and Nanog for the maintenance of their pluripotent state and rely on LIF and 
BMP4 signalling for their self-renewal. In 2007, stable, pluripotent stem cell lines, the 
epiblast stem cells (EpiSCs) were isolated from the postimplantation embryo epiblast 
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between E5.5 to E7.5 [59,60]. These pluripotent cells provide a robust and invaluable 
system in vitro to study the mechanisms underlying the transition from pluripotency to 
differentiation, which cannot be done using embryos at these stages. Furthermore, they 
share some characteristics with ESCs but also possess specific features that renders them 
biochemically and functionally distinct from ESCs. Stem cells can also be derived from the 
extraembryonic compartment. Trophoblast stem cells (TSCs) can be derived from the 
trophoblast of the blastocyst and can only contribute to trophectodermal cell lineages in 
vivo and in vitro as they are restricted in their potency, differentiating only to their 
lineages, the intermediate and giant cells [56,61]. TSCs rely on the FGF and activin/nodal 
signalling for self-renewal and they require the expression of Cdx2, Eomes and other TS-
specific transcription factors. A third type of stem cell has been recently isolated from the 
extraembryonic endoderm, the extraembryonic endoderm (XEN) cells [57]. They are 
morphologically and molecularly similar to the primitive endoderm derivative. They 
depend on Gata6, Sox7 transcription factors. 
 
 
Figure 6. Stem cell types derived from mouse embryos around the time of implantation. At 
implantation, mouse blastocysts comprise three distinct cell types: the trophectoderm; the inner cell mass, the 
primitive endoderm and the early pre-implantation epiblast. Under appropriate in vitro culture conditions, 
three types of stem cell with a comparable potential for differentiation to each of the cell types of the 
blastocyst can be derived: ES cells, trophoblast stem (TS) cells and extraembryonic endoderm (XEN) stem 
cells. Pluripotent stem cells can be derived from the epiblast of the early post-implantation embryo at 5.5 up 
to 7.5 days post coitum. From [62]. 
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Recent studies have provided interesting insight on how the the culture growth factor 
environment and cell to cell interaction can play a critical role in defining the stem cell 
identity during its derivation [63]. 
 
3.3. The key signalling pathways underlying lineage determination and identity  
There are several key pathways governing lineage determination during development and 
the same pathways that underlie lineage segregation in vivo have been found to be 
responsible for the regulation of pluripotency and differentiation of stem cells in vitro. The 
dissection of the signalling mechanisms underlying cell fate decisions is not only important 
in understanding the development of the embryo but also for developing techniques that 
allow the propagation and differentiation of stem cells into pure populations of progenitors 
or functional and mature differentiated cell types under defined conditions in vitro for stem 
cell based therapies. 
3.3.1. JAK/STAT pathway 
The most well known factor that promotes self-renewal is LIF, a member of the interleukin 
6 family of cytokines. Historically, ESCs were derived on a feeder layer of MEFs, however 
it was found that the conditioned medium of MEFs is enough to support the self-renewal of 
ESCs. Subsequently, it was found that MEFs sustain ESCs by secreting LIF [64]. LIF 
binds to the heteromeric complex receptor that consists of the LIF receptor and the 
glycoprotein receptor, gp130. Upon LIF binding, the tyrosine kinase Janus kinase (JAK) 
phosphorylates the tyrosine residues in the intracellular portion of both receptors. This 
results in the recruitment of the signal transducer and activator of transcription (STAT3) 
through its SH2 domain, which in turn is activated by JAK mediated phosphorylation. 
STAT3 then dimerizes and then translocates to the nucleus to activate the transcription of 
its target genes [65], such as c-Myc. LIF signalling can also induce other pathways such as 
the Ras/Erk and PI3 kinase through the JAK activation of a SH2 domain containing 
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phosphatase (SHP2). However, LIF by itself is not sufficient to sustain the self-renewal of 
ESCs, as it cannot sustain the expansion of these cells in the absence of serum, suggesting 
that there are other factors contained in serum that are important for ESC maintainance and 
proliferation. 
Although LIF is required in vitro to derive and maintain pluripotent mouse ESCs, this 
signalling was not required in vivo for early embryonic stages, as embryos lacking LIF can 
develop to stages later than the blastocyst. Interestingly, mouse EpiSCs and human ESCs 
do not rely on this signalling for their self-renewal and it is unknown whether LIF has 
different effects on these cell types. 
3.3.2. TGF-β superfamily 
In the mouse embryo, signalling by bone morphogenetic protein (BMPs), members of the 
transforming growth factor β superfamily, has been shown to be crucial for the 
proliferation of the epiblast, as the genetic deletion of BMP4, BMPR1a or Smad4 leads to 
a reduction in cell proliferation in the epiblast and precocious neural induction. 
Furthermore, BMPs play also an important role gastrulation for mesoderm formation and 
patterning [66,67]. 
In mouse ESCs, BMP4 can replace the requirement of serum in culture for their self-
renewal by maintaining the expression of a family of negative transcriptional modulators, 
the Inhibitor of differentiation (Id) genes, in this way suppressing their differentiation in to 
neural cell types [68]. The binding of BMP triggers the formation of receptor complexes, 
which leads to the phosphorylation of the transcription factors Smads.  The effect of BMP4 
on ESC maintenance depends on the activation of the JAK/STAT pathway by LIF, as in its 
absence. BMP4 drives non-neural differentiation of ESCs. Therefore it is thought that 
instead of directly promoting self-renewal, BMP prevents the differentiation of ESCs. 
BMP4 treatment of ESCs together with LIF is sufficient to sustain ESC self-renewal 
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without the addition of serum or feeders. This led to the view that differentiation is the 
default pathway for ESCs [69]. 
The response to BMP4 of human ESCs and mouse EpiSCs on the other hand are 
completely different. BMP4 promotes trophoblast differentiation of human ESCs [70] 
while in mouse EpiSCs, it promotes the differentiation to non-neural lineages [47]. 
However in these two stem cell types, another member of the TGF-β superfamily, Nodal, 
plays a role in sustaining their self-renewal. Nodal is an important regulator of many 
processes during embryonic development. It is important for the maintenance and growth 
of the epiblast, as embryos without Nodal are detrimental due to loss of expression of Oct4 
and premature differentiation of epiblast into neuroectoderm. Activin, another member of 
the family, also signals through the same receptor as Nodal and is often used in cell culture 
as a substitute for Nodal due its wider availability and comparable activity. In contrast to 
mouse ESCs, Nodal/activin signalling is important for sustaining the self-renewal of 
mouse EpiSCs and human ESCs, as it suppresses their differentiation by regulating the 
expression of another key pluripotency transcription factor, Nanog [71,72]. 
3.3.3. Wnt family 
Wnts are secreted glycoproteins that have many roles in organogenesis. Canoncal Wnt 
signalling is activated upon Wnt binding to the Frizzled receptor on the cell membrane. 
This results in the inhibition of glycogen-synthase kinase 3 (GSK-3) and a subsequent 
accumulation of β-catenin in the nucleus, allowing transcriptional regulation of its target 
genes. For mouse embryonic development, there is no evidence that Wnt signalling has a 
role in the maintenance of the pluripotent epiblast in vivo, as the depletion of Wnt3 does 
not show any effect on the epiblast of the mutants, however in later stages it is crucial for 
the development of the primitive streak, mesoderm and node [73]. 
In mouse ESCs, it was shown that the effect of Wnt mediated signalling depends on the 
balance between the association of β-catenin with p300 and CBP, two transcriptional co-
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activators. It is thought that the association of β-catenin with p300 drives stem cell 
maintenance at the expense of differentiation, however, the exact mechanisms are not 
clear. It seems that in general mimicking the activation of this pathway has beneficial 
effects on ESC self-renewal. The role of Wnt signalling in the maintenance of human 
ESCs and mouse EpiSCs remains uncertain up to date. 
3.3.4. FGF/Erk pathway 
Recent studies showed that ESCs have an autocrine signalling through the fibroblast 
growth factor (FGF) that activates the MAPK pathway, which is important for promoting 
exit from self-renewal and commitment to differentiation [74]. FGF signalling is initiated 
by its binding to the tyrosine kinase receptor FGF-R. There are several FGF ligands and 
they are implicated in different pathways. In particular, FGF4 is produced by ESCs in an 
autocrine manner and it is needed to exit from self-renewal to start the differentiation 
program [74]. 
Until recently, the prevailing view of the molecular basis of ESC self-renewal was that 
they rely on extrinsic determinants for the maintenance of this state. However, recent 
studies have demonstrated that it is sufficient to shield the ESCs from differentiation 
factors to promote their self-renewal, leading to the view that ESCs represent a “ground 
state”. ESCs retain pluripotency and undergo self-renewal by blocking FGF4 mediated 
signalling by chemical inhibitor of MEK to inhibit the activation of Erk1/2 downstream 
[69]. In line with these studies, the use of small molecule inhibitors for MEK and the 
suppression of GSK-3 of the Wnt signalling pathway, which increases the viability of the 
cells, together with LIF, are sufficient to stabilise and sustain mouse ESCs in their 
pluripotent and self-renewing state. 
Interestingly, the same FGF signalling that induces the exit of ESCs from self-renewal 
becomes part of the circuit that sustains self-renewal of mouse EpiSCs and human ESCs. 
In mouse EpiSCs, FGF2 signalling was demonstrated to act by inhibiting the 
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differentiation of these cells to neural fate while at the same time, blocking its reversion to 
an ESC like state [75]. Following studies showed that FGF signalling is crucial for the 
transition from ESC to EpiSC, but the further differentiation to neuroectoderm state is 
actually inhibited by this pathway [76]. 
It is interesting that the same pathways mediate different functions within the different 
types of stem cells, such as the transition of the role of FGF signalling from one pluripotent 
state to another. FGF signalling is regulated at multiple levels and one of the mechanisms 
that have been proposed to allow the differential response of cells to the same stimuli, is by 
expressing negative regulators to attenuate the signal, such as the Sprouty-related protein 
with an EVH1 (Ena/VASP [vasodilator-stimulated phosphoprotein] homology domain 1) 
domain (Spred1) of the MAPK/Erk pathway [77] and adaptor proteins that can recircuit the 
pathway to compartmentalise signalling or mediate cross-talk with other pathways, 
creating completely different outputs from the same stimulus. These regulatory 
mechanisms have profound effects on the downstream signalling of receptors that in turn 
regulate the transcriptional activity of genes. In fact, studies have shown that the 
manipulation of these pathways through the addition or withdrawl of specific cytochines 
and growth factors can even allow the interconversion of one stem cell type to another 
[62,78,79]. 
 
3.4. Pluripotent stem cell lines and their relation to embryonic lineages 
When studying developmental processes in vitro, one must always keep in mind the events 
and the corresponding stages in vivo. Although the predominant view of the identity of 
ESCs were thought to be unequivocally representing the inner cell mass of the blastocyst, 
recent studies are challenging this notion, as recently, other types of pluripotent stem cell 
lines that share properties with ESCs have been derived from different developmental 
stages and mammalian species, as well as from the reprogramming of adult cells by the 
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introduction of transcription factors [80]. The relationship of these cell lines to the lineages 
from which they are established and their relation to one another is still a matter of intense 
debate. 
Pluripotency is a transitory state that exists only during brief and specific time-windows of 
development. When cells are isolated from the embryo during these time-windows, they 
are “captured” in their self-renewing state and by in vitro culture conditions, this transitory 
state becomes permanent as the cells acquire the capacity to undergo self-renewal 
indefinitely. When cells are isolated from the inner cell mass of the blastocyst, the epiblast 
of the post-implantation embryo and the primitive streak and cultured in vitro to derive 
ESCs, EpiSCs and embryonic germ cells (EGCs) respectively, they retain their 
pluripotency and undergo self-renewal indefinitely under their ideal culture conditions. On 
the other hand, the corresponding cells in vivo continue their developmental program and 
differentiate. This suggests that there are signalling pathways that sustain this self-renewal 
ability that must be continuously activated and differentiation programs that must be 
silenced in order for these cells to maintain their identity. These are events that do not 
occur in vivo and so to some extent it is difficult to say with precision the exact identity of 
these cells with the in vivo counterpart. In depth analysis of transcriptional profile, 
epigenetic profile and proteome studies have given some insight to this, however, the exact 
identities are still open questions. 
Over the past few years, several types of pluripotent stem cells have been derived from the 
embryo and although it seems that these cells have a common genetic network of 
transcription factors that is responsible for their pluripotency, several studies have shown 
that they also possess unique properties. Intriguingly, these cells are highly plastic and 
certain cell types can readily convert into other stem cell types upon extracellular stimuli 
(Figure 7). This has lead to the view that each type of pluripotent cell has reached a 
different developmental potential and that the pluripotent state is a continuum of states 
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[81]. Extrinsic regulation of cells play a crucial part in this regulation, as their activation is 
intricately linked to intrinsic mechanisms that determine the state of the cell. 
Understanding how the stem cell types are related to one another and how they can 
interconvert in response to extracellular signals is one of the challenging questions in this 
field today. 
The properties of these various stem cell types are believed to reflect their embryonic cell 
of origin in vivo, although some characteristics must be acquired as adaptive changes made 
in response to propagation and establishment in vitro. 
 
 
Figure 7. The interconversion of stem cells derived from the mouse embryo. Stem cells with different 
characteristics can be derived from the mouse blastocyst or from the early postimplantation embryo. The 
stem cells can be converted to each other through the manipulation of culture conditions and/or enforcing the 
expression of certain genes. Three types of stem cell can be derived from the blastocyst: ES cells, TS cells, 
XEN cells. FAB-SC are a particular type of stem cells that initially are unable to differentiate and they can be 
converted to pluripotency with BMP4 and LIF. ES cells can be converted into TS cells by culturing them in 
MEF-cm containing FGF4, together the expression of the transcription factor Cdx2. ES cells can be turned 
into EPL cells by culturing them in MedII. EpiSCs are derived from postimplanation epiblast in presence of 
FGF2 and activin. EpiSCs cultured in MEF-cm, LIF and FBS become cEpi cells that can be converted into 
ES cells (rES). EpiSCs can also be converted into ES cells by culturing them with LIF and GSK3β and ERK 
inhibitors or by enforced Klf4 expression. ES cells can be turned into EpiSCs by culturing them with activin 
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and FGF2. EpiSCs can differentiate to PG cells with BMP4, noggin, chordin, activin and FGF2. PG cells can 
be converted into EG cells by culturing with LIF, FBS and FGF2. Abbreviations: bFGF, Activin and BIO-
derived stem cells (FAB-SCs), mouse embryonic-fibroblast-conditioned medium (MEF-cm), primitive 
ectoderm-like (EPL) cells, MedII (medium conditioned by the human hepatocarcinoma cell line HepG2), 
fetal bovine serum (FBS), cultured epiblast cells (cEpi), reversed ES cells (rES), primordial germ cells (PG), 
embryonic germ (EG) cells. From [62]. 
 
The relationship between mouse ESCs and EpiSCs represents an interesting example of 
this interconversion between pluripotent states. Although they are both pluripotent, they 
are functionally and biochemically distinct (Figure 8). As described previously, EpiSCs 
share the expression of the core pluripotent transcriptional factors, Oct4, Nanog and Sox2 
but their overall transcriptional profile and epigenetic status are strikingly different from 
that of ESCs [59,60]. EpiSCs also have a morphology different to that of ESCs, as they 
grow as flattened 2-D colonies rather than the 3-D ESC colonies. Furthermore, EpiSCs rely 
on FGF2 and activin signalling for the maintenance of pluripotency and self-renewal in 
culture, whereas ESCs rely on LIF and BMP4. When mouse EpiSCs are cultured under 
stringent ESC conditions of 2i, they are unable to self-renew and they undergo cell death. 
These characteristics are very similar to human ESCs, in fact this has led to the idea that 
human ESCs and mouse EpiSCs might reflect the same origin of derivation. However, 
although human ESCs are derived from the preimplantation blastocyst, the corresponding 
origin is still unclear. 
EpiSCs are pluripotent, as they are able to generate the derivatives of all three germ layers 
during in vitro differentiation and in vivo, in the teratoma assay. However, when they are 
injected into the recipient blastocyst, they are unable to contribute to chimera formation 
probably due to the fact that they represent a different developmental stage. EpiSCs also 
manifest a major epigenetic modification that occurs in vivo after the formation of the post-
implantation epiblast, one copy of the X chromosome is silenced in female embryos. 
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Figure 8. Two phases of pluripotency. ESCs can be induced to differentiate into EpiSCs by exposure to 
activin A and Fgf2. The reverse transition can be made by the overexpression of a pluripotency factor Klf4 or 
in response to LIF-STAT3 signalling.The white asterisks indicate the epiblast. Adapted from [82]. The table 
summarises the biochemical and functional properties of ESCs (ground state) and EpiSCs (primed state). 
 
ESCs can be converted into EpiSCs in vitro, by culturing them in the presence of FGF2 
and activin [78]. EpiSCs can be converted back into ESCs by the exogenous expression of 
Klf4 [78] or as demonstrated recently, by passaging ESCs under the stimulation of LIF-
STAT3 signalling [79]. 
These studies have lead to the idea that ESCs and probably also other pluripotent cells 
although this has not been investigated yet, exist in different metastable states that are 
determined by fluctuations in the expression of pluripotency and differentiation related 
genes. This property might represent “noise” that allows the cells to fluctuate between 
more pluripotent/multipotent state and more poised or biased states, generating the 
plasticity of the cells to readily respond to environment signals. Taken together, the 
regulation of extrinsic signals plays a fundamental role in determining the self-renewal and 
differentiation of pluripotent stem cells and the characterisation of these pathways will be 
very important not only in understanding the biology of these cells but for future 
application in stem cell therapy. 
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4. Aim of the PhD project 
 
The aim of this PhD project is to understand the physiological role and dissect the 
signalling pathway of a previously uncharacterised family member of the Shc adaptor 
proteins, ShcD/RaLP. Based on the expression pattern of RaLP during mouse embryonic 
development and in the adult, we decided to use as a model system, mouse ESCs. This 
system would allow us to investigate the role of RaLP in the pluripotency of mouse ESCs 
and EpiSCs and in the induction of their differentiation.  In parallel, our RaLP knockout 
mouse model, which up to present is the first to be generated, was characterised. 
The study of the function of RaLP would provide insight into the intricate signalling 
pathways governing ESC self-renewal and differentiation, as well as how this family of 
adaptor proteins have evolved to take on distinct functional roles in the organism. 
Furthermore, understanding the physiological function of this protein might provide insight 
into how deregulated levels of this protein is involved in the metastasis of tumours. 
Materials and Methods 
 31 
Materials and Methods 
 
1. Cell culture methods 
 
1.1. Preparation of mouse embryonic fibroblasts for feeder layer 
Wild type mice were set up for timed matings. Pregnant females were sacrificed between 
embryonic days E11.5 and E13.5 following standard procedures. The intact uterus was 
carefully extracted and transferred to a 100-mm dish containing sterile phosphate buffered 
saline (PBS). The uterus was sectioned to release the embryos and each one was placed in 
a 60-mm plate with PBS. The fetal membranes, umbilical cord, head and organs were 
removed and the remaining tissues were collectively transferred to a 100-mm plate 
containing 5 mL trypsin-EDTA (Lonza). The tissues were further dissociated with forceps 
and scissors and incubated at 37°C for 5 to 10 min. The cells and tissue pieces were 
triturated by pipetting up and down and collected in mouse embryonic fibroblast (MEF) 
medium which consists of Dulbecco’s modified Eagle’s Medium (DMEM with high 
glucose, with sodium pyruvate and without L-glutamine; Lonza), 10% North American 
foetal bovine serum (FBS; Gibco), 2 mM L-glutamine (Gibco), 0.1 mM non-essential 
aminoacids (NEAA; Gibco), 50 U/mL penicillin and 50 µg/mL streptomycin (Lonza) and 
0.1 mM β-mercaptoethanol (Gibco). The digested tissue was centrifuged at 280 × g for 5 
min. The pellet was resuspended in MEF medium and cells were plated onto 100-mm 
plates. Cells were cultured in a humidified incubator at 37°C with 5% CO2 and were 
passaged every two days at a 1 to 4 ratio. When cells almost reached confluency, some 
100-mm dishes were frozen in 90% FBS with 10% dymethylsulfoxide (DMSO) to create 
stocks of MEFs. 
For the preparation of feeder layers, MEFs at a maximum of passage three after isolation 
were used. When MEFs reached confluency they were incubated in MEF medium 
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containing 10 µg/mL mitomycin C (Sigma) for 4 h in a humidified incubator at 37°C with 
5% CO2. Cells were then washed with PBS, trypsinised and seeded at a density of 6 × 104 
cells/cm2 onto culture dishes. MEF medium was replaced with ESC medium at least 2 h 
before using them for ESC culture. 
 
1.2. Derivation of mouse embryonic stem cells 
RaLP knockout (KO) males and RaLP heterozygote (HT) females were mated and the 
latter were sacrificed at days postcoitus (dpc) 2.5 and uteri were flushed to collect the 
embryos at the morula stage. They were cultured in vitro in drop cultures of KSOM 
medium (95 mM NaCl, 2.5 mM KCl, 0.35 mM KH2PO4, 0.20 mM MgSO4•7H20, 0.20 
mM glucose, 10 mM sodium lactate, 25 mM NaHCO3 phenol red, 0.2 mM sodium 
pyruvate, 1.71 mM CaCl2• 2H20, 0.01 mM EDTA, 1 mM L-glutamine and 1 mg/mL BSA) 
covered in embryo-tested mineral oil (Sigma) for 24 h in a humidified atmosphere of 5% 
CO2 at 37°C. The blastocysts were transferred individually to 48-wells previously plated 
with mitotically inactivated MEFs. The medium for embryonic stem cell (ESC) derivation 
consists of DMEM, 15% ESC screened FBS (PAN), 0.1 mM NEAA, 2 mM L-glutamine, 
25 mM HEPES and 0.1 mM β-mercaptoethanol, 1000 U/mL Leukemia Inhibitory Factor 
(LIF; prepared by the Transgenic facility, IFOM-IEO campus) supplemented with 50 µM 
mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK1) inhibitor 
PD98059 (Cell Signaling) to facilitate the derivation process by suppressing differentiation 
cues and enhancing the effect of LIF on self-renewal [83,84]. After five to six days, 
blastocyst outgrowths were passaged in trypsin-EDTA containing 1% chicken serum 
(Gibco) following a wash in Ca2+/Mg2+-free PBS (Lonza). Cells were expanded onto 24-
wells plated with inactivated MEFs and allowed to grow for three to five days. After this 
period, the cells were no longer cultured in the presence of the MEK inhibitor. The 
growing cultures were passaged onto progressively larger areas with feeder, for the 
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expansion of the ESC population. Medium was replaced daily and cultures were monitored 
for the appearance of distinct ESC colonies. Usually by the 12-well format, ESC colonies 
could be seen. When they reached 80 to 90% confluency, they were trypsinised and 
transferred onto 6-well plates with feeder for three to four days. Each well was then 
trypsinised and 75% of the cell population was frozen in freezing medium consisting of 
90% FBS and 10% DMSO to have the first stock. The derived ESCs were grown on MEFs 
for two more passages and then adapted to feeder free conditions. 
 
1.3. Culturing of ESCs 
1.3.1. Passaging of ESCs 
Established wild-type ESCs ETg2a.4 (BayGenomics), 46C ESCs [85] and derived RaLP 
HT and KO ESCs were cultured routinely in ESC medium. Medium was replenished daily. 
Cells were passaged at 70 to 80% confluency, every two days. For passaging, cells were 
washed once in PBS and then incubated in trypsin-EDTA for 5 min at 37°C. Cell 
suspension was gently pipetted to have single cells and trypsin was inactivated by the 
addition of the ESC medium. The cells were centrifuged at 280 × g for 5 min and 
resuspended in fresh medium and plated at a density of 2-4 × 105 cells/cm2 (corresponding 
to a splitting ratio of about 1:10) in feeder free conditions. 
ESCs can also be efficiently maintained in culture under defined culture conditions 
containing small molecule inhibitors that block extrinsic differentiation inducing signals, 
the mitogen-activated protein kinase (MAPK/ERK1/2) and glycogen synthase kinase 3 
(GSK3), in the presence of LIF [69]. This medium is called 2i/LIF medium which consists 
of N2B27 medium [DMEM/F-12 + Glutamax™ (Invitrogen) and Neurobasal medium 
without L-glutamine (Invitrogen) at a 1:1 mixture, N-2 (Invitrogen), B-27 (Invitrogen), 0.1 
mM β-mercaptoethanol, 2 mM L-glutamine, 25 mM HEPES] supplemented with 1 µM 
MEK inhibitor PD0325901 (ABCR), 3 µM GSK3 inihibitor CHIR99021 (ABCR) and LIF 
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(prepared by the transgenic facility). Under these culture conditions, cells were passaged 
every three days by detaching them in Accutase® (Sigma) incubated for 5 min at 37°C and 
colonies were dissociated into single cells by pipetting. Cells were collected in 2i/LIF 
medium and centrifuged at 280 × g for 5 min. The cell pellet was resuspended in fresh 
2i/LIF medium and cells were seeded onto 0.1% gelatinised plates at a density of 2-4 × 105 
cells/cm2. 
1.3.2. Freezing and thawing of ESCs 
For the cryopreservation of ESCs cultured in ESC medium, ESCs were detached from 
dishes as described in section 1.3.1 and the pellet was resuspended in freezing medium 
consiting of 90% FBS and 10% DMSO. Approximately 3 × 106 cells were frozen per 
cryovial. For ESCs cultured in 2i/LIF medium, the freezing medium consisted of 70% 
2i/LIF medium, 20% knockout serum replacement (KSR; Gibco) and 10% DMSO. For the 
thawing of cells under both culture conditions, the cryovials were quickly warmed in a 
water bath set at 37°C and the contents were transferred to a conical tube containing 10 mL 
medium. The cells were centrifuged at 280 × g for 5 min and seeded in the corresponding 
medium. 
 
1.4. Differentiation of mouse ESCs 
1.4.1. Embryoid body differentiation 
Embryoid bodies were generated using the hanging drop method [44] in order to obtain a 
homogenous and reproducibile differentiation. The embryoid body (EB) differentation 
medium consisted of ESC medium without LIF. ESCs were resuspended in this medium at 
a concentration of 5 × 104 cells/mL and 20 µL drops of this cell suspension were placed on 
the lid of 100-mm plates that contains PBS at the bottom to prevent evaporation of the 
medium. Cells were allowed to aggregate for two days and then the EBs were transferred 
to bacterial dishes in EB medium for a further nine days. Medium was changed every two 
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days by allowing the EBs to sediment after collecting them into conical tubes. Embryoid 
bodies were collected at different timepoints: day two, three, four, six and nine of 
differentiation for analysis. 
1.4.2. Teratoma assay 
One million RaLP HT and KO ESCs cultured in 2i/LIF medium were injected 
subcutaneously into the hind flanks of (non-obese diabetic severe combined 
immunodeficiency) NOD/SCID (interleukin-2 receptor gamma) IL2R γ chain knockout 
mice. At three, four and five weeks after injection, teratomas were recovered and the major 
and minor axes were measured using a caliper. Tumours were briefly washed in PBS and 
then divided into two pieces, one half of the tumour was fixed in formaldehyde for 
immunohistochemical analysis (section 2.3) and the other half was flash frozen in liquid 
nitrogen for RNA (section 4) and protein analysis (section 2.2). 
 
1.5. Culturing of embryonic stem cell derived neural stem cells 
1.5.1. Derivation of embryonic stem cell derived neural stem cells 
ESCs were differentiated to neural stem cells (ES-NSCs) following the monolayer 
differentiation protocol established by Ying and Smith [48,49]. ESCs were seeded on 0.1% 
gelatinised culture dishes at low density (0.5-1.5 × 104 cells/cm2) in N2B27 medium. 
Medium was replaced daily. Cells were allowed to commit to neural fate under these 
conditions for eight days, after which they were detached in accutase® for 5 min at 37°C, 
resuspended in N2B27 and centrifuged at 280 × g for 5 min. Cells were resuspended in NS 
expansion medium, which consists of Euromed (Euroclone) supplemented with 2 mM L-
glutamine, N-2, 20 ng/mL of Fibroblast growth factor 2 (FGF2; Peprotech) and 20 ng/mL 
Epidermal growth factor (EGF; Peprotech), in T25 flasks (Iwaki). Typically, cells from a 
100-mm plate were replated into two T25 flasks. After two to three days, numerous 
floating aggregates were present in the culture and were harvested by mild centrifugation. 
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The spheres were transferred in fresh NS expansion medium in T25 flasks to allow for the 
selection and expansion of ES-NSCs. After several days, the aggregates attached and 
characteristic bipolar neural progenitor cells outgrew from the spheres. The population was 
gently disaggregated in accutase® at 37°C for 3 min, collected in NS expansion medium 
and centrifuged. The cells were passaged onto T25 flasks at low splitting ratio of 1:2-3. 
After a further two to three passages, differentiated cells were eliminated and the cultures 
consisted of a homogenous population of ES-NSCs that could be maintained in culture 
indefinitely. ES-NSCs were passaged every three days at a splitting ratio of 1:4.  
1.5.2. Freezing and thawing of ES-NSCS 
ES-NSCs were cryopreserved in NS expansion medium and 10% DMSO. Typically, cells 
from a T25 were frozen into one cryovial and from a T75 into two cryovials. ES-NSCs 
were thawed rapidly by warming the cryovial to 37°C and cells were transferred to 10 mL 
of NS expansion media. Cells were centrifuged and then resuspended in fresh medium and 
plated.  
1.5.3. Differentiation of ES-NSCs to neuronal lineages 
ES-NSCs were differentiated to neurons following the protocol established by Conti and 
colleagues [49]. ES-NSCs were seeded at 5 × 104 cells/cm2 onto 24-wells containing 
coverslips double coated with 50 µg/mL poly-ornithine (Sigma) and 5 µg/mL laminin 
(Sigma). Cells were grown for seven days in Euromed supplemented with FGF2, N-2 and 
B-27 and half the volume of medium was replaced every two to three days. After one 
week, the medium was switched to Euromed and Neurobasal (v:v 1:1) supplemented with 
0.25 N-2 and B-27 for an additional three days. Cultures were then analysed by 
immunofluorescence. 
1.5.4. Differentiation of ES-NSC to astrocytes 
ES-NSCs were passaged at 1:4 onto gelatinised culture dishes containing glass coverslips. 
The cell density for this differentiation was not crucial. Cells were cultured in Euromed 
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containing N-2 and 1% FBS. Medium was changed every two days and after seven days of 
culture, coverslips were recovered for analysis of the differentiation by 
immunofluorescence. 
1.5.5. Cell Sorting 
46C ESCs were differentiated to NSCs following the protocol described in Section 1.5.2. 
Cells were collected with accutase® on day two, three and four of differentiation and 
resuspended in PBS containing 1% FBS. Cell suspension was passed through BD Falcon™ 
Cell Strainer nylon with 70 µm pores in order to remove cell clumps. Cells were sorted for 
green fluorescent protein (GFP) positive and negative populations with the appropriate 
controls. 
 
1.6. Culturing of epiblast stem cells 
1.6.1. Derivation of epiblast stem cells from ESCs 
Epiblast stem cells were derived from ESCs (ES-EpiSCs) following the protocol 
established by Guo and colleagues [78]. ESCs were seeded onto 15 µg/mL fibronectin 
(Roche) coated 6-well plates at 1 × 105 cells per well in ESC medium. After 24 h, the 
medium was switched to EpiSC medium [N2B27 supplemented with 12 ng/mL Fgf2 
(Peprotech) and 20 ng/mL Activin A (R&D systems)]. When the cells reached 80 to 90% 
confluency, they were passaged in accutase® at 37°C for 5 min, collected in EpiSC 
medium and centrifuged at 280 × g for 5 min. Cells were resuspended in fresh EpiSC 
medium and were seeded onto 6-well coated with fibronectin, at high density typically at 5 
× 105, corresponding to a splitting ratio of 1:5. From around passage four or five, the 
cultures consisted of mainly ES-EpiSCs colonies. 
1.6.2. Culturing postimplantation embryo derived EpiSCs 
EpiSCs derived from the postimplantation embryo of mice carrying GFP gene under the 
promoter of Oct4 (Oct4-GFP EpiSC; from Prof. A. Smith, Cambridge [78]) were cultured 
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on fibronectin coated plates in EpiSC medium, as for the ES-EpiSCs. Puromycin (Sigma) 
was added to culture medium at 1 µg/mL to select for Oct4 expressing cells and medium 
was replaced daily. EpiSCs were passaged at low splitting ratio of 1:5 to 1:6 every two to 
three days. 
1.6.3. Freezing and thawing of EpiSCs 
Derived and established EpiSC lines were cryopreserved in EpiSC medium containing 
20% KSR and 10% DMSO. Approximately 5 × 106 cells were frozen per cryovial. For the 
thawing of these cells, the cryovials were rapidly thawed to 37°C and the contents were 
transfered to 10 mL of EpiSC medium. The cells were centrifuged at 280 × g for 5 min. 
and the pellet was resuspended in fresh EpiSC medium. Cells were seeded onto fibronectin 
treated plates. 
 
1.7. Culturing of adult neural stem cells 
1.7.1. Derivation of adult neural stem cells 
RaLP wild-type and KO mice were sacrificed according to standard procedures and the 
brains of the mice were carefully dissected and placed in ice cold PBS. Under the 
stereomicroscope, the brain was sectioned into three parts and the central slice was used to 
isolate the area surrounding the subventricular zone. The tissue was cut into small pieces 
with fine scissors and the pieces were placed into 60-mm plates with PBS containing 1 
mg/mL Papain Lyo (Worthington), 0.2 mg/mL Disodium Ethylene Diamine Tetra-Acetate 
(EDTA) and 0.2 mg/mL cysteine (Sigma), and incubated at 37°C for 1 h. The digested 
tissue was collected by centrifugation at 233 × g for 10 min at 4°C. The supernatant was 
carefully discarded and the pellet was resuspended in 1 mL of Neurocult culture medium 
which consists of NeuroCult® NS-A (StemCell Technologies Inc) supplemented with 10% 
NeuroCult® NS-A Proliferation supplements (StemCell Technologies Inc), 10 ng/mL 
FGF2 (Peprotech), 20 ng/mL EGF (Peprotech) and 2 µg/mL Heparin (Sigma). The cell 
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suspension was transferred to 35-mm plates and cultured in a humidified atmosphere of 
5% CO2 at 37°C. Cultures were monitored daily for the appearance of characteristic 
aggregates called neurospheres. 
1.7.2. Culturing NSCs 
Neurospheres were routinely cultured in Neurocult culture medium and passaged every 
three to four days. Neurospheres were collected and centrifuged at 28 × g for 10 min at 
4°C. The spheres were dissociated by gentle pipetting in a low volume of fresh medium. 
Single cells were passaged by seeding 2 × 105 cells in T25 flasks and 6 × 105 cells in T75 
flasks. 
1.7.3. Freezing and thawing of NSCs 
For the cryopreservation of NSCs, the neurospheres were collected by centrifugation and 
resuspended directly in freezing medium (Neurocult culture medium and 10% DMSO) 
without disaggregation of the spheres. For the thawing of the cells, the contents of the 
cryovial were warmed to 37°C, transferred to 10 mL medium and centrifuged at 28 × g for 
10 min at 4°C. The spheres were gently resuspended in fresh medium and seeded into T25 
or T75 flasks. 
1.7.4. Differentiation of NSCs 
24-well plates containing glass coverslips were coated with Matrigel™ (BD Biosciences) 
diluted at 1:100 in PBS, and incubated at 37°C for 2 h. Single cells were plated at 6 × 104 
cells per well in Neurocult medium. After 48 h, the medium was changed to Neurocult 
without FGF2 and EGF, and additioned with 2% FBS, to induce differentiation. Cells were 
analysed after a further three to five days of differentiation, by immunofluorescence. 
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2. Protein methods 
 
2.1. RaLP antibody generation 
The RaLP antibody was generated in collaboration with the Biochemistry Unit at the 
IFOM-IEO campus. Antibodies against the SH2 region of murine RaLP was raised using 
the peptide sequence of 16 amino acids: QPYRKYDNTGLLPPKK [22]. This synthesised 
peptide sequence corresponds to the most carboxy-terminal part of the protein, which is 
specific for RaLP and not present in the other three members of the family. The immunised 
sera was tested on RaLP overexpressing cell lines by Western blotting and the reactive sera 
was immunopurified by Sulfolink columns, according to the manufacturer’s instructions. 
 
2.2. Western blotting 
2.2.1. Lysate preparation 
Cells were washed in PBS and collected by centrifugation. Cell pellets were flash frozen in 
liquid nitrogen and stored at -80°C until use. Cell lysates were prepared on ice using Radio 
Immuno Precipitation Assay (RIPA) buffer (150 mM sodium chloride, 1% Triton X-100, 
0.5% sodium deoxycholate, 0.1% SDS and 50 mM Tris pH8.0) or Laemmli Sample Buffer 
(62.5 mM Tris HCl pH 6.8, 2% SDS, 10% glycerol), freshly supplemented with protease 
inhibitor cocktail Complete Mini (Roche), phosphatase inhibitor mix PhosSTOP (Roche) 
and 50 mM Dithiothreitol (DTT). Benzonase nuclease (Sigma) was added at a final 
concentration of 0.05 units/µL of lysate and was incubated at 4°C for 10 min to digest 
genomic DNA and reduce viscosity. Samples were further lysed by sonication. After 20 
min of incubation on ice, samples were centrifuged at maximum speed (16060 × g) for 15 
min at 4°C to pellet cell debris and the supernatants were collected. Protein concentration 
was determined by the Bradford assay using BSA (Sigma) as a protein standard. Lysates 
were measured at 595 nm with the spectophotometer. 
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2.2.2. Immunoblotting 
Depending on the antigen to be detected, 30 to 100 µg of protein lysate were mixed with 
6× Laemmli Sample Buffer with 0.01% bromophenol blue and added freshly with DTT. 
Samples were denatured at 95°C for 5 min. Samples were electrophoresed on 8, 10 or 12% 
sodium dodecyl sulfate polyacrylamide (SDS-PAGE) gels and prestained and nonstained 
molecular weight markers (Biolabs) were also loaded on the gel for the determination of 
protein size and to monitor the run. The proteins were transferred onto nitrocellulose 
(Whatman) or poly-vinylidene fluoride (PVDF) Immobilon™-P transfer (Millipore) 
membranes in wet conditions using the Mini Trans-Blot® Electrophoretic Transfer Cell 
(BioRad) at 100 V for 1 h or 30 V overnight, at 4°C. The efficiency of protein transfer and 
even loading between the samples were checked by incubating the membrane for 5 min in 
Ponceau Red. Membranes were blocked in 5% skimmed milk powder (w/v) in Tris-
buffered saline with 0.1% Tween 20 (TBST) or 5% BSA (w/v) in TBST for the detection 
of phosphorylated proteins, for 1 h at RT. Primary antibodies were diluted in 1 to 5% 
skimmed milk powder in TBST or 5% BSA in TBST (for working dilutions and supplier 
of antibodies see Table 1) and membranes were incubated at 4°C overnight with rocking. 
Blots were washed for 5 min at least three times in TBST. Membranes were incubated with 
secondary antibodies goat-anti-mouse IgG or goat anti-rabbit IgG conjugated with 
horseradish peroxidase (Bio-Rad) diluted at 1 to 10,000 in 5% skimmed milk powder in 
TBST for 1 h at RT. Membranes were washed three times for 10 min each in TSBT and 
bands were detected using Amersham ECL Plus Western Blotting Detection Reagents (GE 
Healthcare) following the manufacturer’s instructions. 
2.2.3. Membrane stripping and reblotting 
Membranes were stripped of primary and secondary antibodies in Stripping Buffer (2% 
SDS, 62.5 mM Tris pH6.8 in water) freshly added with 100 mM β-mercaptoethanol 
(BDH) and incubated at 56°C for 30 min, with agitation every 10 min. Blots were washed 
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thoroughly in TBST for a total of 30 min and blocked and reprobed for another antigen, as 
described in Section 2.2.2. 
 
Table 1. Primary antibodies used in Western blotting analysis. 
Antigen Working dilution Supplier 
RaLP 1:100 Home-made 
Phospho-Erk1/2 (Thr202/Tyr204) 1:2000 Cell Signaling (9106) 
Erk1/2 1:5000 Santa Cruz (sc-94) 
Phospho-SMAD2 (Ser465/467) 1:1000 Cell Signaling (3108) 
SMAD2 1:1000 Cell Signaling (3103) 
Vinculin 1:15000 Sigma (V9131) 
 
2.3. Immunohistochemistry 
The teratomas were washed in PBS for 30 min to remove blood and fixed in 4% buffered 
formalin for 10 h. After paraffin embedding, consecutive 3 µm sections were mounted 
onto electrostatically charged glass slides. After heat drying, sections were deparaffinised 
in xylene two 5 min treatments and sequentially rehydrated in 100%, 70%, and 50% 
ethanol. Antigen unmasking pretreatments were performed according to the antibody and 
the sections were incubated in 3% aqueous hydrogen peroxide for 5 min to quench 
endogenous peroxidase activity. Primary antibodies for markers of differentiation (for 
working dilutions and supplier see Table 2) were diluted in Dako REAL™ Antibody 
diluent and immunostained using the Autoimmunostainer (DakoCytomation). 
 
Table 2. Primary antibodies used for immunohistochemical analysis. 
Antigen Working dilution Antigen unmasking Supplier 
GFAP 1:400 none Dako (6F2) 
Myogenin 1:800 none Dako (F5D) 
Keratin  1:400 pepsin 5 min 37°C Dako (MNF 116) 
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Commercially available detection kit (Dako EnVision Plus-HRP) was used, according to 
the manufacturer’s instructions. Peroxidase activity was developed with 3-3'-
diaminobenzidine-copper sulfate (Sigma Chemical, St Louis, MO) to obtain a brown-black 
end product. Sections were then counterstained with 1% modified Harris hematoxylin, 
dehydrated in two times for 5 min each in 100% alcohol and twice for 5 min in xylene, and 
mounted with Eukitt™ (quick-hardening mounting medium for microscopy). Images were 
taken using the microscope Olympus Upright BX51 equipped with a Nikon colour camera. 
 
2.4. Alkaline phosphase staining 
ESCs were seeded onto 0.1% gelatinised 6-well plates and allowed to grow for five days. 
Staining for alkaline phosphase was done following the manufacture’s instructions 
(Chemicon). Briefly, sodium nitrite solution and FRV alkaline solution was prepared and 
then the AS-BI alkaline solution was added to the mixture. The cells were rinsed with PBS 
and then fixed in formaldehyde, acetone and citrate solution containing fixative for 30 sec. 
The alkaline solution was added and reaction was allowed to develop at RT for 15 min in 
the dark. The stained wells were then rinsed in water. ESCs stain red for positivity of 
alkaline phosphatase and differentiated cells remain unstained. 
 
2.5. Immunofluorescence 
Cells grown on coverslips were fixed for 15 min in 4% PFA and washed three times in 
PBS for 5 min each. Cells were permealised for 10 min in 0.1% Triton X100. Aspecific 
binding was saturated by blocking in 5% goat serum (v/v; Euroclone) or 2% BSA (w/v) in 
PBS for 45 min at RT. Primary antibodies were diluted in blocking solution (for working 
dilutions and supplier, see Table 3) and cells were incubated for 1 h at RT. Cells were 
washed three times 5 min each in PBS and incubated with the appropriate fluorescently 
labelled secondary antibodies (Invitrogen and Jackson) diluted in PBS (for working 
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dilutions and supplier, see Table 1), for 1 h at RT. Unbound secondary antibody was 
removed by three washes of 5 min each in PBS. Nuclei were counterstained with 1 µg/mL 
4’,6-diamidino-2-phenylindole (DAPI; Sigma) in PBS for 30 min, coverslips were dipped 
in water, blotted to remove excess moisture and mounted onto slides in mowiol 
(Calbiochem). For combination with conjugated antibodies, following the three washes in 
PBS following the secondary antibody incubation, the primary-secondary complexes were 
post-fixed by 4% PFA treatment for 5 min. The cells were rinsed three times 5 min each in 
PBS and permealised for 10 min in 0.1% Triton X100 and blocked again in 2% BSA in 
PBS with 1:250 of mouse Gamma globulin IgG (Jackson) for 20 min at RT. Coverslips 
were incubated with antibodies directly conjugated with fluorochromes for 1 h at RT. Cells 
were washed three times 5 min each in PBS and incubated with 1 µg/mL DAPI in PBS for 
30 min. Coverslips were dipped in water, blotted to remove excess moisture and mounted 
onto slides in mowiol. Images were acquired with an Olympus fluorescence microscope 
equippd with a CoolSNAP EZ CCD camera (photometrics), using the MetaMorph® 
imaging software (Molecular Devices). For clarity, images were adjusted for contrast and 
brightness, and merged using Adobe Photoshop. 
 
Table 3. Antibodies used for immunofluorescence. 
Antigen Working dilution Supplier 
β-III-tubulin 1:2000 Covance (MMS-435P) 
MAP2 1:200 Chemicon (MAB3418) 
Nestin 1:200 Chemicon (MAB353) 
Oct3/4 1:500 Santa Cruz (sc-5279) 
Nanog 1:50 R&D systems (AF2729) 
GFAP 1:500 Dako (6F2) 
Sox1 1:50 Santa Cruz (sc-17318) 
Phalloidin-TRITC 1:10 Sigma (P1951) 
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Cdx2 1:50 Biogenex (CDX2-88) 
Oct3/4-Alexa Fluor 647 1:20 BD Pharmigen (560329) 
Phospho-Erk1/2 (Thr202/Tyr204) 1:500 Cell Signaling (9106) 
Goat anti-rabbit FITC 1:50 Invitrogen 
Goat anti-mouse Cy5 1:400 Invitrogen 
Donkey anti-mouse Alexa Fluor 488 1:100 Jackson 
 
2.5.1. Image acquisition by confocal analysis 
For immunofluorescence of EpiSC cultures, images were acquired using the Leica SP5 
Confocal Microscope at a 40× 1.25 NA oil immersion objective. To preserve statistical 
significant sensitivity and resolution, large fields of view (>1.2 mm) were acquired with a 
mosaic approach using the Matrix Software (Leica Microsystems). 
 
2.6. Flow cytometry analysis for intracellular antigens together with EdU detection 
To measure the proliferation rate of the cells, a thymidine analogue, 5-ethynyl-
2’deoxyuridine (EdU) was added to the cells in culture at a concentration of 10 µm for a 
pulse of 30 min. The supernatant of cells was collected together with the adherent cells, 
which were detached in accutase® at 37°C for 5 min. Cells were dissociated into single cell 
suspension by pipetting and centrifuged at 524 × g for 5 min. The pellet was resuspended 
in PBS and cell suspension was brought to a concentration of 106 cells/mL and distributed 
into tubes. Cells were spun down at 7000 × g for 5 min and resuspended in 500 µL of PBS 
and fixed by the addition of an equal volume of 2% formaldehyde and incubated on ice for 
20 min. Cells were washed in 1 mL 1% BSA in PBS and were resuspended in 500 µL PBS 
and immediately processed for staining or stored at 4°C until use. Cells were permealised 
in 100 µL of Triton X-100 provided by the Click-iT® EdU Pacific Blue™ Flow Cytometry 
Assay Kit (Invitrogen A10034) for 15 min in ice. Cells were washed in 1 mL 1% BSA in 
PBS and resuspended in 100 µL 1% BSA in PBS for 30 min for blocking of unspecific 
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binding. Cells were resuspended in primary antibody diluted in 100 µL of 1% BSA in 
PBS, for 1 h at RT (for working dilutions and supplier, see Table 4). After washing in 500 
µL of 1% BSA in PBS, cells were resuspended in 100 µL of 1% BSA in PBS containing 
secondary antibody and incubated for 1 h at RT (for working dilutions and supplier, see 
Table 4). After another wash in 1% BSA PBS, cells were then processed for EdU detection 
for 45 min at RT, following manufacturer’s instructions. Cells were finally resuspended in 
PBS containing 2.5 µg/mL propidium iodide (PI; Sigma) and 250 µg/mL RNase (Roche) 
and were left at 4°C overnight before acquisition. Negative samples were prepared by 
incubating only with secondary antibody. 
 
Table 4. Antibodies used for FACS analysis. 
Antibody Working concentration Supplier 
Oct3/4  1:100 Santa Cruz (sc-5279) 
Cleaved caspase-3 (Asp175) 1:50 Cell Signaling (9664) 
Goat anti-rabbit FITC 1:50 Invitrogen 
Donkey anti-mouse A647 1:100 Jackson 
 
Samples were acquired using the BD FACS Canto™ II equipped with laser 488 nm, 633 
nm and 405 nm. Data was analysed by the BD FACS Diva software version 6.1.1. 
Aggregates were excluded from analysis by appropriate gating of PI fluorescence. 
 
3. DNA methods 
 
3.1. Genotyping for RaLP 
Genomic DNA (gDNA) was extracted from ESCs cultured on 0.1% gelatin with the DNA 
extraction kit DNeasy Blood and Tissue (Qiagen) following manufacturer’s instructions. 
GDNA was eluted in water. The genotyping strategy was set up in collaboration with 
Materials and Methods 
 47 
Genoway for the generation of the RaLP KO mouse (for details refer to results section 2). 
Two PCR reactions were set up using two sets of primer pairs, differing for the reverse 
primer. With the two PCR reactions, the RaLP allele WT, HT or KO can be distinguished. 
The sequences of the primers are (5’-3’): 
GTRaLPF: AGATCAGATCCTCAGGAGCCAGAGG 
GTRaLPR2: TACCCTCACAGACCTTCAGAGCTGG 
GTRaLPR1: CCTTGGAGCAAAGTGGATCTGACTCTGG 
PCR conditions: denaturation at 95°C for 15 min followed by 35 cycles of 94°C 15 sec, 
65°C 1 min, 68°C 15 min, then 68°C for 10 min. The PCR products were run on a 1% 
agarose gel in Tris-acetate-EDTA (TAE) buffer with 0.5 µg/mL ethidium bromide with 
1kb DNA ladder (Biolabs).  
 
3.2. Genotyping for the presence of the Y chromosome 
For assessing the sex of the ESCs, the PCR strategy for the Y-linked gene Sry was 
employed [86]. 
Sry F: TGACTGGGATGCAGTAGTTC 
Sry R: TGTGCTAGAGAGAAACCCTG 
PCR conditions: denaturation at 95°C for 5 min followed by 35 cycles of 95°C 30 sec, 
65°C 30 min, 72°C 45 min, then 72°C for 10 min. The PCR products were run on a 1% 
agarose gel in TAE with 0.5 µg/mL ethidium bromide with 1kb DNA ladder (Biolabs). 
3.3. Karyotyping 
ESCs plated on 0.1% gelatin at 70% of confluency were cultured in the presence of 0.1 
µg/mL KaryoMAX® colcemid (Gibco) for 1 h, to block the metaphases. Cells were then 
trypsinised, collected and centrifuged at 520 × g for 10 min. After discarding the 
supernatant, 0.075M KCl hypotonic solution was added drop by drop to the pellet and 
incubated at 37°C for 30 min. For pre-fixation, four to five drops of fixative consisting of 
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three parts methanol and one part acetic acid, were added to the solution, followed by 
centrifugation at 520 × g for 10 min. Cells were resuspended gently by adding drop by 
drop while vortexing, 10 mL of fixative and centrifuged at 520 × g for 10 min. The pellet 
was resuspended in 1 mL fixative and 60 µL of the solution was dropped onto each slide 
pre-warmed at 57°C from about 30 cm in height. The drop was allowed to spread over the 
surface and dried. Metaphases and nuclei were stained in 1 µg/mL DAPI in Saline Sodium 
Citrate (SSC) for 5 min and dried overnight and then mounted in mowiol. For each slide, 
ten metaphases were randomly picked and those that were well spread and intact were 
scored for the number of chromosomes. Images were acquired with an Olympus 
fluorescence microscope equipped with a CoolSNAP EZ CCD camera (Photometrics). 
 
4. RNA methods 
 
4.1. RNA extraction and quantification 
Total RNAs were extracted from cells using the RNeasy Mini kit (Qiagen) following 
manufacturer’s instructions. GDNA was digested by on column treatment with RNAse-
Free DNAse (Qiagen) at RT for 15 min. RNA was eluted with RNAse free water. RNA 
was quantified with the Nanodrop ND-1000 Spectrophotometer (Thermo Scientific). 
Total RNA was extracted from blastocysts using the RNA picopuro extraction kit (MDS 
Arctus) following manufacturer’s instructions.  
 
4.2. cDNA synthesis 
For each sample, 1 µg of total RNA was reverse transcribed using Superscript III Reverse 
Transcriptase (Invitrogen) with 250 ng/µL random primers (Invitrogen) and 10 mM dNTPs 
(Invitrogen) in 20 µL of reaction volume, in the presence of 2U/µL of RNase inhibitor 
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RNase OUT™ (Invitrogen). Samples were incubated at 25°C for 5 min, 50°C for 1 h and 
70°C for 15 min. 
4.3. Quantitative real time PCR 
Quantitative real-time PCR (qRT-PCR) was performed on 7900HT Fast Real-Time PCR 
system (Applied Biosystems) using Fast SYBR® Green PCR Master Mix or TaqMan® 
Gene expression assays (Applied Biosystems). Correct PCR products were confirmed by 
melting curve analysis. Each sample was analysed in triplicates and normalised to an 
endogenous control. Normalisation was used to correct sample-to-sample variations in 
RNA concentration and integrity. Relative mRNA amounts were calculated by the 
comparative cycle threshold (Ct) method using the formula 2-ΔCt. Primers that were 
designed in house were done when possible spanning two exons and amplified sequence 
between 100 to 120 bp, using the Primer 3 program. 
 
Table 5. Primer sequences. 
Gene Primer sequence (5’-3’) Application 
RaLP p69  
F: GGGCCCATGGAGCCATTAAAA 
R: CTTTTGCCAAGAACCGTTGTCA 
Reporter: ACTTAACGGGAGCCTTTC 
Custom Taqman gene expression 
assay  
TBP Applied Biosystems ID: Mm00446973_m1 Taqman gene expression assay 
TBP F: CTGGAATTGTACCGCAGCTT R: TCCTGTGCACACCATTTTTC SYBR
® green real-time PCR 
Oct 3/4 F: CCAATCAGCTTGGGCTAGAG R: CTGGGAAAGGTGTCCCTGTA SYBR
® green real-time PCR 
Nanog F: AAGGATGAAGTGCAAGCGGTG R: GGATAGCTGCAATGGATGCTG SYBR
® green real-time PCR 
Rex1 F: GGACTAAGAGCTGGGACACG R: GCGATCCTGCTTTCTTCTGT SYBR
® green real-time PCR 
Klf4 F: CTCTGCTCCCGTCCTTCTC R: AGAGAGTTCCTCACGCCAAC SYBR
® green real-time PCR 
Sox2 F: CTCTGCACATGAAGGAGCAC R: ATGTAGGTCTGCGAGCTGGT SYBR
® green real-time PCR 
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Sox1 F: AGATGCACAACTCGGAGATCAG R: GAGTACTTGTCCTTCTTGAGCAGC SYBR
® green real-time PCR 
Fgf4 F: TGGGTGTGATGCTGTTTCAT R: CTCAGGGTCCTTCTCACTGC SYBR
® green real-time PCR 
Fgf5 F: GCTGTGTCTCAGGGGATTGT R: CATCCGTAAATTTGGCACTTG SYBR
® green real-time PCR 
Otx2 F: ACAAGTGGCCAGTTCAGTCC R: CTGGGTGGAAAGAGAAGCTG SYBR
® green real-time PCR 
Nestin F: AGGCTGAGAACTCTCGCTTGC R: GGTGCTGGTCCTCTGGTATCC SYBR
® green real-time PCR 
Brachyury [87] F: CCTCCCTTGTTGCCTTAGAGTAGTT R: GCAGATTGTCTTTGGCTACTTTGTC SYBR
® green real-time PCR 
Gata 4 F: CTGTGCCAACTGCCAGACTA R: CCTGCTGGCGTCTTAGATTT SYBR
® green real-time PCR 
Gata 6 F: ATGCTTGCGGGCTCTATATG R: TACCGGAGCAAGCTTTTGAC SYBR
® green real-time PCR 
Cdx2 F: TCACCATCAGGAGGAAAAGTG R: CTGCTGCTGCTTCTTCTTGA SYBR
® green real-time PCR 
Hand1 [87] F: CCCCTCTTCCGTCCTCTTAC R: CTGCGAGTGGTCACACTGAT SYBR
® green real-time PCR 
Tbx3 F: GAACCTACCTGTTCCCGGAAA R: CAATGCCCAATGTCTCGAAAAC SYBR
® green real-time PCR 
Foxa2 F: TAGCGGAGGCAAGAAGACC R: CTTAGGCCACCTCGCTTGT SYBR
® green real-time PCR 
Stella F: TGTCGGTGCTGAAAGACCCTAT R: TTTCCTTCGAGCCTTTTTTGTC SYBR
® green real-time PCR 
Cer1 F: CTCTGGGGAAGGCAGACCTAT R: CCACAAACAGATCCGGCTT SYBR
® green real-time PCR 
Sox7 F: ATGCTGGGAAAGTCATGGAAG R: CGTGTTCTGGTCACGAGAGA SYBR
® green real-time PCR 
Flk1 F: GGGTCGATTTCAAACCTCAATGT R: AGAGTAAAGCCTATCTCGCTGT SYBR
® green real-time PCR 
Ck18 F: CAGCCAGCGTCTATGCAGG R: CTTTCTCGGTCTGGATTCCAC SYBR
® green real-time PCR 
Ck19 F: GGGGTTCAGTACGCATTGG R: GAGGACGAGGTCACGAAGC SYBR
® green real-time PCR 
Sox17 F: CGAGCCAAAGCGGAGTCTC R: TGCCAAGGTCAACGCCTTC SYBR
® green real-time PCR 
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4.4. RNA whole mount in situ hybridisation 
Until the hybridisation step, all solutions for washing or incubating the specimens were 
prepared with diethyl pyrocarbonate (DEPC)-treated water or PBS. DEPC was added at a 
final concentration of 0.1% and solutions were autoclaved to hydrolyse any remaining 
DEPC. 
4.4.1. Collection of embryos 
Embryos were dissected away from the extraembryonic tissues in PBS with 1% FBS. 
Embryos were fixed in 4% paraformaldehyde in PBS at 4oC overnight. Embryos were then 
washed in DEPC treated PBS containing 0.1% Tween-20 (PBT) three times, 5-10 min 
each. They were dehydrated in consecutive 5 min treatment in 25%, 50%, 75% methanol 
in PBT and two times in 100% methanol. Embryos were stored at -20oC until use. 
4.4.2. Probe preparation 
For linearisation of the in situ plasmid (Figure 9), 10 µg of plasmid DNA was incubated 
with 10-20 units of the restriction enzyme, NotI for 1 h. An equal volume of 
phenol/chloroform/IAA (25:24:1) was used to extract the digest, followed with a 
chloroform/IAA (24:1) extraction. One µl of glycogen and 5 µl of 3M NaOAc (pH 5.2) 
were added to the extracted DNA and then 110 µl of cold 100% ethanol was added and 
stored at -20 oC for 1 h. To pellet the DNA, the mixture was centrifuged at at maximum 
speed (16060 × g) for 20 min at 4 oC. The pellet was rinsed with 70% ethanol and allowed 
to air dry. The pellet was resuspended in 10 µl DEPC-treated water to have a final 
concentration of linearized plasmid of about 1 µg/µl. For the synthesis of the digoxigenin 
(DIG)-labelled probe, the DIG RNA labeling kit (Boehringer no. 1175 025) was used 
following the manufacturer’s instructions. 
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Figure 9. Map of the plasmid containing the RaLP cDNA used as template to synthesise the anti-sense 
probe for in situ hybridisation. The plasmid was linearised with NotI and the probe was in vitro transcribed 
by T7 RNA polymerase. 
 
4.4.3. In situ hybridisation 
Prior to hybridisation, embryos were rehydrated in reverse order in the methanol/PBT 
series. Embryos were rinsed twice in PBT for 5 min each. Embryos were then bleached by 
incubating for 1 h in fresh 6% hydrogen peroxide (H2O2) in PBT followed by three washes 
of 5 min each in PBT. Embryos were incubated in 10 µg/ml proteinase K in PBT for 5-10 
min and washed for 5 min in 2mg/ml glycine in PBT, twice for 5 min each in PBT and 
fixed again in 4% PFA additioned with 0.2% glutaraldehyde for 20 min at RT. After 
another two washes in PBT, the embryos were washed for 10 min in a 1:1 mixture of PBT 
and hybridisation solution [50% formamide, 5× SSC, 0.1% Tween-20, 0.1% SDS, 50 
µg/mL heparin, 50 µg/mL yeast tRNA and 60 mM citric acid (Sigma)]. Embryos were 
then incubated at 70 oC in hybridisation solution for 2 h and then incubated with 50 to 100 
ng of probe (2-4 µl/ml) in hybridisation solution and incubated overnight at 70oC. The next 
day, embryos were washed in prehybridisation solution for 5 min at 70 oC, followed by 
three 30 min washes in wash solution I (50% formamide, 5× SSC, 0.06 M citric acid, 1% 
SDS) at 70 oC, then another three 30 min washes in wash solution II (50% formamide, 2× 
SSC, 0.024 M citric acid, 0.2% SDS, 0.1% Tween) at 65oC. Then the embryos were 
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washed three times for 5 min each in MAB buffer (0.012 g/mL maleic acid, 0.17 M NaCl, 
0.001% Tween-20; pH was adjusted to 7.5 by the addition of NaOH pellets) at RT. In 
order to prevent nonspecific binding, embryos were incubated for 1 h in MAB with 2% 
Boehringer blocking reagent (from DIG detection kit) containing 10% heat-inactivated 
sheep serum. Blocking solution was then removed and antibody was added and rocked 
overnight at 4 oC. The next day, embryos were washed five times for 1 h each in MAB and 
washed overnight in 2 mM levamisole (Sigma) in MAB at 4oC in order to inhibit 
endogenous phosphatases. For colour development, the embryos were washed for 10 min 
three times in alkaline phosphatase buffer at RT then stained by incubation in development 
solution at RT until the desired level of staining developed. Then reaction was stopped by 
rinsing twice in 2 mM EDTA in PBT. Embryos were post-fixed in 4% PFA/0.1% 
glutaraldehyde in PBT for 1 h at RT or overnight at 4oC and washed twice in PBT. 
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Results 
 
1. Characterisation of RaLP expression in the mouse 
 
In order to gain insight into the function of RaLP and to identify the ideal model system to 
characterise its role and dissect its signalling pathway, the expression pattern of this gene 
during development and in the adult mouse was first investigated. 
 
1.1. Expression pattern of RaLP during embryogenesis 
1.1.1.  RaLP expression in preimplantation and early post-implantation embryos 
Preliminary studies on RaLP expression conducted at the beginning of this PhD project 
using embryonic stem cells (ESCs) and the embryoid body differentiation protocol 
evidenced its expression at low levels in the ESCs and its upregulation during the early 
stages of ESC commitment (described in detail in results section 4). These results 
prompted us to investigate the expression of RaLP in vivo by qRT-PCR and whole mount 
in situ hybridisation (WISH) on the pre-implantation and early postimplantation embryos. 
The qRT-PCR analysis evidenced low RaLP expression in the morula at E2.5 and higher 
expression in the inner cell mass, isolated by immunosurgery, of the early blastocyst at 
E3.5 (Figure 10A). The first differentiation event that occurs in the embryo is during the 
formation of the blastocyst at E3.5 and at this stage, the cells are allocated to either the 
embryonic (inner cell mass) or extraembryonic lineages (trophoblast). In order to confirm 
RaLP expression specifically in the inner cell mass and not in the trophoblast, we decided 
to proceed with WISH of embryos at E3.5 (Figure 10B). We found that RaLP transcript 
was detected only in the inner cell mass. 
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Figure 10. Analysis of RaLP expression in the morula and blastocyst by qRT-PCR and whole mount in 
situ hybridisation. (A) qRT-PCR for RaLP in the morula and inner cell mass (ICM) of wild-type embryos. 
The relative expression values were normalized to TBP. (B) WISH for RaLP in blastocyst at E3.5 shows the 
presence of the transcript in the ICM (indicated by black arrowhead). 
 
The WISH on later stages of embryonic development revealed RaLP expression also in the 
epiblast of the embryo at E4.5 (Figure 11). Around the time of implantation at E4.5, the 
inner cell mass is further segregated into the epiblast and the surrounding primitive 
endoderm (hypoblast). However, from this WISH, the expression of RaLP in the primitive 
endoderm cannot be excluded. The expression of RaLP in the epiblast was transient as it 
could no longer be detected at E5.5 and throughout the stages of E6.5 and E7.5. 
These results suggest a specific function of RaLP in a narrow developmental window 
during which the epiblast of the pre-implantation embryo transforms into the epiblast of 
the post-implantation embryo. 
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Figure 11. Whole mount in situ hybridisation of RaLP in early post-implantation embryos. Embryos at 
E4.5 (peri-implantation), E5.5, E6.5 and E7.5 were probed for the presence of RaLP transcript (upper panel). 
RaLP was detected at E4.5 in the inner cell mass/epiblast (black arrow). The illustration in the lower panel 
describes the formtation of the compartments of the embryo at the same timepoints (adapted from Lu C. et 
al., Curr Opin Genet and Dev 2001 [88]). Abbreviations: anterior visceral endoderm (AVE), days post 
coitum (dpc), inner cell mass (ICM), visceral endoderm (VE). 
 
To investigate whether RaLP expression is then induced after gastrulation stages, embryos 
at E8.5 were analysed (Figure 12). RaLP expression appears in the developing neural tube, 
suggesting that when neural specification begins, RaLP is de novo upregulated. 
 
 
Figure 12. Whole mount in situ hybridisation of RaLP in E8.5 embryo. Signals of the RaLP transcript 
were detected along the neural tube (black arrows). 
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1.1.2. Radioactive in situ hybridisation in embryos from E10.5 to E16 
For the determination of the temporal-spatial expression pattern of RaLP during later 
stages of development, with particular attention as to whether RaLP is expressed in the 
nervous system, RaLP transcripts were detected using radioactively labelled probes on 
sagittal and transversal sections of embryos of day E10.5, E12.5 and E16 (Figure 13). At 
E10.5 RaLP expression was evident in the cephalic ganglions V, VII, VIII, IX, subregion 
of the optic vesicle (ov), dorsal root ganglia (drg), basal region of the forebrain 
corresponding to the septum (se), cortex (cx) and the anterior hypothalamus (ahy). 
Notably, these are all regions that derive from neural crest cells. Signal was also detected 
in the dorsal aorta (da), a region rich in haematopoietic percursors, that is however often a 
source of aspecific signal. 
Slightly later at E12.5, the general expression pattern remained constant, with evident 
expression also in the cephalic ganglion V (V), the pineal gland (pi), the internal ear (ie) at 
the level of the primordial cochlea (co) and the olfactory epithelium (oe). Furthermore, 
RaLP transcripts were observed ubiquitously in the developing central nervous system 
(CNS) and in particular, the subventricular region of the telencephalon (te), diencephalon 
(di), mesencephalon (ms) and the precursor area of the cerebellum (cbp). 
At E16, RaLP expression was maintained in the CNS and signal could be detected also at 
the level of the basal ganglia (ba), in the pons (po) as well as the rostral migratory steam 
(rms) extending to the olfactory bulb (ob). At this developmental stage, it seemed that low 
RaLP levels were present also throughout other organs such as the intestines (gu), kidney 
(ki), liver (li), lungs (lu), thymus (ty), tongue (to) and mandible (ma). 
These results show that RaLP is expressed in areas of the developing brain, suggesting a 
neural function of this gene during later stages of embryogenesis. 
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Figure 13. Radioactive in situ hybridisation for RaLP in E10.5, E12.5 and E16.5 mouse embryos. For 
each embryonic stage, the panel consists of two rows: the upper row shows sagittal sections and the lower 
row shows transverse sections of the embryos, at different heights. Regions of signal are indicated by 
abbreviations and/or white arrowhead. In summary, RaLP transcripts were evidenced in the dorsal root 
ganglia, cranial ganglia and regions of the developing brain. Abbreviations: anterior hypothalamus (ahy), 
basal ganglia (ba), cephalic ganglion V (V), cephalic ganglion IX (IX), cerebellum (cb), cerebellar precursors 
(cbp), cortex (cx), primordial cochlea (co), dorsal aorta (da), diencephalon (di), dorsal root ganglia (drg), 
dorsal thalamus (dt), forebrain (fb), intestines (gu), internal ear (ie), kidney (ki), liver (li), lungs (lu), 
mandible (ma), midbrain (mb), mesencephalon (ms), olfactory bulb (ob), olfactory epithelium (oe), optic 
vesicle (ov), pineal gland (pi), pons (po), rostral migratory stream (rms), septum of forebrain (se), 
telencephalon (te), tongue (to). 
 
1.2. Expression pattern of RaLP in the adult mouse 
Following the specific expression of RaLP in the developing nervous system of the embryo 
during later stages of development, its expression in adult tissues was examined by 
quantitative real-time polymerase chain reaction (qRT-PCR) to determine whether this 
pattern of expression was maintained and whether it could be an interesting area to focus 
our studies on. The results showed that RaLP was expressed in all the different brain 
regions, the olfactory bulb, cerebral hemispheres and cerebellum, at high levels compared 
to the other tissues (Figure 14). The cerebellum expressed the highest levels of RaLP. All 
other tissues had low or undetectable levels of RaLP transcripts. This data is in agreement 
with results published by Jones and colleagues [22], at the protein level. 
 
 
Figure 14. RaLP expression in adult mouse tissues. QRT-PCR analysis of RaLP in different organs. The 
RNA was pooled from three mice. Relative expression level of RaLP was determined by normalisation to the 
expression level of 18S and calibrating to RaLP levels in spleen. 
Results 
 60 
Our analysis of RaLP expression in the mouse during embryogenesis and in the adult 
showed that it was expressed in two time frames. Firstly, during the early stage of 
embryogenesis in the pluripotent epiblast and secondly, during the later stages of 
development in regions of the developing nervous system. Then its expression persists in 
the mature central nervous system in the adult. This data suggests that RaLP could have 
distinct functions in the two different windows of time during development. We decided to 
pursue the studies of RaLP in both these contexts and therefore, the PhD project has been 
subdivided into these two broad lines of research: 
- The role of RaLP during early embryonic development 
- The role of RaLP during neurogenesis 
 
2. The generation of the RaLP knockout mouse model 
 
One of the most powerful tools for investigating and understanding the function of a gene 
in vivo, is the generation of a mouse mutant for the gene of interest. There are several 
strategies to obtain mutations in mice, one of the most widely used methods is to introduce 
a mutation by gene targeting in embryonic stem cells (ESCs) and to then introduce it into 
the animal through the germ-line transmission. 
We decided to investigate the role of RaLP by generating a RaLP knockout (KO) mouse 
model in collaboration with Genoway. Although I was not directly involved in the work, 
the strategy, experimental procedures and results will be briefly explained in this section as 
it is pertinent to the following thesis work. 
 
2.1.  Mapping of the murine RaLP gene 
With the murine C57Bl/6 BAC sequence (BAC AC104549) containing the RaLP gene, we 
identitified the corresponding murine RaLP locus in the C57Bl/6 Ensembl database. The 
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analysis of these two sequences allowed the rearrangement of the BAC sequence that was 
non-linear and to fill in the gaps in the Ensembl sequence. The murine RaLP gene is 
located on chromosome two and extends over more than 96 kb. The gene consists of 12 
exons and 11 introns. The translation intitiation site is located in exon one and the coding 
region extends to exon 12.  
 
2.2. Strategy for the genetic deletion of mRaLP gene 
As the mRaLP gene extends over more than 96 kb and the deletion of the whole gene is 
technically difficult. For this reason, the null mutation has to be generated by targeting a 
specific domain of the mRaLP gene. The mRaLP protein contains, like the other Shc 
family proteins, two functional domains that mediate protein to protein interaction: from 
the amino-terminal end, the phospho-tyrosine binding domain (PTB) and the Src 
homology domain (SH2). These two domains are preceded by a region called the collagen 
homology domain two (CH2) and bridged by the collagen homology domain one (CH1). 
There were two main aspects that were taken into consideration for selecting the region of 
the gene to target. Firstly, the homology of the regions and domains across the family 
members was investigated. Generally, the domains are well conserved among the Shc 
proteins, whereas the regions show lower similarity. In fact, RaLP had the lowest 
similarity in the CH2 region compared to the other family members [22], suggesting that 
this region may sustain an important specificity for the RaLP protein. Secondly, we 
considered the expression pattern of RaLP. The tissue specific and temporally regulated 
expression suggests the existence of regulatory elements upstream of the gene at the level 
of the promoter. Therefore, the region to disrupt was decided to be the mRaLP exon one, 
as this exon encodes for the whole CH2 region, together with the removal of a 2 kb region 
containing 1.5 kb of the promoter region and the first exon which contains the translation 
intiation site, ATG. Furthermore, at the level of exon five, there is another gene Eid1 that 
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is transcribed in the reverse direction, so targeting exon one, the expression of this gene 
may not be perturbed. The general scheme of the targeting strategy is illustrated below in 
Figure 15. 
 
 
Figure 15. The targeting strategy for the generation of the knockout RaLP allele. Part of the promoter 
region and exon one containing the transcription intiation site was targeted by homologous recombination. 
The targeted allele can then be excised upon Cre treatment. 
 
This strategy also allows the development of a conditional KO model from the same 
targeted embryonic stem cell (ESC) clone or chimera, as the mice carrying the targeted 
allele could be bred to specific mice expressing Cre in a tissue specific manner, to remove 
RaLP expression only in those tissues. 
 
2.3. Cloning of the mRaLP targeting construct 
The targeting vector was generated by first amplifying the two homology arms (the long 5’ 
homology arm and the short 3’ homology arm) by PCR from the BAC sequence containg 
the murine RaLP gene (BAC AC104549). These homology arms were subcloned into a 
pCR4-TOPO vector and the sequence was verified. The selection cassette FRT-NEO-FRT-
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loxP was inserted at the 5’ end of the short homology arm. In the long homology arm, the 
second lox-P site was introduced, and these arms were then joined together. 
The final targeting vector (LAF1-HR) has the following features: 
- two homology arms 
- total homology with the targeting allele for 8 kb 
- asymetrical repartion of the homology on the selection cassette sides (short and long 
homology arms) 
- FRT sites allowing the Flp-mediated excision of the positive Neo selection cassette 
- LoxP sites allowing the CRE-mediated deletion of exon one together with part of its 
promoter region of the RaLP gene 
- DTA negative selection cassette 
 
2.4. Targeting of ESCs by homologous recombination 
For the introduction of the targeting vector in ESCs, the vector was first linearised by 
digestion with KpnI restriction enzyme and the resulting 16.5 kb fragment was purified by 
phenol/chloroform extraction followed by ethanol precipitation. Then 100 µg of linearised 
plasmid was then electroporated into 100 million 129Sv ESCs (from GenOway) at 800 
Volt, 300 µF. Positive selection for clones that have internalised the plasmid was started 48 
h after electroporation by the addition of 200 µg/mL of G418. 
175 geneticin resistant clones were harvested and amplified in 96-well plates. These ESC 
clones were then screened by PCR for the detection of the homologous recombination 
event. 
 
2.5. In vitro excision of the targeted region and ESC blastocyst injection of clones 
The successfully targeted clones #2A6 and #3A5 that were verified by southern blot 
analysis for the integration were employed for the Cre-mediated excision of the target 
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region. The clones were electroporated with 40 µg of supercoiled Cre-expressing plasmid. 
The transfected cells were then plated at low density and allowed to form colonies. No 
selection was applied at this stage. Clones with the best morphology were then isolated and 
amplified in 96-well plates. The clones were then used for the PCR identification of the 
right CRE-mediated excision event. 
ESCs that have successfully undergone Cre-mediated excision, #2A6-5 and #2A6-10, were 
injected into C57BL/6 blastocysts and were transferred into CD1 pseudo-pregnant females. 
The results are summarized below in Table 6. 
 
Table 6. Summary of Cre-mediated excised clones blastocysts injections. 
Clone 
number 
 
Injected 
blastocysts 
 
Foster 
mothers 
Pregnant 
foster 
mothers 
Total 
number of 
pups 
Death Male Chimera 
Female 
chimera 
2A6-5 60 4 1 5 0 - 1 
2A6-10 60 4 2 14 10 - - 
2A6-5 30 2 1 2 0 - - 
2A6-10 30 2 0 0 - - - 
 
The injections performed gave rise to 21 pups among which one female with 90% 
chimerism. As female chimeras have low probability of germ line transmission, this female 
was not selected for further breeding. As no male chimeras were obtained even at such 
large number of injections, we decided to pursue an alternative approach to accelerate the 
time of generation of the KO model. 
 
2.6. In vivo excision of the targeted region and generation of floxed mRaLP mouse 
The alternative approach taken for the generation of the KO model was to mediate Cre-
excision in vivo by breeding the targeted mRaLP mice to ubiquitously Cre-expressing 
mouse line. To this end, the three floxed ESC clones #3A5, #2A6 and #2A12 were injected 
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into C57BL/6 blastocysts and were transferred into CD1 pseudopregnant females. The 
results are summarized below in Table 7. 
 
Table 7. Summary of mRaLP floxed ESC clones blastocyst injections. 
Clone 
number 
 
Injected 
blastocysts 
 
Foster 
mothers 
Pregnant 
foster 
mothers 
Total 
number of 
pups 
Death Male Chimera 
Female 
chimera 
2A12 44 3 1 7 0 1 - 
2A6 13 1 0 - - - - 
3A5 30 2 1 1 0 - - 
2A6 15 1 1 6 0 1 - 
 
The injections gave rise to 14 pups among which were two male chimeras, one at 95% 
generated from clone 2A12 and another at 65% of chimerism generated from clone 2A6.  
These two males carrying the mRaLP floxed allele, were bred with 129Sv CMV/Cre-
expressing female mice. From the breeding with chimera generated from ESC clone 
#2A12, 15 F1 mice were obtained, among which seven wild-type animals, two mRaLP 
floxed heterozygous animals and six mRaLP KO heterozygous animals. The resulting six 
animals in which the Cre-mediated deletion of the mRaLP promoter region, exon one and 
the slection cassette was observed, were further anlysed by Southern blot. The results 
further confirmed that these animals were true heterozygous mRaLP KO mice. 
For the generation of the F2 animals, the heterozygous mRaLP KO male was then 
intercrossed with three heterozygous mRaLP KO females. This breeding resulted in the 
generation of 23 mice. Nineteen animals with the complete deletion of the targeted region, 
were obtained. These animals were then used for breeding to establish the RaLP KO 
colonies in our lab. 
Up to date, the RaLP KO animals generated are viable and fertile. They show no gross 
morphological abnormalities at the levels of the organs, analysed by 
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immunohistochemistry. Detailed analysis of the KO animal will be described later in 
results section 5.3. 
 
3. The derivation and characterisation of RaLP heterozygote and 
knockout ESCs 
 
For in vitro studies to understand the function of a gene during embryogenesis, the system 
of choice is ESCs. ESCs are isolated from the pre-implantation embryo and are pluripotent, 
as they can differentiate towards any lineage of the three germ layers and self-renewing, as 
they can propagate indefinitely in vitro [37,38]. ESCs allow the circumvention of the 
limitations of quantity and inaccessibility that one encounters when manipulating early 
stage embryos. 
For investigating the role of RaLP in early development, RaLP heterozygote (HT) and 
knockout (KO) ESCs were derived. For the derivation strategy, we followed the protocol 
optimised by Stefano Casola (IFOM-IEO campus), which consists in transferring the 
blastocysts and passaging the cells onto inactivated mouse embryonic fibroblasts (MEFs) 
in the presence of a specific mitogen-activated protein kinase/extracellular signal-regulated 
kinase (MEK1) inhibitor PD98059, which has been shown to facilitate the derivation 
process by suppressing differentiation cues and enhancing the effect of LIF on self-renewal 
[83,84]. In the first ESC derivation experiment, three couples of RaLP HT female and 
RaLP KO male mice were set-up. We obtained only twelve morulae from one female. 
Eight blastocysts could be used for the derivation and we obtained one ESC line, which 
revealed to be a RaLP HT ESC line (for the genotyping strategy, see section 3.1). We 
immediately proceeded with a second derivation experiment in order to obtain RaLP KO 
ESCs and we increased the number of couples, by setting up matings between eight 
couples of RaLP HT female and RaLP KO male mice. Three females were plugged and 23 
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morulae were recuperated at dpc 2.5 and after 48 h of in vitro culture, and 15 blastocysts of 
adequate quality were obtained which were used for ESC derivation. From this first 
experiment, four ESC clones were successfully derived. To have independently established 
RaLP KO ESC lines, a third derivation experiment was done, this time intercrossing three 
RaLP KO female and males. Sixteen morulae were flushed from two females and 15 
blastocysts were used for the derivation. From this experiment, nine ES clones were 
obtained. 
 
Table 8. Summary of ESC derivation experiments. 
Derivation 
experiment 
Crossing 
 
Number of 
blastocysts 
Number of ESCs 
derived 
1 HT♀ × KO♂ 8 1 
2 HT♀ × KO♂ 15 4 
3 KO♀ × KO♂ 15 9 
 
3.1. Genotyping of derived ESCs 
The established cell lines were genotyped using the PCR strategy designed by Genoway. 
The strategy consists in using two primer pairs that use a different reverse primer in order 
to distinguish the KO allele from the wild-type allele. The first primer pair is the 
GTRaLPF which anneals upstream of exon one and the targeted region, and FGRaLPR1 
which anneals flanking the downstream region of exon one, which is no longer present in 
the knockout allele as it is excised upon Cre treatment. With this primer pair it is possible 
to distinguish the WT and HT from the KO allele, as the KO will not have any amplified 
product. The second primer pair, the GTRaLPF and the GTRaLPR2, which anneals to the 
sequence after the targeted region, will yield two different products for the wild-type and 
KO allele. The wild-type alle will give rise to a longer product of 6 kb, whereas the KO 
allele which a part of this region has been excised, will give rise to a shorter fragment of 
3.5 kb. The PCR reaction with this primer pair yields one product of 6 kb for the wild-type 
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allele, two products of 6 kb and 3.5 kb for the heterozygote and only the 3.5 kb for the KO 
allele. This reaction however, will favour the amplification of the shorter product and 
therefore it is difficult to distinguish both the bands in the HT, and so it will only 
discriminate between the WT and HT allele. The summary of the genotyping strategy and 
the PCR reactions for the derived ESCs that were used for this study can be seen in Figure 
16. 
 
 
Figure 16. Genotyping strategy and RT-PCR for RaLP wildtype, heterozygote and knockout alleles. 
(A) The relative annealing positions of primer pairs GTRaLPF and GTRaLPR1, FGRaLPF and FGRaLPR2 
are shown together with the amplified products that they will yield in the wild-type and KO allelels. (B) The 
RT-PCR with the primer pairs for the derived ESCs used for this study. The controls are gDNA from mice 
that have been previously genotyped. 
 
3.2. Karyotyping of derived ESCs 
As a next step in the characterisation of the derived ESCs, the karyotype analysis was done 
to exclude chromosomal abnormalities. ESCs are known to accumulate abnormalities and 
metacentric chromosomes are the most frequent chromosome abnormality observed 
throughout the period of culture. Aneuploidy in ESCs is the major cause of failure in 
obtaining contributions to all tissues of chimeras including the germ line [89], as well as a 
source of misinterpretation of data in in vitro experiments. Furthermore, ESCs with 
abnormal karyotype can still retain ESC markers such as Oct3/4 and SSEA-1 [90], 
therefore the control of chromosomal number in addition to the expression of ESC markers 
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is essential. Generally, ESCs with 70 to 80% normal karyotype are used for chimera 
production, therefore we decided to use as the requisite for ESC lines to use for our 
studies, a threshold of 80% and above of normal karyotype. Representative pictures of the 
karyotype of the ESC lines used for this study are in Figure 17. One heterozygote line 
(HT3) carried a metacentric chromosome and was excluded from the studies. 
Studies have shown that also long-term culturing of ESCs favours the accumulation of 
chromosomal abnormalities even in lines that start off with a normal karyotype [90]. 
Therefore, for our studies, our derived ESCs were used for experiments at the maximum of 
30 passages in culture. 
 
 
Figure 17. Karyotype of derived ESC lines used for this study. Reverted images of DAPI banded 
karyotypes of wild-type (WT) ESCs at passage 23, RaLP heterozygous (HT1, HT2 and HT3) and RaLP 
knockout (KO1 and KO2) ESC lines. The RaLP HT and KO ESCs have been karyotyped at early passages as 
soon as stable lines were established. Red dots indicate chromosomes and the total number of chromosomes 
(2n=40) is indicated in red at the top left corner of each image. An example of chromosomal abnormality 
observed in HT3, with the presence of a metacentric chromosome indicated by a black arrowhead. 
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3.3. Characterisation of derived ESCs for pluripotency markers 
ESCs possess three defning properties: self-renewal, pluripotency and primary chimera 
formation. The property of pluripotency is governed by a triad of transcription factors: 
Oct4, Nanog and Sox2 [91,92]. The derived ESCs were analysed for the expression of the 
pluripotency markers Oct3/4 and Nanog by immunofluorescence and alkaline phosphatase 
activity (Figure 19). All ESC lines were positive for Oct3/4, Nanog and alkaline 
phosphatase activity. Several other markers are also expressed in ESCs, such as Klf4, 
Rex1, Sox2 and Fgf4. The expression of these markers was confirmed in all cell lines by 
qRT-PCR (Figure 18). 
 
 
Figure 18. qRT-PCR for ESC markers Fgf4, Sox2, Rex1 and Klf4 in WT, derived HT (HT1 and HT2) 
and KO (KO1 and KO2) ESC lines. All ESCs express the pluripotency markers. Bars represent the means 
± S.D. of triplicates. 
 
The commonly used E14Tg2a WT ESCs and the two derived RaLP HT ESCs (HT1 and 
HT2) were used as independent control populations for all experiments. ESCs are mutable 
in culture and can display different behaviour among cell lines, therefore it is important to 
validate any observed phenotype on more than one cell line. Unless otherwise specified, all 
the experiments presented in this thesis have been performed with at least two 
independently derived RaLP KO ESCs (KO1 and KO2). 
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Figure 19. Characterisation of derived ESCs. WT ESCs and derived ESCs RaLP heterozygote (HT1 and 
HT2) and knockout (KO1 and KO2) lines were characterised for ESC markers. Panels from left to right: first 
panel shows a bright field picture of ESCs grown on inactivated feeder cells. The second panel is alkaline 
phosphatase staining of ESCs grown on gelatin. Third panel is immunofluorescenct images of Oct3/4 and 
merged with DAPI. Fourth panel is immunofluorescent images of Nanog merged with DAPI. Scale bar 
represents 50 µm. White arrowheads in the immunofluorescence images of ES WT indicate nuclei of MEFs 
as an example, they are present in also all the other images. 
 
3.4. Genotyping of derived ESCs for Y-chromosome linked gene SRY 
The ESCs were also genotyped for the Y-linked gene Sry, by RT-PCR. ESC lines used for 
experiments are shown below in Figure 20. The WT, KO1, KO2 and HT1 ESC lines 
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resulted positive for the Sry gene, therefore are male whereas the HT2 line resulted 
negative and therefore, female. 
 
 
Figure 20. RT-PCR for Sry in ESC lines used for this study. The derived ESCs were genotyped for their 
sex by RT-PCR for the Y-linked gene, Sry. 
 
3.5. Summary 
It is possible to derive, in the absence of RaLP, self-renewing ESCs. Under self-renewal 
culture conditions in the presence of LIF and serum, RaLP KO ESCs showed no overt 
difference in morphology, expression of ESC and differentiation markers, compared to WT 
or RaLP HT ESCs. We conclude that the absence of RaLP does not impair the derivation 
and the establishment of bona fide ESCs. 
 
4. In vitro functional characterisation of RaLP during development  
 
4.1. Analysis of RaLP expression during embryonic stem cell differentiation  
4.1.1. Embryoid body differentiation of ESCs and the regulation of RaLP expression 
Firstly, we examined whether RaLP expression was regulated in a similar manner as in 
vivo, by inducing ESC differentiation that comprises the change of culture conditions from 
a two-dimensional monolayer to a three-dimensional suspension culture and subtracting a 
cytochine that promotes the self-renewal of ESCs, the Leukemia Inhibitory Factor (LIF), 
from the medium. Under these conditions, ESCs form spheroid aggregates and these 
structures were first termed embryoid bodies (EBs) because of their resemblance to mouse 
blastocysts [40]. EBs are used as a model system for investigating events in embryogenesis 
in vitro as they recapitulate many aspects of early mammalian development in a 
Results 
 73 
progressive manner. They first generate the visceral/primitive endoderm and subsequently, 
the three embryonic germ layers endoderm, ectoderm and mesoderm are formed. The germ 
layers then develop into more differentiated lineages such as neural progenitors [93], 
haematopoeitic cells [94], cardiomyocytes [95] and hepatocytes [96]. Although EBs are 
able to form a wide variety of cell types and follow events occurring during 
embryogenesis, it was thought that it takes place in a rather disorganised manner. 
However, a recent study revealed that EBs display an unexpected degree of self-
organization, seen by the establishment of anteroposterior polarity and the formation of a 
primitive streak-like region that is dependent on the local activation of the Wnt pathway 
[45]. This strongly supports the use of EBs as a good model system to address 
developmental questions. 
There are several protocols for the production of EBs, the most used are suspension culture 
in bacterial-grade dishes [44], methylcellulose culture [97] and hanging drop culture [94]. 
Each method has its advantages and disadvantages, and one of the important issues to 
consider is the formation of a homogenous population of EBs. The size and shape of EBs 
influences their differentiation bias and speed and therefore, heterogeneously sized EBs 
will rapidly lose synchrony and grow at different rates while generating different lineages 
in varying proportions. This will be an issue for interpreting results within a single 
experiment as well as the reproducibility between experiments. For these reasons, we 
decided to use the hanging drop protocol for the derivation of EBs (Figure 21A), as it 
provides a system to control the number of ESCs aggregating in a single EB. First, we 
optimised the protocol in our hands. WT and RaLP HT ESCs were allowed to aggregate to 
form EBs and the differentiation was monitored by verifying the gene expression pattern 
during the process by qRT-PCR on day zero (ESCs), day two, day three, day four, day six 
and day nine of differentiation (Figure 21B). It is known that the first three days of 
differentiation correspond to the pre-implantation to peri-implantation stage of 
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embryogenesis. In fact, also in our system the pattern of gene expression was in agreement. 
Rex1, a stringent marker of the inner cell mass or ESC, decreased rapidly after day one of 
differentiation (Figure 21C). ESC and epiblast markers Oct3/4, Fgf4 and Nanog were 
gradually downregulated between day zero to day three, and then their expression became 
negligible. Day two, which marks the formation of the epiblast as seen by the upregulation 
of its marker Fgf5, was accompanied by the upregulation of the endoderm marker Gata 4 
and postimplantation epiblast and mesoderm marker, Brachyury, were also upregulated at 
the beginning of the differentiation. After the first phase (first three days of differentiation) 
during which the three primary germ layers have been generated, a central cavity starts to 
form in the EB and they resemble the embryo in the egg cylinder stage and gastrulation at 
this stage. This is reflected by the upregulation of markers of more differentiated cell 
types, such as Sox1 for the neuroectoderm and nestin for neural precursors. Both WT and 
HT ESCs gene expression profiles were similar. Overall, the gene expression profile were 
in agreement with previous studies that have characterised the EB differentiation process 
[47,50], confirming that the protocol is efficient and is reproducible in our hands. 
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Figure 21. Embryoid body differentiation of ESCs. (A) Scheme of the method used for ESC 
differentiation to embryoid bodies. Single ESCs were allowed to aggregate by hanging drops and after two 
days, the EBs were transferred to bacterial dishes for suspension culture. (B) The morphology of EBs at the 
stage of differentiation corresponding to the experimental points in which EBs were collected for analysis. 
Day two and day three EBs are known as simple EBs and from day four onwards are termed cystic EBs as 
they start to cavitate. (C) The qRT-PCR analysis of marker gene expression patterns during EB 
differentiation. Three groups of marker genes were analysed: ICM and epiblast markers Oct3/4, Nanog, Fgf4 
and Rex1; the germ layer markers Fgf5 (epiblast/primitive ectoderm), Brachyury (epiblast/mesoderm) and 
Gata4 (endoderm); and neuroectoderm markers Sox1 and Nestin. Bars represent the means ± S.D. of 
triplicates. 
 
We then studied the kinetics of RaLP expression during EB formation by qRT-PCR 
analysis. Results evidenced its low levels of expression in ESCs and its tight upregulation 
during a narrow time-window spanning day two and day three of differentiation (Figure 
22). Previous studies [47,98] and our gene expression profiles during the EB 
differentiation have shown that this time-window corresponds to the formation of the 
primitive ectoderm or post-implantation epiblast. Notably, after day three after the 
formation of the three germ layers, RaLP transcript levels were rapidly downregulated and 
remained at low levels of expression. These results evidenced that: 1) ESC differentiation 
to EB mimics closely the events in vivo, 2) RaLP expression is correlated to the emergence 
of the epiblast and is downregulated once the epiblast differentiates further and 3) RaLP 
regulation in vitro using the EB system, is similar to in vivo. 
 
 
Figure 22. The kinetics of RaLP expression during EB differentiation of ESCs. (A) RaLP expression 
was analysed by qRT-PCR at different timepoint of EB differentiation of WT ESCs. RaLP was upregulated 
sharply during day two and three of differentiation. RaLP expression levels were normalised to Gapdh and 
ESCs. Bars represent the means ± S.D. of triplicates. 
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Next, we examined the response of RaLP KO ESCs to EB differentiation. Overall, the 
differences in gene expression of some of the markers could be seen in the time window 
during which RaLP is expressed, day two and three (Figure 23). The pluripotent marker 
Oct4 gradually downregulated in the HT while in the KO on day two it remains at the same 
levels and followed by a sudden drop in expression. Rex1, another pluripotent marker 
behaved in the same way between HT and KO. Interestingly, all the early germ layer 
markers, Fgf5, Gata4 and Brachyury were upregulated in anticipation in the KO. It was 
very difficult to give an interpretation to these results as the population consists of several 
cell types. Perhaps in the absence of RaLP, ESCs respond to differentiation more quickly, 
although this cannot account for delay in Oct4 downregulation on day two. A more 
specific differentiation protocol is necessary to dissect the effects more precisely. 
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Figure 23. Comparison of gene expression profiles during embryoid body differentiation of RaLP HT 
and KO ESCs. Analysis of Oct4, Rex1, Fgf5, Gata4, Brachyury (T) and Sox1 during the EB differentiation 
by qRT-PCR. Bars represent the means ± S.D. of triplicates. Shown are representative results from five 
independent experiments. 
 
4.1.2. Neural differentiation of ESCs 
To confirm that the transient RaLP expression is due to the formation of epiblast during in 
vitro differentiation and not due to the phenomenon of the aggregation of ESCs, we 
transferred ESCs into a differentiation induction system comprising an adherent monolayer 
culture in the absence of exogenous growth factors and feeder-free conditions [48]. These 
conditions are permissive for neural commitment and are driven by autocrine signalling. It 
is the best characterised system for derivation of neural lineages from ESCs. Studies have 
shown that this differentiation in vitro appears to accurately mirror what occurs in vivo 
both in terms of the order of events and the signalling pathways [50,51]. 
In order to be able to monitor the differentiation process and to ascertain that it is 
undergoing optimally in our hands, we first used a reporter cell line, the 46C ESCs (Austin 
Smith, Cambridge) that harbours a knock-in of GFP to one allele of the neural 
specification marker gene Sox1 [85]. Sox1 is the earliest neural specific marker of neural 
precursors in the mouse embryo [99] and during the monolayer differentiation, its 
expression gradually increases during the first few days as the ESCs commit to neural fate 
and this can be followed by FACS analysis for GFP positive cells. At day four in our 
differentiation, the population of cells consisted of 50% GFP positive cells as was reported 
[85] and furthermore, the qRT-PCR analysis of gene expression markers showed the 
expected pattern of downregulation of pluripotency markers Oct4 and Rex1, transient 
upregulation of epiblast marker Fgf5 and gradual upregulation of neuroectodermal marker 
Sox1, confirming that the protocol is optimal also in our hands (Figure 24). 
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Figure 24. Expression profile of pluripotent and differentiation markers during the first days of neural 
differentiation of ESCs. Analysis of Oct4, Rex1, Fgf5 and Sox1 during the first days of differentiation by 
qRT-PCR. Bars represent the means ± S.D. of triplicates. 
 
During the first few days of neural induction, ESCs acquire the epiblast identity prior to 
undergoing neural commitment [50]. This was also observed during our differentiation 
with the upregulation of epiblast marker Fgf5 and downregulation of inner cell mass 
marker Rex1, by qRT-PCR. To assess whether the upregulation of RaLP during epiblast 
formation is a general event in vitro and not only confined to the EB system, we subjected 
the 46C ESCs and RaLP WT ESCs to neural commitment conditions and monitored the 
kinetics of RaLP expression in the differentiating cells at several stages: day zero (ESCs), 
day two, day four, day six and day eight by qRT-PCR (Figure 25A) and Western blotting 
(Figure 25B). RaLP expression showed a similar pattern to the one observed in EB 
differentiation. It was regulated in a narrow-time-window, being upregulated on day two of 
differentiation and then rapidly downregulated by day four, both at the RNA and protein 
level in WT ESCs. Also the RaLP HT ESCs showed the same RaLP expression pattern as 
the WT ESCS (data not shown). The 46C ESCs showed similar pattern although there 
RaLP protein persisted for a longer time, as a weaker band was present at day four. The 
peak of RaLP expression at day two was consistent. The slower downregulation of RaLP 
in the 46C is probably due to an instrinsic characteristic of the cell line. 
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Figure 25. RaLP expression profile during the neural differentiation of ESCs. (A) RaLP expression by 
qRT-PCR shows a timed upregulation on day two of differentiation in WT ESCs. Expression level was 
normalised to TBP as housekeeper gene and ESC as calibrator. Bars represent the means ± S.D. of triplicates. 
(B) Western blotting of RaLP on WT ESCs show the same kinetics as RNA regulation, with a peak of 
expression on day two. (C) RaLP expression in a commonly used ESC line 46C show a slightly different 
kinetics with longer window of RaLP expression, but with the same peak on day two. 
 
Shc family proteins are known to mediate the stress response of cells [13]. In order to 
discriminate whether RaLP upregulation in this differentiation protocol is not due to stress 
caused by change in culture conditions (for example by the removal of serum), we 
examined separately the components that were removed for the differentiation in relation 
to the increase in RaLP transcript levels, by qRT-PCR after 48 h (Figure 26). Results 
showed that RaLP is not upregulated by the removal of serum; therefore it is not caused by 
a stress response of the cells to change in culture conditions. In contrast, RaLP was 
upregulated only in the conditions that allowed differentiation, i.e. when the self-renewal 
factor LIF was removed, suggesting that RaLP upregulation is strictly correlated to the 
differentiation process of ESCs. 
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Figure 26. RaLP expression under several culture conditions. WT ESCs were cultured under several 
culture conditions for 48 h: normal ESC conditions (control), ESC medium without LIF (-LIF), ESC medium 
without FBS (-FBS) and neural differentiation medium (N2B27). RaLP expression was analysed by qRT-
PCR. RaLP was not upregualted due to the removal of FBS and was upregulated only under conditions that 
allow the exit from self-renewal (i.e. –LIF and N2B27). Bars represent the means ± S.D. of triplicates. 
 
The expression pattern during ESC to NSC differentiation of the other Shc family 
members was analysed by qRT-PCR (Figure 27). p66ShcA is the only member that is 
expressed in ESCs and its levels gradually decrease during neural differentiation. 
Interestingly, ShcB/Sli and ShcC/Rai had a complementary pattern to p66ShcA, starting 
with low levels in ESCs and increasing during the differentiation, with the highest levels 
when the ESCs are fully committed to neural fate. This in vitro data is in agreement with in 
vivo studies that have shown that ShcA proteins are expressed in non-neuronal tissues 
while ShcB and ShcC are expressed in nervous tissue [100]. Furthermore, it has been 
shown that there is a switch from ShcA to ShcC when the neural progenitor cells 
differentiate and mature into neurons [101]. RaLP showed a distinct pattern from the rest 
of the members of the family, with a sharp peak on day two of differentiation. Each Shc 
family member displayed their own specific expression pattern that did not overlap with 
that of RaLP, suggesting a unique role of this member in this the process of ESC exit from 
self-renewal and commitment to the epiblast identity. 
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Figure 27. Expression profiles of Shc family members during the neural differentiation of ESCs. The 
kinetics of expression of the Shc family members (RaLP, p66ShcA, Rai and Sli) were analysed by qRT-PCR. 
The relative expression values were normalised to TBP. Bars represent the means ± S.D. of triplicates. 
 
These data, together with the in vivo data, confirm the epiblast -specific expression of 
RaLP, suggesting a specific role/s of this protein in this cell type. Furthermore, the similar 
regulation of RaLP expression in this in vitro system compared to the in vivo counterpart, 
sustains the use of ESCs for our purpose of characterising the function of RaLP.  
 
4.2. RaLP is specifically expressed in Epiblast stem cells 
The transient pattern of RaLP expression during the EB and NSC derivation protocols 
provides only a two-day time-window in the context of a population that comprises several 
cell types, to study the role of RaLP. This represented an important challenge for our 
studies and in fact, initial experiments using these differentiation protocols (see previous 
section 4.1.1) did not give clear-cut results and were difficult to interpret. To facilitate our 
studies of dissecting the function of RaLP, we decided to use an alternative ESC 
differentiation protocol, based on our in vivo and in vitro data that suggests that RaLP 
expression is epiblast-specific. Epiblast stem cells (EpiSCs) have been isolated from the 
egg cylinder of the early post-implantation mouse embryo [59,60]. These cells are self-
renewing and pluripotent as they can be maintained in culture indefinitely and can form 
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derivatives of the three germ layers in vitro and generate teratomas. On the basis of their 
global gene expression and epigenetic patterns, these cells are considered most similar to 
the pluripotent cells of the post-implantation epiblast [59,60,78]. We decided to investigate 
whether RaLP expression is truly specific to the epiblast by qRT-PCR in two 
independently established post-implantation embryo derived EpiSC lines, OE6 and OE7 
(renamed for our studies, EpiSC1 and EpiSC2, respectively), compared to OES ESCs 
(from Austin Smith, Cambridge [78]). These ESC and EpiSC lines have been derived from 
mice carrying the Oct4GiP transgene [102], in which the GFP and puromycin resistance 
genes are under the control of the pluripotent cell-specific Oct4 promoter. This allows the 
monitoring of the cell population and to select only for cells that express Oct4 either by 
GFP or by puromycin resistance, allowing therefore, in both ESCs and EpiSCs to have a 
homogenous pluripotent population of cells in culture. The qRT-PCR analysis for RaLP 
expression showed that it was indeed expressed at very high levels in the two EpiSC lines 
(Figure 28) and its fold induction relative to its levels in ESCs was between 80 to 100-fold. 
This was significantly higher compared to the induction of RaLP observed during the EB 
and NSC differentiation protocol, as previously described. This was probably due to the 
fact that these differentiation protocols generate a mixed population and do not consist of a 
pure epiblast population. This data confirms that RaLP expression is specific to the 
epiblast in vivo and in vitro. 
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Figure 28. RaLP expression in ESC and EpiSC lines. qRT-PCR for RaLP in ESCs, EpiSC lines EpiSC1 
and EpiSC2 derived from Oct4-GFP mice. MRNA levels of RaLP were determined by normalising to TBP 
and ESC. Bars represent the means ± S.D. of triplicates. 
 
It is possible to study the formation of the epiblast by a protocol recently established by 
Guo and colleagues [78]. It consists in plating ESCs on fibronectin and culturing them in 
the presence of factors important for the self-renewal of EpiSCs; basic Fibroblast growth 
factor (bFGF) and activin A (Figure 29A). These cells can be propagated for many 
passages in culture and can also be cryopreserved. The protocol was first optimised in our 
hands. We saw that the optimal initial seeding density was low at 100,000 cells per 6-well. 
After 24 h the medium was switched from ESC medium to N2B27 medium containing 
bFGF and activin A. ESCs grew as flattened colonies consisting of morphologically 
homogenous small cells growing in close contact to one another (Figure 29B). After the 
first passage of these cells, the differentiation is accompanied by a notable amount of cell 
death, probably due to a selection of those cells that are not able to undergo the program of 
differentiation towards the epiblast. We observed that the key to an optimal differentiation 
is to maintain the cell density high during passaging. After several passages, usually 
between passage four and five, it was possible to obtain a relatively homogenous 
population of ESC derived EpiSCs (ES-EpiSCs). It must be mentioned however, that a 
certain degree of differentiation is always present in the culture, as reported also by others 
[103]. The cells generated at these passages grow as tight, flattened colonies that are 
morphologically indistinguishable from EpiSCs derived from the post-implantation 
embryos (Figure 29C). Alkaline phosphatase activity is a hallmark of ESCs [104] and 
primordial germ cells (PGCs) [105] Therefore the lack of alkaline phosphatase activity of 
the ES-EpiSCs distinguishes them from ESCs, PGCs and embryonic germ cells (EGCs) 
(Figure 29D). QRT-PCR analysis for ESC and EpiSC markers on cultures at passage five, 
showed the characteristic gene expression profile of EpiSCs (Figure 29E): maintenance of 
the expression of Oct4, which is a marker for both cell types and the downregulation of 
Results 
 84 
inner cell mass and ESC markers Rex1, Klf4 and Tbx3 [59,60] was observed. Stella is an 
ESC marker as well as a germ cell marker and it was also downregulated [106,107]. Nanog 
was slightly downregulated but still expressed in EpiSCs, although its expression was 
slightly lower when not cultured on feeders [103]. In contrast to ESCs, EpiSCs express 
early lineage specification markers, underlining their more “primed” state to differentiate. 
Markers of the primitive ectoderm, Fgf5 and Orthodenticle homeobox 2 (Otx2) and of the 
early mesoderm Brachyury were all expressed in our ES-EpiSCs. Postimplantation epiblast 
associated genes such as Cerberus 1 (Cer1) and Forkhead transcription factor 2 (Foxa2) 
were also highly upregulated. Furthermore, as an assay to test the pluripotency of the ES 
derived EpiSCs, we differentiated them towards EBs, as they should retain the ability to 
differentiate into the three germ layers. And indeed, they could form EBs that when then 
transferred to adherent conditions, could differentiate as they attached and expanded with 
many cell types outgrowing from the EBs (Figure 29F). After ten days of differentiation of 
the EBs they expressed many markers of derivatives of all three germ layers, ectoderm, 
mesoderm and endoderm at high levels, evidencing their advanced differentiation status. 
They also expressed the trophoectoderm markers Cdx2 and Hand1, which has also been 
previously reported in postimplantation derived EpiSCs [60]. To our knowledge, this is the 
first time that ES-EpiSCs have been shown to have the capacity to form EBs. In summary, 
this protocol effienciently derives EpiSCs that possess the markers and ability of the 
postimplantation embryo derived EpiSCs and is an ideal system to study the commitment 
of the ESCs towards EpiSC fate. 
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Figure 29. Characterisation of the derivation of EpiSCs from ESCs. (A) Scheme of the protocol for the 
derivation of EpiSCs from ESCs. ESCs were plated at low density on fibronectin in ES medium. After 24 h 
the medium was changed to N2B27 containing Activin A and Fgf2 and the cells are passaged at high density. 
(B) The morphology of cells at each passage of differentiation corresponding to the experimental points in 
which cells were collected for analysis. Black arrowheads indicate EpiSC colonies and asterisks indicate 
differentiated non-EpiSC cells (C) Comparison of morphology of postimplantation derived EpiSCs (left) 
with ESC derived EpiSCs (right) grown on MEFs. ES-EpiSCs show typical flattened colonies 
indistinguishable from the postimplantation derived EpiSCs. (D) Alkaline phosphatase (AP) staining of ESCs 
before the differentiation and EpiSCs after differentiation. EpiSCs are negative for AP. (E) Gene expression 
profile of EpiSCs at passage five of differentiation; The relative expression of each gene is compared to its 
expression level before differentiation. Bars represent the means ± S.D. of triplicates. (F) Embryoid body 
differentiation of postimplantation derived EpiSCs and ESC derived EpiSCs. EB susp is an EB in 
suspension, EB ad is EB allowed to attach and differentiate further in a culture dish for seven days. Shown 
below is the gene expression profile of EpiSCs derived EBs after ten days of differentiation, The expression 
of each gene is relative to the housekeeper TBP. Bars represent the means ± S.D. of triplicates. 
Abbreviations: ectoderm (Ect), mesoderm (Mes), endoderm (End) and trophectoderm (Troph). 
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After optimising the protocol in our hands and critically assessing its validity, we looked at 
the kinetics of RaLP expression during this differentiation. Interestingly, it was 
upregulated starting from passage two and its levels remained more or less constant even 
up to many days in culture (passage ten, which corresponds to about one month in culture) 
as long as the cells were of EpiSC identity (Figure 30A). At the protein level, RaLP 
expression could be detected already at passage one although at much lower levels than at 
passage two. The weaker bands at passage four and five could be due to lower amounts of 
protein loaded on the gel, compared to the previous passages. However, the differences in 
loading are not so large to completely account for the lower levels of RaLP protein at these 
passages. It cannot be excluded that there could be possible post-translational regulation of 
RaLP, for example through microRNAs. This aspect would be definitely worth 
investigating further. In summary, this protocol allowed us to have a system with a longer 
timeframe and specific cell population to study the role of RaLP. Furthermore, its 
upregulation during this differentiation strongly suggests its possible role in epiblast 
formation. 
 
 
Figure 30. RaLP expression pattern during ESC to EpiSC differentiation. (A) QRT-PCR analysis of 
RaLP expression at sequential passages during the differentiation. Relative levels of RaLP transcript were 
normalised to TBP and calibrated to ESCs. Bars represent the means ± S.D. of triplicates. 
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4.3. Derivation of EpiSCs from RaLP HT and KO ESCs 
To assess a potential contribution of RaLP to the formation and/or maintenance of epiblast 
identity, RaLP HT and KO ESCs were subjected to EpiSC differentiation. 
4.3.1. Morphology and cell growth of RaLP HT and KO cells 
After plating of RaLP HT and KO ESCs and during this first passage of differentiation, no 
significant morphological differences nor starting number of cells, could be observed. 
Depending on the progression of the differentiation replicate, morphological and cell 
growth differences between the RaLP HT and KO ESCs could be seen at the earliest at 
passage two (Figure 31). A fraction of RaLP KO cells started to acquire a more flattened 
and enlarged morphology compared to the HT, as well as the WT. The striking differences 
in morphology was consistently observed at passage three and four, when RaLP KO cells 
consisted of very few colonies and most of the cells were large and flattened and no longer 
growing in close contact to one another. 
 
 
Figure 31. Morphology of RaLP HT and KO cells during ESC differentiation to EpiSCs. Bright field 
images of RaLP HT and KO cells at passage one (p1), passage two (p2) and passage four (p4) of 
differentiation. Large images are taken at magnification x 10 while the smaller boxed images at top right 
corner are images taken at a magnification of x 20. 
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During the differentiation, the number of cells in KO cultures gradually decreased from 
passage three and was significantly lower in RaLP KO cultures compared to the HT 
(Figure 32) in which the cells grew at a steady rate. 
 
 
Figure 32. Cumulative growth curve of RaLP HT and KO cells undergoing EpiSC differentiation. 
RaLP HT and KO ESCs are plated at a starting number of 100,000 cells for the differentiation and 
cumulative cell numbers were plotted at each passage of differentiation. For the first few passages cells grow 
at similar rates to HT. At passage three there was already a slight drop in growth rate of KO cells and the 
lower proliferative capacity persists into later passages. 
 
4.3.2. Analysis of ESC to EpiSC differentiation by multiparameter FACS 
In order to distinguish whether the lower number of cells in RaLP KO culture is due to a 
higher amount of cell death by apoptosis, a lower proliferation rate or the result of both the 
conditions and taking into account the possible heterogeneity of the cells composing the 
entire population, it was necessary to use several markers simultaneously to analyse the 
population. We decided to analyse the cultures by a multicolour fluorescence activated cell 
sorting (FACS) strategy using several markers: cleaved Caspase-3, Oct4, 5-ethynyl-
2’deoxyuridine (EdU) and propidium iodide (PI). This analysis provides us with several 
advantages when having to study differentiation in vitro, as firstly, it allows the analysis of 
a higher number of cells compared to the immunofluorescence method in a statistically 
significant manner. Secondly, the cleaved Caspase-3 staining allows the discrimination 
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between the apoptotic population and viable population, thereby not only obtaining 
information on the apoptotic index but also to analyse the viable population separately 
from apoptotic cells as the latter may downregulate markers because of their state. Thirdly, 
Oct4, which is a marker of both ESCs and EpiSCs, would allow us to follow the 
pluripotent population in relation to proliferation and apoptosis, during the differentiation. 
Fourthly, EdU in combination with DNA content measurement by PI allows us to analyse 
the distribution of the population during the different phases of the cell cycle and to 
investigate the proliferative capacity of the Oct4 expressing and not expressing cells. EdU 
is a thymidine analogue and is used as a substitute to BrdU to measure cell proliferation, as 
it can be given to live cells for a specific amount of time and only proliferating cells will 
incorporate EdU and in contrast to BrdU, it allows simultaneous detection of other 
antigens as it is not necessary to denaturate the DNA to detect it. Analysing the 
proliferation of the cells is important to discriminate whether the RaLP KO cells are 
cycling slower overall (therefore the completion of one cell cycle takes longer, i.e. the 
doubling time) or are persisting in a certain phase of the cell cycle for a longer period of 
time (for example, they are stuck in G1 for a longer time). For the analysis, HT and KO 
cells were collected at several timepoints during the differentiation: the starting population 
of ESCs, passage two, three and four. 
Setting up the protocol for flow cytometry using four fluorochromes was not so 
straightforward, as several parameters must be taken into consideration and tested. Not 
only the combination of fluorochromes must be considered but also the intensity relative to 
the abundance of the antigen that must be measured, fixation and permealisation methods 
that allow efficient detection of intracellular antigens as well as DNA in order to obtain a 
clean read-out. Many conditions as well as combinations of fluorochromes were tested and 
after several trials, we found that the most efficient combination resulted in the detection of 
cleaved caspase-3 in FITC, Oct4 in Cy5, EdU in pacific blue and DNA with PI. 
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As could be seen by observing the cultures during the differentiation, this protocol was 
accompanied by a substantial amount of cell death and this was also confirmed by the 
FACS analysis (Figure 33). The subG1 population seen by PI staining (columns one and 
three from the left) show a gradual increase of cell death during the passages and it is by 
programmed cell death, as cells stained positive for cleaved Caspase-3 (columns two and 
four from the left). Both in the HT and KO ESCs, the starting amount of apoptotic cells in 
the population are the same and constitute a minority of the population, as expected. 
Starting from passage two, there is an overall increase in apoptotic cells in both 
populations. Overall, KO cells showed similar amount of cell death as the HT. In 
particular, at passage three, there were slightly lower amounts of Caspase-3 positive cells. 
This cannot account for the significantly less number of cells observed during the 
differentiation in KO compared to the HT, indicating that there must be other processes 
that could provide the explanation, for example, differences in the rate of proliferation of 
the cells. 
We then decided to analyse the proportion of the pluripotent cells at each passage by using 
the region defined on the basis of cleaved Caspase-3 negativity (Figure 33, lower region) 
to analyse Oct4 expression only in the viable population (shown as green dots in lower 
region). 
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Figure 33. Analysis for the overall cell death and rate of apoptosis during the derivation of EpiSCs 
from ESCs by FACS staining for cleaved Caspase-3. RaLP HT (columns one and two from the left) and 
KO (columns three and four from the left) cells were analysed for cleaved Caspase-3 at passage zero (ESCs), 
two (p2), three (p3) and four (p4) of differentiation. The analysis is shown in a dot plot with PI intensities on 
the x-axis and FITC intensities on the y-axis. The cleaved Caspase-3 negative population is the region below 
and the Caspase-3 positive in region above. Shown as green dots are cells expressing Oct4 within the cleaved 
Caspase-3 negative region. 
 
An interesting general trend of Oct4 regulation could be observed during the transition of 
ESCs to EpiSCs (Figure 34). In the ESC population, there is a small fraction of cells 
(between 2 to 4%) that are negative for Oct4.which are probably differentiated cell types 
co-existing in culture with the ESCs. This is expected, as a certain degree of differentiation 
in culture is always present in ESC cultures. Upon differentiation initiation by the 
withdrawl of LIF and addition of FGF2 and activin A, there is a general downregulation of 
Oct4 which is the most striking at passage three when the majority of the population 
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becomes negative, leaving a 4 to 10% of cells expressing Oct4 in the HT and KO 
respectively. Then Oct4 expression is restored gradually so that by passage four in the HT, 
approximately half of the cells of the population are positive for Oct4 and this probably 
corresponds to the timewindow when EpiSCs are established, as can be seen already by the 
gene expression profile of the cultures. 
 
 
Figure 34. FACS analysis of Oct4 expression in HT and KO cells during ESC to EpiSC differentiation. 
Oct4 expressing (Oct4+, in yellow) and Oct4 non-expressing (Oct4-, in green) populations for the RaLP HT 
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(left column) and KO (right column) were analysed at passage zero (ESCs), two (p2), three (p3) and four 
(p4) of differentation. Shown are dot plots with Cy5 intensities on the y-axis and PI on the x-axis. For each 
sample, percentages of Oct4 positive cells are indicated. 
 
The comparision of the profiles between HT and KO evidenced an overall similar pattern 
of Oct4 regulation. However, the restoration of the Oct4 positive population at passage 
four is retarded in the KO, as the portion of cells expressing it remains lower in the KO 
compared to the HT, 42.09% and 36.71%, respectively. This observation could be due to 
the fact that the Oct4 expressing cells cannot differentiate efficiently and/or have 
proliferative defects in the absence of RaLP. 
In order to investigate further whether these differences could be explained by different 
proliferation capacities, we analysed separately on the Oct4 positive and negative 
population (both from the cleaved Caspase-3 negative population), the EdU incorporation 
in the HT (Figure 35) and KO cells (Figure 36). EdU together with DNA content by PI 
allows us to distinguish the cell cycle phases into S phase (EdU positive), G0/G1 (EdU 
negative, DNA content 2n) and G2/M (EdU negative, DNA content 4n). 
Generally we observed that in the ESC population, as it has been described in numerous 
studies, a significant portion of the cells expressing Oct4 are cycling cells (from 35 to 
50%) seen from the high number of cells that have incorporated EdU. On the other hand, 
the majority of the Oct4 negative cells were EdU negative and in the G0/G1 or G2/M 
phases, indicating that they were either cycling at a slower rate or not cycling at all. This 
could also be seen clearly from the different profiles of the DNA content by PI (first and 
third columns from the left in both Figures), where there are two high peaks corresponding 
to the cells in G0/G1 and G2/M phase of the cell cycle in the Oct4 negative populations. 
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Figure 35. FACS analysis of cell proliferation by EdU incorporation, classified according to Oct4 
expression in HT cells during ESC to EpiSC differentiation. Oct4 positive RaLP HT cells (columns one 
and two from the left) and Oct4 negative RaLP HT cells (columns three and four from the left) analysed for 
EdU at passage zero (ESCs), two (p2), three (p3) and four (p4) of differentiation. Columns one and three 
show the cell cycle of viable cells (Caspase-3 negative). Columns two and four are dot plots with Pacific 
Blue intensities on the y-axis and PI on the x-axis. The cell cycle phases were gated according to their EdU 
positivity and negativity, and DNA content based on their PI intensity. For each, the percentages of cells in S 
phase, G1 phase and G2/M phase are indicated. 
 
Interestingly, as ESCs are subjected to these differentiation conditions both the Oct4 
positive and negative populations contain cycling cells. The Oct4 negative cells now have 
an increase in their proliferation ability as a substantial portion of the cells have 
incorporated EdU. The proliferation capacities were particularly evident, at passage three 
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at which the majority of the Oct4 positive and negative populations in the HT are cycling 
cells (50.76% and 27.2%, respectively) whereas, in the KO there was a lower proportion of 
cells that have incoporated EdU in both the Oct4 positive (21.88%) and positive 
populations (8.73%). These differences from the HT were still evident at passage four, 
indicating that the absence of RaLP results in a defect in proliferative capacity. 
 
 
Figure 36. FACS analysis of cell proliferation by EdU incorporation, classified according to Oct4 
expression in KO cells during ESC to EpiSC differentiation. Oct4 positive RaLP KO cells (columns one 
and two from the left) and Oct4 negative RaLP KO cells (columns three and four from the left) analysed for 
EdU at passage zero (ESCs), two (p2), three (p3) and four (p4) of differentiation. Columns one and three 
show the cell cycle of viable cells (Caspase-3 negative). Columns two and four are dot plots with Pacific 
Blue intensities on the y-axis and PI on the x-axis. The cell cycle phases were gated according to their EdU 
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positivity and negativity, and DNA content based on their PI intensity. For each, the percentages of cells in S 
phase, G1 phase and G2/M phase are indicated. 
 
Taken together, this FACS experiment (which has been confirmed by an independent 
experiment and an additional control biological control with WT ESCs, data not shown) 
has shown interesting dynamics of the behavior of the Oct4 expressing cells during the 
differentiation of ESCs to EpiSCs. Furthermore, the absence of RaLP results in a defective 
ability of the cells to undergo proliferation and to maintain the Oct4 positive cells in their 
population. 
We next analysed the RaLP HT and KO EpiSCs cultures by immunofluorescence to assess 
whether the proliferative defect is overcome by long-term passaging (passage 10, which 
corresponds to about one month in culture; Figure 37). Firstly, the Oct4 staining clearly 
evidenced the two subpopulations observed in the FACS analysis: Oct4 expressing cells 
growing in colonies surrounded by Oct4 negative cells, suggesting that EpiSC cultures are 
heterogenous even at later passages. The HT cultures consisted of large colonies with the 
majority of the cells that were Oct4 positive. The RaLP KO cultures consisted of smaller 
Oct4 positive colonies surrounded by a majority of Oct4 negative cells, suggesting that 
there were still growth defects that affected particularly the Oct4 expressing compartment, 
suggesting that the phenotype caused by the absence of RaLP is not a transient 
phenomenon in this in vitro system. 
 
Results 
 97 
 
Figure 37. Immunofluorescence for Oct4 on RaLP HT and KO EpiSC cultures at passage 10. Images 
were taken at x40 and assembled with mosaic approach to view a wider field. Boxed images in the merged 
panel are zoom-in of EpiSC colonies. 
 
4.3.3. Investigating the heterogeneity of the EpiSC cultures 
The FACS data indicated the lower number of Oct4 positive cells in the RaLP KO cultures 
during the formation of the epiblast population and observing the cells during culturing, 
striking morphological differences could be seen. To visualise whether the Oct4 positive 
and negative population possessed different morphological characteristics, we stained the 
cells at the same timepoints taken for FACS, with Oct4 and actin (Figure 38). 
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Figure 38. Immunofluorescence for Oct4 and actin on HT and KO cells at passage four of EpiSC 
differentiation. At passage four, the majority of RaLP KO cultures consisted of Oct4 negative cells that 
were large and flattened and grew in isolation. Scale bar represents 50 µm. 
 
The immunofluorescence also confirmed lower levels of Oct4 overall seen by the FACS 
analysis, in the RaLP KO population. In particular, at passage four almost all cells in 
culture consisted of large, flattened, polinucleated cells that were Oct4 negative. Notably, 
the presence of these enlarged, flattened cells during the differentiation was not a 
phenomenon restricted to the KO cultures, as they were also present in the controls, the 
RaLP HT ESCs (Figure 39) and WT ESCs (data not shown). These large flattened cells 
typically arise on the borders of the colonies and they grew in isolation. 
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Figure 39. Immunofluorescence for Oct4 and actin of HT cultures at passage four of EpiSC 
differentiation. Images were taken at x40 and assembled with mosaic approach to view a wider field. The 
white arrowheads indicate the enlarged, flattened cells that are Oct4 negative typically located around the 
colonies and grow in isolation. 
 
The lower proliferation rate could be a result of the cells unable to undergo proper 
differentiation and therefore become senescent or the generation of a cell type that divide 
slower. The large, polinucleated morphology of the cells seemed reminiscent of a 
senescent phenotype, which could be caused by DNA damage. The RaLP KO and HT cells 
from passage zero to passage four were stained for DNA damage and senescent markers by 
immunofluorescence to examine this aspect (data not shown). p53 and phospho-
histone2AX signals were present but there were no differences between the RaLP HT and 
KO. There are studies that suggest that these markers might have a physiological role in 
ESC and in their differentiation process, in particular, p53 [108] and pH2AX (Andrew 
Xiao, personal communication). This would be an interesting aspect to examine, however, 
they are not informative markers in the contest of these studies and furthermore, we did not 
see any differences that could suggest that the KO are more senescent or have undergone 
more DNA damage than the HT. So we decided to shift our attention to understanding the 
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identity of the KO cells, in other words, whether the cells generated in the KO cultures are 
of another embryonic lineage, caused by a perturbed signalling pathway in the absence of 
RaLP, To this end, we screened for several markers of all lineages types by qRT-PCR on 
RaLP HT and KO cells from ESCs to passage five of differentiation (Figure 40). 
Oct4, which is a marker of ESC and EpiSCs, show fluctuating expression levels during the 
differentitiation but it is always expressed during the process. There did not seem to be 
striking differences of Oct4 between the HT and the KO. Nanog and Klf4 are 
downregulated more dramatically than Oct4, and their levels did not show any differences 
between the genotypes. Marker of EpiSC, FGF5 seemed slightly higher at passage two and 
three in the HT, however the general trend and upregulation was also observed in the KO. 
Endoderm (Gata6), postimplantation epiblast and mesoderm (Brachyury) markers showed 
overall a similar pattern of regulation between the HT and the KO, although they seem to 
be expressed at slightly lower levels in the KO at later passages. Overall, these markers did 
not show behave in very different manner, in the absence of RaLP. 
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Figure 40. qRT-PCR profiles of pluripotency and early lineage genes on RaLP HT and KO ESCs 
during EpiSC differentiation. Analysis of Oct4, Nanog, Klf4, Fgf5, Gata6 and Brachyury (T) during the 
EpiSC differentiation by qRT-PCR. Bars represent the means ± S.D. of triplicates. Shown are representative 
results from three independent experiments. 
 
However, when cells were analysed for extraembryonic trophoblast markers, the 
transcription factors caudal-type homeobox protein 2 (Cdx2) and the basic helix-loop-helix 
gene Hand1, the KO cells consistently showed an upregulation starting from passage two 
with a much higher expression fold by passage four (Figure 41.A). The formation of the 
trophectoderm and the inner cell mass marks the first differentiation event that occurs 
during embryogeneisis. The morula gives rise to the blastocyst with an outer epithelial 
layer which is the trophoblast, surrounding a compact mass which is the inner cell mass, in 
the cavity, the blastocoel at E3.5. The trophectoderm is fundamental for the implantation 
of the embryo and generates the specialised population of trophoblast cells that will form 
the placenta. Cdx2 is among the first transcription factors that are expressed to determine 
the trophoblast lineage and is required for trophoblast survival and maturation [109]. The 
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qRT-PCR data was confirmed at the protein level by immunofluorescence for Cdx2 on 
cells at passage four (Figure 41.C). Almost all cells in the KO cultures showed clear 
nuclear staining for Cdx2, whereas the majority of the HT cells showed weak cytoplasmic 
staining. This seems to suggest that in the absence of RaLP under EpiSC generating 
conditions, the majority of the cells in culture are trophoblast-like. Furthermore, several 
other important trophoblast specification genes such as Gata3 [110] and TEAD4 [111] 
were also expressed and at higher levels in the KO (Figure 41.B). The platelet derived 
growth factor receptor α (PDGFR) is expressed in a more differentiated type of trophoblast 
cells, the labyrinthine trophoblasts [112] and it was also expressed suggesting that in these 
cultures besides the presence of undifferentiated trophoblast-like cells, there was also 
differentiated subtypes. 
Notably, these Cdx2 positive cells were present also in the HT and WT. This is an 
interesting aspect, as murine ESCs contribute poorly to extraembryonic lineages of the 
trophoectoderm and endoderm when reintroduced into early embryos [42]. In fact, also in 
vitro, murine ESCs do not readily differentiate into cells of extraembryonic origin. These 
limitations could only be overcome by the genetic manipulation of key transcription 
factors that govern trophoblast development such as, Oct4 [113] and Cdx2 [114], or as 
shown recently by specifically manipulating cell culture conditions by modulating Wnt 
signalling [115] and the extracellular matrix [116]. 
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Figure 41. Trophectoderm markers are highly upregulated during EpiSC derivation in RaLP KO 
cells. (A) QRT-PCR for Cdx2 and Hand1 in RaLP HT and KO cells during differentiation at sequential 
passages. The relative expression levels for these markers have been normalised to TBP. Bars represent the 
means ± S.D. of triplicates. (B) QRT-PCR for TEAD4, Gata3 and PDGFR in RaLP HT and KO cells at 
passage four of differentiation. The relative expression levels for these markers have been normalised to 
TBP. Bars represent the means ± S.D. of triplicates. (C) Immunofluorescence for Cdx2 in RaLP HT and KO 
cells at passage four. Images were taken at x40 and assembled with the mosaic approach. Right panel are 
zoom-in images. 
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4.3.4. Dissection of the signalling pathway of RaLP 
ESCs and EpiSCs rely on different signalling pathways for their self-renewal in vitro. 
ESCs depend on the LIF-STAT3 and bone morphogenetic protein (BMP4) signalling, 
whereas EpiSCs are dependent on FGF-Erk1/2 and Nodal/Activin A-Smad2/3 signalling. It 
is very interesting that FGF-Erk1/2 signalling have opposite effects in these two cell states, 
as its activation is a differentiation cue in ESCs and in contrast, they are a self-renewal 
factor in EpiSCs. In order to gain insight in the role of RaLP and to understand how the 
absence of RaLP causes a defect in EpiSC formation in vitro, it is necessary to collocate 
this adaptor protein in a signalling pathway. We decided to start examining these two 
pathways that are important for the establishment and maintenance of EpiSCs, by Western 
blot analysis. Smad2/3 levels did not differ in a significant manner between the HT and 
KO during differentiation (Figure 42). However, Erk1/2 levels were consistently higher in 
the KO compared to the HT from passage two. 
 
 
Figure 42. Activation of Smad2 and Erk1/2 during EpiSC differentiation of RaLP HT and KO ESCs. 
The levels of phospho-Erk1/2 and phospho-SMAD2 were analysed at passage zero (ESCs), two, three and 
four of differentiation by Western blotting. 
 
There are several genetic manipulations that can be done to induce trophoblastic 
differentiation of ESCs: the knockdown of Oct4 [113], overexpression of Cdx2 [114], 
knockout of DNA methylase Dnmt1 [117] and overexpression of constitutively activated 
form of Ras [118]. Studies have shown that the Ras-MAPK signalling pathway during 
embryonic development can determine different lineage outcomes according to the levels 
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of its activation - higher levels determines differentiation towards extraembryonic lineages 
and moderate levels leads to the segregation to embryonic lineages. Although Erk 
activation is higher in the RaLP KO population, this effect might simply be a consequence 
of the perturbation of another pathway that is crosstalking with the Ras-MAPK pathway. 
In fact, the kinetics of Erk activation followed closely that of the Cdx2 expression during 
the differentiation of the KO cells, which could suggest that higher Erk1/2 levels are due to 
the higher number of trophoblast-like cells in the population. We investigated this further 
by immunofluorescence for phospho-Erk1/2 (Figure 43) on passage three of differentiation 
when the biggest differences was seen between the HT and KO by Western blotting. 
Generally, pErk1/2 is present within the population of both HT and KO, indicating that 
indeed during differentiation, this pathway is activated. Interestingly, different localisation 
of pErk1/2 was observed within the cell types within the population: cells growing in 
colonies had cytoplasmic pErk1/2 while isolated cells or cells located on the periphery of 
the colonies had nuclear pErk1/2. Furthermore, more cells with nuclear phospho-Erk1/2 
were observed in the KO population compared to HT. This data is in agreement with the 
hypothesis that the cells that are growing isolated are the differentiated cells and those that 
upregulate Cdx2, which is downstream of MAPK/Erk signalling. 
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Figure 43. Phospho-Erk1/2 by immunofluorescence at passage three of ESC to EpiSC differentiation of 
RaLP HT and KO cells. HT cultures (top panel) are mostly constituted of small cells growing as colonies 
and occasional isolated cells while the majority of the cells in the KO cultures (bottom panel) are growing as 
isolated, large cells. Images were taken at x40 and assembled with mosaic approach to view a wider field. 
The zoom-in (right column) of the mosaic images (left column) shows the different localisation of pErk1/2 
within the population. 
 
Firstly, in order to understand whether also in this context, the higher levels of Erk 
activation provides an instructive signal for the differentiation to Cdx2 positive trophoblast 
cells, we decided to inhibit its activation during the differentiation, starting from the 
timepoint when RaLP is upregulated (passage two) and to monitor its effects on Cdx2 
expression. A specific inhibitor of the upstream effector of Erk, MEK, the PD0325901 was 
added to the cultures at different concentrations, in order to have a partial inhibition of Erk, 
as abolishing its activity completely would have negative effects on the differentiation 
process itself (Figure 44A) [74]. 
The results show that firstly, high levels of Erk inhibition with the addition of 1 µM of PD 
caused overall cell death and it was not possible to obtain samples for analysis. Therefore 
we analysed only concentrations of 0.1 µM and 0.5 µM. The addition of the inhibitor did 
not counteract the morphological difference of the KO compared to the WT (Figure 44B). 
There are several possible explanations: one is that the inhibitor itself is not enough to 
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block the differentiation as other pathways are involved in the process or the addition of 
the inhibitor at passage two was too late, so once the cells are committed to this 
differentiation, the addition of the inhibitor does not disrupt them, as can be seen from the 
majority of flattened cells that survive even at high doses of PD0325901 both in the HT 
and in the KO. This could suggest that once the cells have committed to trophoblast fate, 
phospho-Erk1/2 provides only a sustaining signal. The interesting observation was that HT 
and KO populations showed a different sensitivity to the presence of the inhibitor. Most 
HT cells died and the only ones that survived and continued to grow were the flattened 
cells. In the KO, the majority of the population survived and there was less cell death 
overall than in the HT. 
 
 
Figure 44. Inhibition of phospho-Erk by MEK inhibitor PD0325901 during ESC to EpiSC cell 
differentiation passage two and three of RaLP HT and KO cells. (A) Scheme of the experimental set-up. 
Results 
 108 
Different concentrations of PD0325901 was added starting from passage two when RaLP is upregulated. (B) 
The morphology of the cells with and without the PD0325901. (C) QRT-PCR analysis for Cdx2 expression 
in RaLP HT and KO cells at different concentrations of the inhibitor at passage two and three of 
differentiation. The relative expression levelsof Cdx2 were normalised to TBP. Bars represent the means ± 
S.D. of triplicates. 
 
This reflects the different composition of the population of the HT and KO. EpiSCs cannot 
survive under ESC conditions of 2i/LIF and probably most cells that have died are because 
they are of EpiSC identity. 
We then analysed whether the partial attenuation of Erk1/2 activation has a consequence 
on overall Cdx2 levels in the RaLP HT and KO cultures, by qRT-PCR. At passages two 
and three, as has been observed previously, Cdx2 transcripts levels were higher in the KO 
compared to the HT. In the KO cultures at passage two, the addition of the PD0325901 at 
0.5 µM resulted in a lower level of Cdx2 compared to the control KO culture. At passage 
three, the decrease of Cdx2 expression was also observed in the presence of the 
PD0325901 at a lower concentration of 0.1 µM, in both RaLP HT and KO cultures. This 
data indicate that in this in vitro system, higher levels of phospho-Erk1/2 are correlated to 
higher levels of Cdx2. 
This experiment does not provide, however, a direct connection of RaLP with MAPK 
signalling. Previously in our lab, RaLP was proven to mediate MAPK signalling in the 
context of metastatic melanoma cells by its association to Grb2 upon IGF stimulation [12]. 
Further experiments are necessary to investigate how RaLP is involved in the regulation of 
MAPK signalling in this in vitro system and this will be described in the future plans in the 
discussion. 
 
4.4. Teratoma assay of RaLP HT and KO ESCs 
As an alternative assay to assess the effect of the absence of RaLP in ESC differentiation 
in vivo, we performed a teratoma assay using RaLP HT and KO ESCs. One million cells 
were injected subcutaneously into the hind flank of immunocompromised mice, the 
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interleukin 2 (IL2) gamma chain KO mice. The teratoma were measured and recuperated 
at three, four and five weeks after innoculation. The tumors were photographed and 
measured along the two major axes before and after the careful removal of the surrounding 
skin. At week four and five, the KO teratomas were reduced in size compared to the HT. 
All tumours at the three timepoints showed no presence of adherences with no extensions 
to the underlying fascia. Grossly, all the tumors were firm and homogenous, fleshy on the 
cut surface. No haemorrhage and necrosis were apparent. Internals organs were also 
grossly examined to exclude the presence of macroscopic metastatic deposits. 
Immunohistochemical analysis by hematoxylin and eosin staining of teratomas at three and 
four weeks evidenced the presence of derivatives of all the three germ layers in HT and 
KO (Figure 45A). This analysis also allowed distinguishing the nondifferentiated, 
proliferative portion of the tumour from the highly differentiated areas. The KO teratomas 
showed reduced areas of proliferative areas compared to the HT on several sections (data 
not shown). 
Immunohistochemical analysis of the teratomas was done using specific markers to further 
confirm the presence of differentiated tissues. Glial fibrillary acidic protein (GFAP; 
ectoderm), myogenin (mesoderm) and cytokeratin (endoderm) were all present in the HT 
and KO teratomas (Figure 45B), implicating that the differentiative ability in the absence 
of RaLP is not perturbed. 
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Figure 45. Analysis of RaLP HT and KO teratomas by immunohistochemistry.(A) Hematoxylin and 
eosin staining of RaLP HT and KO teratomas at 3 weeks (first row) and 4 weeks (second row). Derivatives 
of all three germ layers were present in both genotypes, first column of each genotype is at a magnification of 
X10. * glandular tissue (endoderm), ** muscular tissue (mesoderm) *** nervous tissue (ectoderm). **** 
Proliferative non differentiated areas of the teratoma (boxed in red) are shown in the second column at a 
higher magnification of X40, for each genotype. (B) Immunohistochemical analysis of the germ layer 
derivatives by staining with specific markers (for each genotype, right column) together with the 
corresponding hematoxylin and eosin staining (for each genotype, left column), magnification of X40. Glial 
fibrillary acidic protein (GFAP) for ectoderm, myogenin for mesoderm and cytokeratin for endoderm. 
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5. Functional characterisation of RaLP in neurogenesis 
 
5.1. Derivation and characterisation of RaLP HT and KO NSCs from ESCs 
The RaLP expression data during embryogenesis and in the adult, suggests a strong 
correlation with brain development and a brain specific function in the adult. In order to 
investigate which role RaLP plays in this context, we decided to derive neural stem cells 
(NSCs) from ESCs, using the monolayer differentiation protocol under defined conditions 
[48] which was already introduced in section 4.1.2 of results. As mentioned earlier, as 
ESCs commit to neural fate, they undergo distinct transitory states, which correspond to 
specific phases during development. 
We decided to use this protocol to investigate the role of RaLP but this time, allowing the 
cells to continue further through the process instead of stopping at day eight. On this day, 
the population of cells that have been primed to commit to neural fate are selected further 
for the neural stem cell population by culturing them in a medium containing factors 
important for proliferation and survival of NSCs, FGF2 and epidermal growth factor 
(EGF) (Figure 46A). Cells undergo profound morphological changes under these 
differentiation conditions (Figure 46B). The round colonies of the ESCs after two days 
flatten and enlarge and by day eight, the colonies have expanded with numerous cells 
branching out from them, forming the typical neural rosettes. At this point the cells are 
harvested and grown in the presence of FGF2 and EGF. Under these conditions there is a 
selection for the cells that have committed to NSC fate and in fact, after a few days these 
cells form neurospheres, which is a hallmark of their identity. The neurospheres are 
allowed to proliferate further and then gently disaggregated and allowed to outgrow. The 
cells at this stage now consist of a homogenous population of self-renewing NSCs that 
grow as adherent cells that can be indefinitely propagated and undergo multi-lineage 
differentiation to the three populations of oligodendrocytes, astrocytes and neurons [49]. 
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We confirmed the NSC identity of our cells by immunfluorescence for the neural 
progenitor marker, nestin (Figure 46C). The cells were almost completely negative for the 
markers of differented cell types, GFAP and beta III tubulin. Characterisation by RT-PCR 
for ESC and NSC markers showed that ESC markers Oct4 and Nanog were no longer 
expressed in these cells, while they maintained Sox2 expression and they upregulated 
neural specification markers such as Otx2 and Musashi (Figure 46D). Taken together, the 
ESC monolayer differentiation protocol worked optimally in our hands and the NSCs that 
we obtained are of true neural progenitor identity. 
 
 
Figure 46. Characterisation of the neural differentiation of WT ESCs. (A) Schematic representation of 
the different phases of monolayer differentiation protocol. (B) Characteristic morphology of the 
differentiating cells during the protocol. During the first phase (day zero to day eight), ESCs commit to 
neural fate. In the second phase, neural progenitors are selected and amplified. During this phase, the neural 
progenitors first proliferate as neurospheres (day 14) and then they adhere (day19) and neural progenitors 
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grow out from the spheres and can then be expanded as adherent population of NSCs. (C) 
Immunofluorescence for neural marker Nestin and markers for differentiated lineages GFAP for astrocytes 
and beta-III-tubulin for neurons. (D) RT-PCR for ESC markers Oct4 and Nanog, neural markers Otx2 and 
Musashi, and Sox2 which is expressed in both cell types. RPPO and GAPDH are housekeeper genes. 
 
During the neural specification of ESCs, several pro-neural genes are upregulated during 
this process, as can be seen from the qRT-PCR profiles for Sox1, Pax6 and nestin. RaLP 
expression was also investigated during the entire length of the differentiation protocol by 
qRT-PCR (Figure 47). As was seen previously, RaLP is upregulated on day two of 
differentiation when the epiblast is forming and then is downregulated. Interestingly, as the 
population contains neural progenitors and more differentiated progeny, RaLP was 
upregulated and steadily increased during the process and remained expressed in the 
homogenous population of NSCs at the end of the protocol (day 23). This suggests that 
RaLP has a dual function, firstly as an epiblast stem cell lineage gene then as a neural 
specific gene. 
 
 
Figure 47. Neural specification markers and RaLP expression by qRT-PCR during the neural 
differentiation of ESCs. Bars represent the means ± S.D. of triplicates. 
 
When RaLP WT and KO ESCs were subjected to the differentiation process, during the 
first few days RaLP KO cells seem to differentiate even faster than HT cells. This could be 
seen already by day two when the cultures contained larger flattened colonies compared to 
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the RaLP WT cultures. As the differentiation progressed, on day eight, the KO culture dish 
was completely covered with characteristic neural rosettes that were Nestin and Sox1 
positive whereas the WT cultures contained smaller neural rosettes (Figure 48). Although 
these differences were consistently observed, it was difficult to quantify and to 
characterise, as the population at these timepoints were heterogenous, consisting of 
committing neural progenitors, ESCs and as well as a small percentage of non-neural cells 
[85]. 
 
 
Figure 48. Immunofluorescence for pluripotent and neural differentiation markers of RaLP HT and 
KO ESCs during the first phase neural commitment. Cells have been stained for Oct4 and Nanog on day 
two. On days four, six and eight, cells were stained for Nestin and Sox1. As the cells progress through the 
differentiation, the formation of neural rosettes was observed. 
 
There are two possible explanations to this phenomenon of premature differentiation. The 
first is, a possible compensatory mechanism by another family member, which results in a 
sudden spurt of differentiation. There is evidence that the upregulation of p66ShcA is 
involved in this process [119] and in this study, the overexpression of p66ShcA resulted in 
an accelerated differentiation of these ESCs towards neural fate. It is possible that the 
absence of RaLP results in a “physiological” overexpression of p66ShcA, therefore 
resulting in the faster differentiation of the RaLP KO ESCs. The second explanation is 
based on our data that suggests that RaLP is involved in the process of ESC to EpiSC 
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transition. Perhaps the absence of RaLP causes an inefficient transition to EpiSC stage and 
directly goes through to the successive differentiation stages. 
The RaLP KO cells were nevertheless able to differentiate to NSCs as efficiently as the 
wild-type cells. The RaLP KO NSCs had similar morphology to the WT NSCs (Figure 
49A) and uniformly stained positive for nestin (Figure 49B). They showed very low 
presence of differentiated cell types such as astrocytes and neurons. Furthermore, the RaLP 
KO NSCs showed the exact same profile of markers as the WT NSCs, as they were no 
longer positive for ESC markers Oct4 and Nanog while they retained Sox2 expression and 
upregulated the neural markers Otx2 and Musashi (Figure 49C). 
 
 
Figure 49. Characterisation of ESC derived RaLP KO NSCs. (A) Bright field image of cells at the end of 
the differentiation protocol. The cells are homogenous and possess the characteristic bipolar shape of NSCs. 
(B) Immunofluorescence for neural marker Nestin and markers for differentiated lineages GFAP for 
astrocytes and beta-III-tubulin for neurons. (C) RT-PCR for ESC markers Oct4 and Nanog, neural markers 
Otx2 and Musashi, and Sox2 which is expressed in both cell types. RPPO and GAPDH are housekeeper 
genes. 
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According to this differentiation protocol, the absence of RaLP does not prevent the 
determination of ESCs to NSCs. As RaLP expression is brain specific, we investigated 
further whether the absence of RaLP could have effects on the capacity of these cells to 
differentiation to more specified lineages, the astrocytes and neurons. 
 
 
Figure 50. Astrocytic and neuronal differentiation of RaLP KO NSCs. Immunofluorescence for beta-III-
butulin to visualise the neurons and GFAP for the astrocytes. RaLP KO NSCs showed a defect in neuronal 
differentiation whereas they did not show an impairment in the differentiation towards astrocytes. 
 
The differentiation of RaLP WT, HT and KO cells towards neuronal fate showed that in 
the absence of RaLP there is a strong defect, as the number of neurons present in culture 
were dramatically lower in the KO (Figure 50). The KO neurons also showed less 
branching and as can be seen from the nuclear staining by DAPI, the cells have not 
organised into networks typically seen in neuronal cultures, that is evident in the WT: 
Interestingly, the capacity to undergo astrocytic differentiation did not seem perturbed in 
the RaLP KO culture, suggesting that RaLP might be involved specifically in the neuronal 
differentiation of NSCs. 
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5.2. Characterisation of RaLP WT and KO adult neural stem cells 
 
The effects of defective neurogenesis in the absence of RaLP could be due to a result of 
altered NSCs that have formed due to a non-upregulation of RaLP in the first time window 
of differentiation. In order to distinguish whether this could have affected the final capacity 
of the derived NSCs, we decided to use an alternative system to see whether we could also 
observe a defect in neuronal differentiation. This system consists in the direct the isolation 
of NSCs from the subventricular zone of the adult brain. It was possible to derive KO 
neurospheres as efficiently as the WT, confirming the result of ESC differentiation to 
NSCs. The derived neurospheres were then characterised for growth in vitro and 
differentiation abilities. 
When WT and KO neurospheres were plated and subjected to differentiation, the same 
neuronal defects were observed during the differentiation of RaLP KO NSCs. This 
protocol differs from the neuronal differentiation protocol used for ES derived NSCs, as 
both astrocytes and neurons are generated. The number of GFAP and beta-III-tubulin 
expressing cells were quantified by immunofluorescence. The number of astrocytes in the 
population did not differ between WT and KO (data not shown), whereas the percentage of 
neurons were significantly less in the KO (Figure 51). 
 
 
Figure 51. The differentiation of WT and KO adult NSCs isolated from the SVZ. The differentiation 
ability was analysed by immunofluorescence for neuronal marker beta-III-tubulin and astrocytic marker 
GFAP after 10 days of differentiation. The percentage of neurons in the cultures were calculated by counting 
the cells staining positive for beta-III-tubulin over the total number of cells by DAPI. Scale bar represents 50 
µm. ** p < 0.01. 
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Neurons undergo migration during their differentiation process, and we asked whether 
there is a defect in migratory abilities in the absence of RaLP in this context, as previous 
studies in our laboratory have shown that the intereference of RaLP expression in 
metastatic melanoma cells abrogates this ability [12]. We employed two different 
techniques to measure migration: the Boyden chamber and wound healing assay, in the 
presence and absence of serum, EGF and FGF2. We did not observe any differences in the 
migratory abilities between the WT and KO (data not shown), therefore excluding this 
possibility as an explanation to the neuronal differentiation defects. 
 
5.3. Characterisation of RaLP in the brain 
The in vitro data seems to suggest a specific neuronal defect in the absence of RaLP. We 
examined how RaLP expression varies during postnatal development, as in mice the 
development of the brain is very intense during these stages with synaptogenesis. RaLP 
expression gradually increases during this processs suggesting that it also has a function 
during postnatal development of the brain. 
 
 
Figure 52. RaLP expression during postnatal synaptogenesis. QRT-PCR analysis for RaLP expression on 
postnatal mice brains at different stages P1, P5, P10, P20, P30, P90 and P180. Expression levels of RaLP are 
relative to histone H3 used as housekeeper gene and calibrated to P1 stage. Bars represent the means ± S.D. 
of triplicates. 
 
Results 
 119 
Next, we decided to investigate whether this neuronal defect could also be seen in vivo. 
Adult brains were sectioned and stained for glial specific marker, GFAP and pan-neuronal 
marker, NeuN to analyse the proportions of these populations in the brain, however, there 
were no significant differences (data not shown) suggesting that RaLP probably enacts 
during the first stages of neuronal commitment from the neural stem cells/progenitors. 
Further characterisations of the brains are needed and are currently ongoing. 
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Discussion 
 
This study revealed novel aspects on the role of ShcD/RaLP, a new member of the Shc 
family of adaptor proteins, in the context of development and the formation of early 
lineages. The physiological role of this member was unknown previously to this study and 
our results support its role in the determination of epiblast fate and in the proliferation of 
epiblast stem cells (EpiSCs). We showed that RaLP is expressed in vivo, in the epiblast of 
the preimplantation and peri-implantation embryo and in vitro, during epiblast formation in 
the embryoid body, neural differentiation and EpiSC derivation of embryonic stem cells 
(ESCs). This expression pattern was unique for this family member, underlining its 
specific role in this developmental context. 
EpiSCs have been isolated from the early postimplantion embryo for the first time in 2007 
and represent a new tool in the research field of pluripotency [59,60]. These cells are a 
functionally distinct type of pluripotent stem cell from mouse ESCs and are a 
developmentally relevant system to directly study the mechanisms involved in 
specification events that occur during gastrulation, that cannot be done with ESCs [120]. 
EpiSCs express the core pluripotency factors Oct4, Sox2 and Nanog, however they are not 
able to contribute to blastocyst chimeras. Interestingly, these cells are morphologically and 
molecularly more similar to human ESCs and yet, they are derived from the 
postimplantation embryo while human ESCs are derived from the preimplantation 
blastocyst [43], raising many questions regarding the true identity and in vivo counterpart 
of these pluripotent stem cell populations. There are still many questions that have yet to 
be answered on how pluripotency is determined and maintained in these cells through the 
specific signalling pathways. 
The transition of the preimplantation epiblast to the postimplantation epiblast is very 
difficult to study in vivo due to their limited accessibility, quantity and low temporal 
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precision in this short window of time. The protocol recently published in 2009 by Guo 
and colleagues that allows the commitment of ESCs to EpiSC fate [78], provides a useful 
tool to dissect the mechanisms involved in this process. Furthermore, as described in the 
paper, these ES derived EpiSCs are comparable to the postimplantation derived EpiSCs, as 
their gene expression profiles and epigenetic markers are superimposible. We have shown 
in addition to this characterisation, that these cells can differentiate to embryoid bodies, 
providing a functional proof of their pluripotency. Through our studies on RaLP using this 
model system, we have analysed in detail the commitment of ESCs to epiblast fate and to 
our knowledge, we have described for the first time, a characteristic regulation of the 
pluripotency marker Oct4 and trophectoderm marker Cdx2 expression together with 
proliferation and apoptosis occurring during the differentiation and provided some insight 
into this uncharacterised process. 
Firstly, we observed an intriguing pattern of the regulation of Oct4 during EpiSC 
establishment. We found that Oct4 levels are downregulated generally in the whole 
population during the first passages of differentiation (most evident at passage three). The 
overall downregulation is dramatic and it involves the majority of the cells and to an extent 
that it is difficult to argue that the low levels is simply because of the selection process. In 
fact, such a dramatic downregulation is not accompanied by an equally high extent of 
apoptosis, suggesting that ESCs must first downregulate Oct4 to undergo commitment to 
EpiSC fate and then upregulate it again when it has become committed. 
Immunofluorescence for Oct4 on control cells also support the FACS data as there is an 
overall decrease in Oct4 intensity at these passages even in the cells growing in the EpiSC-
like colonies. This speculation is in line with the sudden increase in Oct4 levels at the 
following passage of differentiation (after two days), which cannot be due only to the 
proliferation of the few cells that have maintained Oct4 expression. This observation could 
be partially explained by the fact that Oct4 expression is regulated under different enhancer 
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elements [121]. In particular, ESCs use the distal enhancer while the proximal enhancer is 
used in the mouse postimplantation epiblast in vivo and has been found also by EpiSCs in 
vitro [75]. It has been shown that there is an enhancer switch during implantation and 
perhaps during this switch in enhancer usage in vitro, Oct4 expression is transiently 
downregulated. After this characteristic drop in Oct4 expression, by the following passage 
(typically by passage four or five of differentiation), Oct4 levels are increased overall in 
the population, indicating that the majority of the cells are pluripotent and have now 
committed to EpiSC fate, as can be seen by their morphology and their gene expression 
profile. 
Our approach with the multiparameter FACS analysis allowed us to dissect in detail not 
only Oct4 expression, but also its regulation in conjunction with apoptosis and 
proliferation occuring within the differentiating population, providing a useful method to 
simultaneously assess several events. In the absence of RaLP, we found that the 
commitment of ESCs to EpiSC fate is deregulated. The RaLP KO ESCs manifested a 
similar pattern of Oct4 regulation during the differentiation as the RaLP HT, however the 
reconstitution of the pluripotent population after the drop in Oct4 levels is not as efficient 
as in the controls, with Oct4 levels remaining lower. The analysis of proliferation and cell 
cycle phases of the Oct4 positive and negative population provided some insight to this 
observation. ESCs are able to undergo rapid symmetric cell division and this is 
accomplished by a shortened G1 phase and a constitutively active cyclin E (cdk2) that is 
independent of cell cycle phase that allows to bypass the restriction checkpoint R in the 
early G1 phase [122]. In fact, our analysis confirmed that within the ESC population, 
almost all Oct4 positive cells have incorporated EdU and therefore are in the S phase of the 
cell cycle. This was observed for both the RaLP HT and the KO ESCs. The Oct4 negative 
cells present in ESC cultures are cycling slower, as most of them are EdU negative and 
according to the DNA content, they are in G0/G1 or G2/M phase. As the cells are induced 
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to differentiate, also the Oct4 negative cells show an increase in EdU uptake as this 
population also acquires the ability to proliferate. During later passages, when the Oct4 
population is reconstituted, both the Oct4 positive and negative compartment in the HT 
continue to be proliferative with a clear subpopulation in the S phase, whereas in the KO 
there is a depletion of the proportion of cells in S phase even at passage four, indicating 
that in the absence of RaLP the Oct4 positive population are less proliferative. In fact, from 
these passages onwards, the time necessary to passage the KO cultures are approximately 
double that of the controls (every five to six days compared to every two days), indicating 
that the population is proliferating at a slower rate. This lower rate of proliferation was also 
confirmed by the lower growth curve of the KO during these passages. Even at late 
passages (passage 10), the RaLP KO EpiSC colonies are smaller in size and the majority of 
the population consists of Oct4 negative cells, suggesting that in this in vitro context the 
phenotype is not transient. 
The FACS analysis also revealed an interesting general pattern of Oct4 regulation during 
the cell cycle of ESCs and this relation has not been described to date. We observed that 
there is an increase in Oct4 expression with respect to the DNA content of the cell by PI. 
This increase is non-linear, meaning that it cannot be simply accounted for the fact that the 
cell is preparing for division. This kind of profile is characteristic of genes involved in 
proliferation, such as c-Myc. This aspect could be interesting for further studies. 
 “It is the population as a whole that is regulated rather than individual cells” [123]. The 
concept of cells within a population possessing functional heterogeneity was first 
suggested by Till and McCulloch using simple biological system to trace the fate of cells 
within the population. In fact, recent studies have provided insightful information on the 
heterogenic nature of both embryonic stem and adult stem cells, suggesting that this 
property might be an intrinsic characteristic of these cells. Using ESCs as a population 
system, it was possible to observe the intrinsic nature of these cells and how they were not 
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a homogenous but a heterogenous population of cells in different states, according to their 
transcriptional status. One of the first trancription factors that was found to be 
differentially expressed within the ESC population was Nanog. Under standard culture 
conditions, approximately 80% of cells express Nanog, while the remaining population do 
not [124,125]. The Nanog low population expresses Gata6, which is a transcription factor 
important for primitive endoderm formation. Interestingly, this heterogeneity is not a 
phenomenon of the presence of two distinct populations in culture, as the isolation of these 
two populations and culturing them separately restored this distribution, demonstrating that 
these populations interconvert. This heterogeneity is not an in vitro phenomenon, as it has 
also been seen in vivo. In the blastocyst stage, the inner cell mass expresses in a mutually 
exclusive manner, Nanog and Gata6 [126]. Furthermore, reinforcing the idea of the how 
these intrinsic transcriptional control is sensitive to extracellular signals, the expression of 
these factors in this way has been linked to the MAPK pathway signalling through the 
Grb2 adaptor protein, as the deletion of Grb2 results in the uniform expression of Nanog in 
the ICM at the expense of Gata6, resulting in the absence of primitive endoderm 
formation. 
We found that EpiSCs cultures are heterogenous cultures, consisting of Oct4 positive and 
negative cells, even at their steady state when the cultures are established. During the 
establishment of EpiSCs, we observed that the viable (cleaved Caspase-3 negative) Oct4 
negative cells within the population are cells expressing the extraembryonic marker of the 
trophoblast lineage, caudal-type homeobox protein (Cdx2). In contrast to the Oct4 
expressing cells that grow in tight contact with one another as colonies, the Oct4 negative 
cells are flattened, large and growing in isolation and they arise at the border of the 
colonies. These cells are proliferative as could be seen from the FACS analysis for EdU 
incorporation of the Oct4 negative cells, albeit at lower rates, co-exisiting with the Oct4 
expressing cells. The heterogeneity of EpiSC cultures has been studied with respect to the 
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presence of primordial germ cells (PGCs) and visceral endoderm cells that are generated 
spontaneously [127]. We have provided evidence that during the establishment of EpiSCs, 
Cdx2 positive cells also emerge. Interestingly, RaLP seems to play an important role in the 
formation and maintenance of the Oct4 positive population as in its absence, the 
population is made up by a majority of Cdx2 expressing cells, as was evidenced by 
immunofluorescence. These cells have been further characterised by markers and express 
several others of the trophoblast lineage, such as Hand1, Gata3 and TEAD4, and their 
levels were higher in the KO at passage four. An interesting question arises from this 
observation. From which cells do these Cdx2 positive cells originate from? There are three 
possible scenarios: (i) these cells are generated from ESCs together with the EpiSCs during 
the differentiation, (ii) the cells derive from an intermediate population that is generated 
during the differentiation or, (iii) the cells are continuously delineated from the EpiSCs 
once they are present in the culture. The first scenario is quite controversial, as numerous 
and important studies have already shown that mouse ESCs rarely generate 
extraembryonic lineages. In order to obtain trophoblast cells from ESCs, most studies 
required the genetic manipulation of key transcription factors of trophoblast development 
such as the knockdown of Oct4 [113], overexpression of Cdx2 [114], knockout of Sox2 
[128], and the genetic deletion of DNA methyltransferase Dnmt1 [117]. Up to date, only 
two studies have also shown that it is possible to generate trophoblast cells by the specific 
manipulation of cell culture conditions [115,116]. There is an observation that has been 
made during this study that could account for the second scenario. As described 
previously, during the early passages of differentiation there is an overall drop in Oct4 
levels. This “physiological” downregulation could create a window of time during which 
these metastable cells that have not yet committed to EpiSC fate, to either initiate the 
commitment definitively to EpiSC, to differentiate to another cell type that can survive 
under these culture conditions or undergo cell death. It could be possible that these 
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intermediate cells that are no longer ESCs nor EpiSCs yet (as can be seen from their gene 
expression profile) that do not apoptose and are unable to upregulate Oct4, (as was seen 
from the FACS analysis) then differentiate. It is known that Oct4 represses the expression 
of Cdx2, and Cdx2 is rapidly upregulated upon Oct4 downregulation in ESCs [114]. 
Perhaps this momentary downregulation of Oct4 during the differentiation allows these 
Cdx2 expressing cells to emerge. And for several passages, these cells persist in culture, as 
they do have proliferative ability but the majority are eventually eliminated with 
progressive passaging, as by late passages (around passage 10) their presence is a minority. 
This was also suggested by preliminary observations showing the presence of few Cdx2 
positive cells in the postimplantation embryo derived EpiSCs (data not shown). 
It has been reported that mouse EpiSCs can differentiate into extraembryonic tissues upon 
their stimulation by bone morphogenetic protein (BMP4) and the inhibition of the activin 
receptor [60] and we have also shown that trophoblast markers are upregulated upon the 
EB differentiation of ES derived EpiSCs. BMP4 also promotes the differentiation of 
human ESCs, which are considered to be similar to mouse EpiSCs, to trophoblast fate [70]. 
Furthermore, a persistent fraction of Oct4 negative cells with flattened morphology around 
the human ESC colonies has been observed [129]. These reports do support the notion that 
the Cdx2 positive cells observed during the derivation of EpiSCs could derive from the 
EpiSCs themselves. However, this ability has never been described within the context of 
normal EpiSC culture conditions where Fgf2 and Activin A are continuously present. More 
specific experiments are needed to provide a definitive answer. Furthermore, as Cdx2 is 
also expressed later during development in the endodermal gut lineages, in order to firmly 
confirm the trophoblast identity of these cells, it would be important to characterise them 
with more specific markers expressed solely in trophoblast lineages such as MASH-2, 
Placental Lactogen 1 (PL-1) and Trophoblast specific protein alpha (Tpbpa/4311) at the 
protein level. 
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To clarify the origin of the Cdx2 positive cells, one approach that could be taken is to 
investigate the lineage segregation occurring during the differentiation by clonal analysis. 
This approach however, could be accompanied by many difficulties as EpiSCs do not 
possess high clonogenic capacities as the ESCs [60]. An alternative to this approach, 
although less stringent, is to use the EpiSCs with Oct4-GFP [78] to separate the GFP 
positive and negative cells (using stringent gating or double sorting methods) and culture 
them separately to monitor the emergence of Cdx2 expressing cells. This would certainly 
be an important question to address in order to understand the identity and differentiation 
capacities of ESCs and EpiSCs, and to dissect the function of RaLP in balancing the two 
subpopulations emerging in culture during the derivation of EpiSCs. 
ESCs and EpiSCs are pluripotent cells and their self-renewal abilities are sustained by 
completely different mechanisms. This is an interesting aspect to investigate in terms of 
mechanisms underlying the regulation of signal transduction. For example, the same 
pathway that is responsible for triggering the differentiation of ESCs, the FGF/Erk 
pathway, is crucial for the maintenance of EpiSCs [59,60]. This implies that the pathway 
must be rewired in EpiSCs in order to be able to generate a different response upon the 
same stimulation. One possible mechanism to achieve this is by the differential expression 
of regulators of the pathway. As RaLP is expressed at very low levels in ESCs and is 
highly upregulated in EpiSCs and in the absence of RaLP we observed a defect in EpiSC 
commitment of ESCs, we believe that RaLP plays a role in the formation and maintenance 
of these cells and therefore is involved in the regulation of the pathways determining 
EpiSC fate and self-renewal. Although we have not yet conclusively dissected the pathway 
in which RaLP is implicated, our data have shown that the absence of RaLP during EpiSC 
formation results in an enhanced activation of the MAPK/Erk signalling pathway from 
passage two of differentiation when RaLP is upregulated. The higher levels of phospho-
Erk1/2 seen in the RaLP KO cells during the differentiation could be a direct or indirect 
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effect. The kinetics of the higher levels of phospho-Erk1/2 was very similar to the timing 
of the appearance of Cdx2 positive cells in culture. One could argue that the enhanced 
levels mirrors the composition of the culture, as Cdx2 expression has been demonstrated to 
be downstream of high Erk1/2 activation, in fact, the overexpression of a constitutive 
active form of Ras proto-oncogene is sufficient to obtain Cdx2 expressing trophoblast cells 
from ESCs [118]. Furthermore, we observed by immunofluorescence that the large 
flattened cells growing in isolation show intense nuclear localisation signal of phospho-
Erk1/2, suggesting that the non-EpiSC differentiated cells have higher levels of phospho-
Erk1/2 than the EpiSCs. In addition, we showed that also in this in vitro context of the 
commitment of ESCs to EpiSC identity, Cdx2 levels were correlated to Erk activation 
since its attenuation by the inhibition of MEK, resulted in a downregulation of overall 
Cdx2 levels during the differentiation. Taken together, the data suggests that the enhanced 
Erk1/2 activation in the RaLP KO cultures could be due to the presence of more 
differentiated cells in the population compared to the HT. This indirect effect of higher 
MAPK/Erk activation could be due to the deregulation of a signalling pathway in which 
RaLP is involved that cross-talks with the MAPK/Erk. However, the possiblity that higher 
phospho-Erk1/2 levels could be a direct effect of the absence of RaLP cannot be excluded. 
In this case, RaLP would function as a negative regulator of this pathway and it could be 
responsible for fine-tuning the final levels of Erk1/2 signalling during the differentiation to 
promote epiblast fate and shield the cell from taking on an extraembryonic fate. Such 
inhibitory role of signal transduction has been described for many adaptor proteins, such as 
Ruk for PI3K signalling [130], Grb10 for PI3K and MAPK signalling [131] and as well as 
p66ShcA for Ras and MAPK activation [132,133]. One possible mechanism that could be 
envisioned to achieve the attenuation of MAPK signalling by RaLP, is the competitive 
sequestration of one of the positive transducers of this pathway such as the Grb2 adaptor 
protein. It has been reported that RaLP possesses an extra Grb2 binding site, compared to 
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the three binding sites present in the other Shc family members [22]. A dramatic increase 
in RaLP protein levels, as was seen by western blot during the formation of the EpiSC 
stage, together with its higher capacity to bind to Grb2, could result in the attenuation or 
inhibition of this signalling pathway by sequestering it from transducing the signal. This 
possibility would certainly be worth investigating, for example by the first testing the 
interaction of RaLP with Grb2 by immunoprecipitation and then to assess the importance 
of RaLP in the negative regulation of MAPK by knocking down Grb2 in the RaLP KO 
background. 
Further studies are needed in order to assign the role of RaLP within a signalling pathway. 
To address this aspect, the postimplantation derived EpiSCs Oct4-GFP would be a 
valuable tool as it would allow us to directly investigate the immediate effects of the 
knockdown of RaLP on this pathway. Together with more detailed studies of the possible 
role of RaLP in MAPK/Erk1/2 signalling, there are two other candidate signalling 
pathways worth examining; the E-cadherin/β-catenin signaling and the BMP4/Smad 
pathway. The opposing effects of Ras-MAPK and the β-catenin signalling has been well 
studied for determining polarity in epithelial cells [134]. This study has demonstrated that 
prohibitin is necessary for MAPK/Erk activation and modulates cell adhesion and 
migration of epithelial cells. In the absence of prohibitin, more β-catenin is localized to the 
cell membrane at the level of the adherens junctions, resulting in less activation of its 
target genes. Interestingly, prohibitin has come up in our mass spectometry studies as a 
potential binding partner of RaLP (data not shown). Furthermore, our initial studies in the 
comparison of the glycogen synthase kinase 3β (GSK3β) activation, β-catenin and its 
target gene levels during the neural commitment of ESCs have shown that there is an 
upregulation of this signalling in the absence of RaLP during the time window 
corresponding to its expression (data not shown). It would be worth investigating whether 
RaLP could regulate the MAPK/Erk pathway by binding to and inhibiting prohibitin. The 
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absence of RaLP would result in an enhanced activation of Erk1/2, loss cell to cell contact 
and higher levels of β-catenin target genes, which would explain the phenotype we have 
observed. 
The BMP4/Smad pathway is another example of a signalling pathway that plays opposing 
roles in ESCs and EpiSCs. In ESCs, it is important for promoting pluripotency together 
with the LIF/STAT pathway by repressing non-neural differentiation [68]. A recent study 
using embryoid bodies as a model system to study epiblast commitment of ESCs have 
shown that in the two day window of epiblast formation (corresponding to when RaLP is 
expressed) BMP4 switches its function from maintaining pluripotency to promoting non 
neural differentiation [47]. The possible involvement of RaLP in this pathway should also 
be investigated. 
In the light of the studies using the ESC to EpiSC differentiation system, we obtained more 
information to better interpret previous experiments that did not allow us to understand the 
effects of the absence of RaLP. For example, the gene expression profiles during RaLP HT 
and KO ESCs during the EB differentation showed consistent differences on day two and 
three, of Oct4, Nanog and early germ layer marker levels between the genotypes. 
However, providing an explanation of the differential behavior of the markers was difficult 
in this context. The EB differentiation has recently been convincingly demonstrated to 
transit through the epiblast phase as it is possible to derive EpiSCs from day two of the 
differentiation [47]. If we apply our findings of the defect of proliferation of the pluripotent 
epiblast population that was observed in the absence of RaLP, we could speculate that 
perhaps in the context of the EB differentiation there is a similar defect. If this were true, it 
would mean that the pluripotent population cannot be sustained and proliferate as 
efficiently as in the HT and therefore result in the premature differentiation of the cells and 
hence the appearance of differentiated markers in anticipation and an immediate decrease 
in their expression (see Oct4, FGF5 and Brachyury expression). This is also in line with 
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what was observed with the neural commitment of ESCs, a protocol that has also just 
recently been shown to go through an epiblast stage and from which it is possible to derive 
EpiSCs (again, corresponding to the time-window of RaLP upregulation) [51]. Also in this 
context we observed a faster differentiation of cells depleted of RaLP starting from day 
two when RaLP is expressed. 
The in vivo assay of the differentiation potential, the teratoma assay, showed similar 
observations as for the EB and NSCs differentiation of ESCs. We found that in the absence 
of RaLP, the teratomas are reduced in size and the tumours contained a higher proportion 
of differentiated cells compared to the nondifferentiated proliferative part of the tumour 
compared to the HT. This seems to suggest that the absence of RaLP confers a 
proliferative disadvantage to the pluripotent intermediate population and faster 
differentiation. 
Despite the early expression of RaLP during development and the dramatic effects of its 
absence in the in vitro model of ESCs to EpiSCs transition, the RaLP KO mice are viable. 
This suggests that there are biochemical and/or functional compensatory mechanisms that 
enter to take part in the process in which RaLP is implicated. There are several possible 
scenarios that could be envisioned. The first more immediate one is the functional 
redundancy of a family member or its isoforms. For the latter, we checked carefully the 
expression of the two putative isoforms of RaLP by qRT-PCR during all the protocols that 
we have used for our studies and found that the levels of expression were very low that 
they can be considered not expressed (data not shown). Furthermore, we did not see any 
compensatory upregulation of both isoforms in the RaLP KO cells. The possible 
redundancy by another family member leaves us with only ShcA as the possible candidate, 
as the other two members ShcB and ShcC are not expressed during RaLP upregulation in 
epiblast formation. P66ShcA is an interesting member of the family to investigate, as in 
terms of protein structure and homology of sequence, it is the closest to RaLP. 
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Furthermore, the overexpression of p66ShcA was seen to result in the anticipation of 
neural differentiation of ESCs [119]. To explore this in more detail, it would be necessary 
to knockdown this Shc protein in the RaLP null background and perform the 
differentiation and analyse its effects. If the phenotype is even more striking, it might be 
worthwhile to consider generating a double KO mutant for p66ShcA and RaLP. 
Functional compensation mechanisms confer, to a certain extent, plasticity and adaptability 
to the organism. Especially during embryogenesis, the embryo is surprisingly compliant to 
adversities, such as the removal of blastomeres or exposure to various environmental 
stressors. They have evolved adaptive mechanisms that allow them to override 
unfavourable condition in order to be able to continue development [135]. If the RaLP null 
embryos have a smaller epiblast that is not below the threshold that threatens the viability 
of the embryo, such functional compensation mechanisms could permit such embryos to 
develop to term. It would be interesting to examine the RaLP KO embryos at the blastocyst 
stage to investigate whether there is a higher ratio of trophoectoderm cells versus the 
epiblast. 
In addition to these future studies, it would be important to confirm the results by the 
rescue of the RaLP KO phenotype. One approach would be to re-express RaLP in the 
RaLP KO ESCs and perform the ESC to EpiSC differentiation. However, considering that 
RaLP is not expressed in ESCs, its overexpression at this stage would result in a non-
physiological reconstitution of this protein as it would be expressed precociously and this 
might not yield clear-cut results. Furthermore, as RaLP is a regulator of signal 
transduction, besides the timing of expression, physiological protein levels must also be 
achieved. The ideal system for the phenotype rescue would be to mimic correctly both the 
level and timing of expression and this could be achieved by introducing the BAC 
containing RaLP cDNA together with its regulatory elements into ESCs. 
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RaLP showed a characteristic bi-phasic pattern of expression during embryogenesis, as it is 
transiently expressed in the early epiblast then re-expressed during the formation of the 
neural tube and the development of the central and peripheral nervous system. This pattern 
of expression was recapitulated in the in vitro neurogenesis system, strongly suggesting 
that RaLP may also play a role in this process. In parallel to the characterisation of RaLP 
in EpiSC formation and maintenance, we also began to investigate its function in 
neurogenesis using our RaLP HT and KO ESCs and adult neural stem cells isolated 
directly from the brain. Both systems evidenced a specific defect in neuronal 
differentiation of the NSCs, in the absence of RaLP. The ESC derived NSCs however 
show some restrictions in their neuronal differentiation ability, as they have been shown to 
preferentially generate inhibitory GABAergic neurons in vitro [136]. Preliminary studies 
of brain sections by immunohistochemistry of our WT and KO mice however, did not 
show significant differences in the neuronal population in the brain (data not shown). We 
think that RaLP is probably involved in early onset of neuronal differentiation. Further 
studies are currently being investigated to clarify the role of RaLP in this context. 
In summary, this study showed for the first time the involvement of the newest member of 
the Shc family of proteins, RaLP, in EpiSC formation and maintenance. Furthermore, we 
have described in detail the process of ESC commitment to EpiSC fate, which was not 
characterised before. We think that RaLP plays an important role in the switch of a key 
pathway/s involved in determining EpiSC identity and that the absence of RaLP perturbs 
the commitment process, resulting in an enrichment of the population of Oct4 negative and 
Cdx2 positive cells. This role is unique for this family member and provides an interesting 
insight in the mechanisms provided by an adaptor protein, that the cell has evolved to 
regulate signalling pathways in a cell specific manner. 
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